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Abstract 
Although the industrial era has undoubtedly improved standards of living, it has 
also resulted in a gradual but definite increase in atmospheric carbon dioxide 
levels. Consequently, undesirable weather events have intensified. Thus, the 
use of carbon dioxide as a feedstock is attractive, particularly if the reaction 
takes place under mild conditions. In this work, we utilise carbon dioxide in the 
conversion of epoxides to enantio-enriched cyclic carbonates, which may be 
used en route to the production of valuable pharmaceuticals. The application of 
aluminium(salen), chromium(salen), and cobalt(salen) catalysts enables this 
100 % atom-economical process to take place under 1 bar of CO2.  
The kinetic resolution of epoxides via the insertion of carbon dioxide has 
hitherto been reported only for cobalt(salen) complexes. Jacobsen’s study of 
kinetic resolution of epoxides using water as the ring-opening agent in the 
presence of the same cobalt(salen) catalysts showed that cobalt(salen) 
complexes form a “stepped” bimetallic transition state, which presents as a 
second-order rate dependence on catalyst. In this thesis, we show that ring-
opening with carbon dioxide may operate via a different pathway as a second-
order rate dependence on catalyst was not observed. Investigation of existing 
crystal structures of aluminium(salen), cobalt(salen), and chromium(salen) 
complexes in the Cambridge structural database were similarly inconclusive in 
demonstrating the relationship between the “step” of the complex and the 
enantioselectivity. 
Furthermore, we demonstrate the successful kinetic resolution of both phenyl 
glycidyl ether and N-(2,3-epoxypropyl)diphenylamine in the presence of 
aluminium(salen) and chromium(salen) complexes, which has not previously 
been reported. The maximum krel value obtained for N-(2,3-
epoxypropyl)diphenylamine as substrate was 15.38 with our aluminium(salen) 
catalysts, and 7.32 with our chromium(salen) catalysts. In contrast, the 
maximum krel value obtained using our cobalt(salen) complexes was 2.26.
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1. Introduction 
1.1. Hypotheses drawn from the hydrolytic kinetic resolution of epoxides 
In Jacobsen’s hydrolytic kinetic resolution (HKR) of terminal epoxides, chiral 
cobalt(salen) complexes ring-open epoxides in the presence of water to form 
the diol enantioselectively. These catalysts are not only highly enantioselective 
(krel>50 for almost all substrates studied, where 𝑘𝑟𝑒𝑙 =
ln(1−𝑐(1+𝑒𝑒))
ln(1−𝑐(1−𝑒𝑒))
),1 but are 
also applicable to a large range of substrates.  
In the presence of a co-catalyst such as a tetrabutylammonium halide salt, 
Jacobsen’s chiral catalysts utilise carbon dioxide instead of water as the ring-
opening agent to produce cyclic carbonates (Scheme 1). Literature precedent 
shows that this reaction is similarly enantioselective. However, 
enantioselectivity in the formation of cyclic carbonates from epoxides and CO2 
has hitherto been observed only with cobalt(salen) catalysts (Section 1.5.2, 
page 11),2-5 i.e. similar metal(salen) catalysts have failed to generate enantio-
enriched cyclic carbonates.6-8 Consequently, we desired to establish if the 
conclusions drawn from Jacobsen’s mechanistic studies could be used to 
elucidate reasons for this unique characteristic of cobalt(salen) complexes.9 
 
Scheme 1: Conversion of epoxides to 1,2-diols via the HKR process (left),1 and to cyclic 
carbonates using Jacobsen's catalysts (right). 
 
In the HKR process, stereoselectivity is conferred by the structure of the 
bimetallic transition state. Although each chiral cobalt(salen) molecule may 
appear to take on a planar arrangement about the metal centre (Figure 1, left), 
both crystal structures and computational methods indicate otherwise. Figure 1 
(right) clearly displays a significant tilt of both aryl rings with respect to the 
equatorial plane, which is described as a “step”. The comparable activities of 
cobalt(salen) catalysts with similar steps, but different diamine backbones, is 
verification of the importance of the step produced as opposed to the identity of 
the backbone itself. 
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The putative transition state is formed by the activation of substrate by one 
catalyst molecule (Figure 1, top right), and the separate activation of water by a 
second catalyst molecule from the bottom. It follows that the framework 
significantly hinders the approach of a mismatched epoxide molecule. Approach 
of the mismatched epoxide is further inhibited by bulky substituents on the aryl 
rings, as corroborated by enhanced selectivity conferred by catalysts with larger 
functional groups at the 5,5’ position. On the other hand, the R-group of the 
preferred isomer of substrate projects out into open space (Figure 1, coloured 
black). As a result, these catalysts are able to kinetically resolve a wide range of 
epoxides without loss of enantioselectivity. Thus, Jacobsen demonstrates that 
the stepped conformation of chiral cobalt(salen) catalysts, in combination with a 
bimetallic transition state, confers stereoselectivity in the HKR process.9 
 
 
Figure 1: Transition structure formed between two molecules of (S,S)-N,N′-bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediaminocobalt(III) hydroxide and one molecule of (R)-propylene 
oxide. The grey dashed line indicates bond breaking. The blue dashed line indicates bond 
formation. The R-group of the epoxide (coloured black) projects into unhindered space which 
explains the broad substrate scope of Jacobsen’s catalyst.9 
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There are therefore two hypotheses to be tested for the enantioselectivity of 
cobalt(salen) catalysts in cyclic carbonate synthesis: 
1. The rate is second order w.r.t. cobalt(salen) catalysts, but not w.r.t. 
aluminium(salen), or chromium(salen) catalysts. 
2. Out of the three metal(salen) systems we propose to study, 
cobalt(salen) complexes exhibit the most pronounced tilt.  
1.2. Industrial importance of cyclic carbonates 
Cyclic carbonates are industrially important in a wide range of applications such 
as being used in extraction media and the production of plastics and 
electrolytes.10 As cleaning agents, they are also superior to conventional 
options.11-13 For example, propylene carbonate, which remains liquid over a 
wide range (-48 °C to 242 °C) and can therefore be used at elevated 
temperatures,10 is soluble in both water and several organic solvents. 
Additionally, it is easy to recover, low in viscosity, and has good solvating 
capabilities. Ethylene carbonate (liquid over 36 °C to 246 °C) is similarly 
versatile, with an added characteristic of being solid at room temperature. 
Ethylene carbonate may be used as solvent with or without propylene 
carbonate in the spinning of polyacrylonitrile solutions.14 
     
Based on factors such as environmental impact, recycling issues, and both 
acute and chronic effects on human health, both propylene carbonate and 
ethylene carbonate are excellent alternatives to traditional hazardous 
solvents.15,16 That said, cyclic carbonates are used not only as inert media, but 
also as reactive intermediates. For instance, they undergo reaction with 
carboxylic acids, diols, and amines to produce hydroxyalkyl esters, 
polycarbonates, and hydroxyalkylurethanes.17,18  
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Although cyclic carbonates are frequently used as racemic mixtures, 
enantiopure cyclic carbonates are equally, if not more, valuable materials. In 
particular, they may be readily converted into carboxylic esters, amino acids,19 
and ureas, to be used en route to the production of pharmaceutically important 
compounds.20 In medicines where enantiopurity is pertinent, the consumption of 
single-isomer drugs would alleviate unintended side-effects arising from the 
consumption of the undesired isomer.21,22 An example supporting the cause for 
enantiopure pharmaceuticals is the drug Citolopam, where only the (S)-
enantiomer exhibits an antidepressant effect.23 
However, the cost of enantiopure cyclic carbonates remains prohibitive. 
According to 2013 chemical catalogue prices on a lab scale, prices exceed 
GBP 20,000 dm-3. Given the fact that several therapeutic groups are 
stereoisomeric mixtures, pharmacists have identified chirality in drugs as an 
“across-the-board” problem.24 The downstream effects of making enantiopure 
cyclic carbonates more affordable, would therefore impact many users. 
1.3. High-yielding methods for cyclic carbonate production 
The traditional route for the large-scale production of dimethyl carbonate 
involved using phosgene (COCl2) as a C1 building block. When passed through 
methanol in the presence of concentrated sodium hydroxide, dimethyl 
carbonate is produced in good yield and purity.25,26 However, the high toxicity of 
phosgene will likely see its large-scale use being phased out in favour of safer 
alternatives.27 
One such phosgene-free route for the commercial production of dimethyl 
carbonate involves oxidising cuprous chloride in methanol at 70 °C and 8 atm, 
followed by the addition of carbon monoxide. The reaction is almost entirely 
selective in producing dimethyl carbonate from methanol,28 and is industrially 
viable on a 12 000 tonne/y scale.10 
Likewise, phosgene is unneccesary for the production of propylene carbonate. 
Sakakura et al. used homogenous catalyst 1a for the 100 % atom-economical 
formation of propylene carbonate from propylene oxide and supercritical CO2 
with excellent yield and selectivity (Scheme 2). Problems typically encountered 
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during catalyst/product separation were neatly sidestepped due to phase 
separation concurrent with the accumulation of propylene carbonate. Removal 
of the lower phase containing the desired product, followed by replenishment of 
epoxide, enabled catalyst recycling without significant loss of activity for three 
consecutive runs.29 
 
Scheme 2: Synthesis of propylene carbonate from propylene oxide by Sakakura et al.29 
 
In 2008, Yin and Shimada reported 98 % yield of propylene carbonate using 
robust bismuth complex 1b (Scheme 3). Such complexes are postulated to 
behave as Lewis acids, and are highly active at ambient temperature and 
pressure (1 atm CO2, 25 °C),30 resulting in an net consumption of CO2 on top of 
100 % atom economy. It follows that similar reactions not requiring heating, 
cooling, or pressurising, represent excellent sequestration options for CO2.  
  
Scheme 3: Synthesis of propylene carbonate by Yin and Shimada.30 
 
As a direct result of deforestation and fossil fuel combustion, CO2 levels have 
risen by 35 % since the industrial era. Because CO2 both absorbs and emits 
infrared radiation, an increase in levels produces a warming effect on the 
Earth’s climate. In turn, heat waves, downpours, and similar extreme weather 
conditions are intensified,31,32 hence the urgent need for CO2 capture and 
sequestration.33 Furthermore, being non-toxic, abundant, cheap, and 
renewable, CO2 is an environmentally-friendly and affordable feedstock in the 
large-scale manufacture of carbonates.25  
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While many metal(salen) catalysts have been known to catalyse the synthesis 
of  racemic carbonates from epoxides, the production of enantiopure cyclic 
carbonates is far more difficult. While stereoselective synthesis from 
enantiopure epoxides may be achieved with relative ease,8,34 it remains an 
extremely costly option. To illustrate, 2013 chemical catalogue prices for 
enantiopure propylene oxides (99 % purity) exceeds GBP 20,000 dm -3. In 
contrast, the same catalogue indicates a mere GBP 25 dm-3 price tag for the 
racemate (99 % purity). Therefore, from a commercial perspective, the 
production of enantiopure carbonates from inexpensive racemic terminal 
epoxides via chiral catalysts would be advantageous. 
1.4. Basis for the kinetic resolution of cyclic carbonates using metal(salen) 
catalysts 
Because salen complexes are active for a broad range of reactions, they have 
been described as “privileged”.35 For instance, besides being used in the HKR 
process and our desired synthesis of cyclic carbonates from epoxides, 
metal(salen) complexes are also used in the epoxidation of alkenes36-38 and in 
the formation of oxazolidinones from epoxides and isocyanates.39,40  
Chiral cobalt(salen) catalysts are able to carry out kinetic resolution because 
they form diastereomeric transition states with enantiomers (Figure 2). As a 
result one pathway has a lower activation energy than the other, thus favouring 
the formation of one enantiomer of the desired product. Ideally, the reaction 
would come to a standstill on depletion of the favoured enantiomer, thus 
producing a theoretical maximum yield of 50 % from racemic substrate.  
 
Figure 2: Energy profile diagram for a theoretical kinetic resolution where ΔG‡ is the Gibbs energy 
of activation. Enantiomers are equivalent in energies, but the diastereomeric substrate-catalyst 
transition states have distinct energies. This produces different rates of reaction for each 
enantiomer. 
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Jacobsen demonstrated that the step of the salen ligand is crucial to the 
stereoselectivity of the HKR process. These stepped, chiral ligands are readily 
synthesised from the desired corresponding salicyaldehydes and diamines, 
enabling easy modification of their electronic and steric properties.41 Careful 
selection of the desired synthon allows functional groups to be tacked onto the 
phenyl rings or the diamine bridge, with immobilisation onto solid supports as a 
further option.42-46 A variety of metals also readily undergo complexation with 
salen ligands in a tetradentate fashion, to form monometallic, bimetallic, and 
polymetallic complexes.34,43,47  
Our initial plan was to synthesise a variety of metal(salen) complexes (Figure 3)  
which preserve the ligand structure to determine how the identity of the metal 
affects the kinetic resolution of terminal epoxides. The activity and 
enantioselectivity of catalysts 2a to 4c was then investigated to study the 
relevance of the two hypotheses discussed earlier. 
 
Figure 3: Structures of metal(salen) complexes 
1.5. Literature Precedent 
Until recently, researchers in the field have utilised either styrene oxide or 
propylene oxide as substrates. Examples of literature precedent have been 
limited to the use of propylene oxide as substrate where possible. However, 
aluminium(salen) complexes studied by the North group have utilised styrene 
oxide as substrate instead.6,34,43 Similarly, phenyl glycidyl ether has been used 
as an alternative substrate for metal-free catalysis in recent years.48-50 
Nonetheless, the research presented herein retains relevance as this thesis 
makes use of both styrene oxide and phenyl glycidyl ether. 
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1.5.1. Aluminium(salen) complexes 
North et al. demonstrated ca. 10 % conversion of styrene oxide to styrene 
carbonate using catalyst 5a under solvent-free conditions (1 atm CO2, 25 °C, 
400 min, 2.5 mol % 5a w.r.t. epoxide, 2.5 mol % tetrabutylammonium bromide 
w.r.t. epoxide). In contrast, bimetallic aluminium(salen) complex 5b afforded ca. 
50 % conversion under identical conditions. After 24 h at room temperature, 
catalyst 5b at 2.5 mol % catalyst loading afforded 98 % conversion of styrene 
oxide using 1 atm of CO2 when used in combination with tetrabutylammonium 
bromide (1:1 ratio).34 Optimal yields were obtained using monosubstituted 
epoxides. 77 % yield of propylene carbonate was obtained after 3 h (1 atm CO2, 
0 °C, 2.5 mol % 5b w.r.t. propylene oxide, 2.5 mol % tetrabutylammonium 
bromide w.r.t. epoxide. No byproducts resulting from polymer formation, 
epoxide hydrolysis, or epoxide rearrangement were detected.  
 
Since the reaction was carried out without solvent, propylene carbonate was 
purified by distillation from the reaction flask. Catalyst reusability was 
demonstrated for 60 consecutive runs by replenishing the vessel containing 
catalyst residue with fresh propylene oxide and CO2. Any loss of activity was 
attributed to decomposition of tetrabutylammonium bromide. Addition of fresh 
tetrabutylammonium bromide co-catalyst restored activity. 
Mechanistic studies showed that two molecules of tetrabutylammonium bromide 
are involved in the reaction (Scheme 4). The first generates a tributylamine 
molecule to be used in the activation of carbon dioxide, while the second 
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molecule ring-opens the terminal end of the coordinated epoxide. The 
coordination of the bimetallic complex to both the epoxide and the activated 
CO2 in the rate-determining step then sets up an intramolecular reaction to form 
the carbonate.6 Although reactions using only (R)-styrene oxide afforded 
enantiomerically pure styrene carbonate as assessed by chiral HPLC,34 
indicating retention of the stereocentre, kinetic resolution of styrene carbonate 
was not observed. 
 
Scheme 4: Proposed mechanism for the formation of cyclic carbonate from epoxides and CO2 
using catalyst 5b adapted from Clegg et al.34 Notably, only one molecule of catalyst is proposed to 
be involved in the rate-determining step. 
 
A single-component catalyst (5c) containing both Lewis acid and quaternary 
ammonium bromide elements produced 97 % conversion of styrene oxide 
under ambient conditions (1 atm CO2, 25 °C, 6 h, 2.5 mol % 5c w.r.t. styrene 
oxide).43 Catalytic activity was proven for nine additional terminal epoxides and 
retained the stereochemistry of the substrate. Having eliminated the need for a 
separate addition of tetrabutylammonium bromide, immobilisation on various 
supports was performed to facilitate application in continuous flow reactors. 
Using catalyst 5c immobilised on polystyrene, 100 % yield to styrene carbonate 
was obtained in an initial run, which decreased to 70 % after three consecutive 
runs.43 
A modified version of complex 5c immobilised on amorphous silica (5d) was 
then packed into a column which was installed in a gas-phase continuous flow 
reactor. Thee conversion of waste CO2 into cyclic carbonates using this single-
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component immobilised catalyst in simulated flue gas streams was then 
investigated. Using a gas stream of 21 % CO2 at 60 °C, catalyst 5d converted 
97 % of the CO2 introduced into ethylene carbonate over 7 h. Further testing 
demonstrated that the catalyst was robust enough to withstand exposure to 
typical flue gas components such as NO (661 ppm), NO2 (36 ppm), and SO2 
(1700 ppm). In comparison, flue gas streams of power stations powered by 1 % 
sulphur bituminous coal are usually about 90 % of those levels.43 Given the 
near-complete consumption of CO2, the ability of the catalyst to tolerate 
exposure to flue gas contaminants, and the widespread availability of 
inexpensive aluminium supplies, scale-up of this technology would be a highly 
promising alternative to carbon-capture. 
 
Alternatively, aluminium(salen) complexes containing phosphonium salts 
instead of quaternary ammonium halides may be used as single-component 
catalysts with enhanced thermal and moisture stability. This enabled 
experiments to be carried out at temperatures of up to 120 °C, which afforded 
turnover frequencies of 1760 h-1. However, there was an upper limit of 140 °C, 
after which catalyst decomposition occurred as evidenced by decreased 
conversion and turnover frequency. The best runs using catalyst 5e were 
performed at 100 °C, producing 88.6 % conversion (19.7 atm CO2, 4 h, 0.025 
mol % Al(III) w.r.t propylene oxide).7 
O
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1.5.2. Cobalt(salen) complexes 
Unlike aluminium(salen) complexes, cobalt(salen) complexes are known to be 
capable of carrying out a kinetic resolution of epoxides. In 2004, Lu et al. 
reported that complex 6a gave up to 70.2 % ee propylene carbonate in favour 
of the (S)-isomer at 40 % conversion in the presence of tetrabutylammonium 
chloride as co-catalyst (krel = 8.99). Good conversions ranging from 48.2 % to 
52.4 % were obtained (11.8 - 14.8 atm CO2, 0 °C, 15 h, 0.1 mol % Co(III) w.r.t. 
epoxide, 0.2 mol % tetrabutylammonium chloride w.r.t. epoxide). Further 
experiments revealed that bulkier counterions on Co(III) enhanced 
enantioselectivity. Higher yields but lower enantioselectivities were observed at 
higher temperatures.2 Berkessel and Brandenburg later used the same catalyst 
to obtain 65 % ee of propylene carbonate with a 36 % yield with a krel of 6.69 
(1.0 atm CO2, -20 °C, 18 h, 0.1 mol % Co(III) w.r.t. epoxide, 0.5 mol % 
tetrabutylammonium chloride w.r.t. epoxide).3 
A similar multi-chiral Co(III)salen catalyst (6b) in conjunction with 
bis(triphenylphosphine)iminium-2,4-dinitrophenoxide (PPN+DNP-) later elevated 
enantioselectivity to an unprecedented 97.1 %. Using racemic propylene oxide 
as substrate, 6b afforded 10 % conversion to (S)-propylene carbonate (8.2 atm 
CO2, - 25 °C, 12 h, 0.05 mol % Co(III) w.r.t. epoxide, 25.0 mol % PPN+DNP- 
w.r.t. epoxide), giving a krel of 75.58. The amount of co-catalyst used was 
deliberately increased to favour the formation of cyclic carbonate over 
polycarbonate. The presence of a bulky cation and an anion with poor leaving 
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ability were found to be crucial factors in maximising the extent of kinetic 
resolution.4 
 
Application of a related chiral salen catalyst 6c to racemic propylene oxide and 
carbon dioxide afforded 83 % ee of propylene carbonate in 45 % yield (krel = 
21.79) in favour of the (S)-isomer (5 atm CO2, 25 °C, 3 h, 0.1 mol % Co(III) 
w.r.t. epoxide, 0.01 mol % 1-butyl-3-methylimidazolium hydroxide w.r.t. 
epoxide). Both enantioselectivity and activity were improved by lowering 
catalyst loading or by adding an inorganic base such as KOH, K2CO3 or 
KHCO3. The effect was more pronounced with stronger bases, which facilitated 
CO2 adsorption onto the base.51 
In continued research, Jang, Jang, Kim, and Kim reported that the 
enantioselectivity of a chiral Co(III)-Co(BF4)2 salen catalyst could be enhanced 
by immobilisation. Immobilisation was achieved by a straightforward reflux of 
the homogeneous Co(III)-Co(BF4)2 salen catalyst with the silica-alumina support 
in THF for 5 h. The resultant heterogeneous system (6d) afforded up to 65 % 
ee of (S)-propylene carbonate (10.0 atm CO2, 25 °C, 14 h, 1.0 mol % Co(III) 
w.r.t. epoxide) in ca. 25 % conversion (krel = 5.39). The proximity of the support 
hinders the approach of the reactant epoxide to the Co(III) centre, which was 
confirmed by a decreased enantioselectivity of 45 % ee using the 
homogeneous catalyst (krel = 3.09).  
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Despite the non-covalent nature of the catalyst-support bonds, multiple washes 
with polar solvents did not detach catalyst from the support. Catalyst recycling 
was proven for up to three times - any loss of enantioselectivity was attributed 
to the detachment of the metal from the support and could be easily restored by 
attaching more homogeneous catalyst. Furthermore, the system was 
responsive to only (S)-propylene oxide, leaving (R)-propylene oxide largely 
unchanged at the end of the run.5  
 
Interestingly, this sense of chiral discrimination is largely true for the complexes 
described in this section – (R,R)-cobalt(salen) complexes favour the formation 
of the (S)-propylene carbonate over the other isomer. Jacobsen observed the 
same phenomenon in the conversion of epoxides to diols as the bimetallic 
nature of the putative transition structure and the step of the salen ligand 
causes coordination of the mismatched enantiomer to be energetically 
unfavourable. The literature precedent for cobalt(salen) catalysts in the 
conversion of epoxides to cyclic carbonates reinforces the notion that both 
mechanisms are intrinsically linked. 
1.5.3. Chromium(salen) complexes 
The ability of chromium complexes to convert terminal epoxides to cyclic 
carbonates was first demonstrated by Kruper and Dellar.52 Turnover numbers of 
10,000 were observed for terminal epoxides as substrate at 50 atm CO2 and 
temperatures of 60 to 80 °C for 16 to 48 h. Paddock and Nguyen later designed 
chromium(salen) catalysts, which could be produced in improved yields in 
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comparison with the chromium(porphyrin) complexes. It was noted that the 
performance of meso complex 7a was significantly superior to that of the 
racemic anagolue (trans complex 7b).  A turnover number of 507 was obtained 
after 2 h (7.0 atm CO2, 75 °C, 1.0 mol % 7a w.r.t. propylene oxide, 1.0 mol % 
(4-dimethylamino)pyridine w.r.t propylene oxide, 0.5 mL dichloromethane as 
solvent). In contrast, the racemic trans complex 7b afforded a lower turnover 
number of 253 as the coordination site was less accessible than in the meso 
complex. A 100 % yield of propylene carbonate was obtained under optimized 
conditions (3.5 atm CO2, 75 °C, 1.5 h, 1.0 mol % 7a w.r.t. propylene oxide, 1.0 
mol % (4-dimethylamino)pyridine w.r.t. propylene oxide).8 
 
Undesirable polycarbonate formation may be avoided by judicious selection of 
reaction conditions, such as increasing the amount of co-catalyst present. By 
using a 2:1 ratio of (4-dimethylamino)pyridine: Cr(III), Chen et al. obtained only 
monomeric propylene carbonate (92.7 % yield, 14.8 atm CO2, 40 °C, 3 h, 0.05 
mol % 7c w.r.t. propylene oxide, 0.1 mol % (4-dimethylamino)pyridine w.r.t. 
propylene oxide). The authors postulated that initial polymer formation is 
followed by depolymerisation via back-biting on coordination of (4-
dimethylamino)pyridine to the Cr(III) centre.53 
A variation on the ligand involved putting a bulky nucleophile on the diimine 
bridge of the salen ligand to produce a single-component catalyst 7d. Under 
optimum conditions, 7d produced a 42.4 % yield of propylene carbonate (19.7 
atm CO2, 80 °C, 1 h, 0.02 mol % Cr(III) w.r.t. epoxide). However, the presence 
of N-methylimidazole, whether covalently attached to the salen ligand via a 
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flexible arm or added separately, suppressed catalytic activity. This decrease in 
activity was attributed to competitive coordination of N-methylimidazole to the 
central Cr(III) ion thus hindering approach of the epoxide. As such, bulky co-
catalysts are necessary to ensure high activity. In addition, like the 
aluminium(salen) complexes discussed briefly under Section 1.5.1, the 
chromium(salen) catalysts were able to preserve the stereochemistry of the 
substrate, but were unsuccessful in producing enantiopure cyclic carbonates 
from racemic epoxides.54  
 
However, chromium(salen) catalysts have been reported to kinetically resolve 
epoxides using trimethylsilyl azide as the ring-opening agent, with a second-
order rate dependence on catalyst. One chromium(salen) molecule coordinates 
to the ring-opening azide anion while the other activates the epoxide. Jacobsen 
et al. obtained 76 % conversion of styrene oxide to several side products, 
presumably including azido silyl ethers (Scheme 5). Although undesirable 
decomposition of the substrate was also observed, the e.e. of remaining 
substrate was an excellent 98 % in favour of the (R)-isomer. Studies carried out 
on the remaining catalyst residue showed that the active catalyst (7f) was 
generated in situ.55 
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Scheme 5: Kinetic resolution of styrene oxide via ring-opening with trimethylsilyl azide using pre-
catalyst 7e by Jacobsen et al.55  
 
Jacobsen then extended this methodology to the kinetic resolution of propylene 
oxide. The use of active catalyst 7f instead of pre-catalyst 7e afforded the ring-
opened product in much-improved yield and selectivity (98 % and 97 % 
respectively) with a krel of 230 (Scheme 6). It is implicit that the unreacted 
propylene oxide removed by rotary evaporation was the (R)-isomer.56  
 
Scheme 6: Kinetic resolution of propylene oxide via ring-opening with trimethylsilyl azide using 
active catalyst 7f by Jacobsen et al.56  
 
Although kinetic resolution of epoxides using trimethylsilyl azides in the 
presence of chromium(salen) catalysts has been successfully demonstrated, 
kinetic resolution using carbon dioxide as the ring-opening agent has yet to be 
established. 
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1.5.4. Metal-free catalysts for the conversion of epoxides to cyclic carbonates 
Although tetrabutylammonium halides are usually used as co-catalysts,2,3,6 they 
do exhibit catalytic activity when used alone. Calό et al. demonstrated that 
using molten 8a as solvent effectively converts mono-substituted epoxides to 
cyclic carbonate (Scheme 7). (Phenoxymethyl)-ethylene carbonate was 
obtained in 90 % yield in one hour (1.0 atm CO2, 120 °C, 20 g substrate, 50 g 
tetrabutylammonium halide). The bromide anion is thought to attack the less 
hindered end of the epoxide, generating an activated oxo-species which then 
reacts with CO2 and ring-closes to afford cyclic carbonate product (Scheme 
8).48 
 
Scheme 7: Synthesis of (phenoxymethyl)ethylene carbonate by Calό et al.48 
 
 
Scheme 8: Postulated mechanism for the formation of cyclic carbonate from epoxides and CO2 
using molten tetrabutylamonium halides as catalyst, showing nucleophilic attack at the 
unsubstituted position of the epoxide.48  
 
Aoyagi, Furusho, and Endo later demonstrated the synthesis of cyclic 
carbonates under ambient conditions using ammonium iodide 8b in the 
presence of 1-methyl-2-pyrrolidone as solvent (Scheme 9). (Phenoxymethyl)-
ethylene carbonate was obtained in 85 % yield (1 atm CO2, 25 °C, 24 h, 5 mol 
% 8b w.r.t. epoxide, 0.2 mL 1-methyl-2-pyrrolidone as solvent). The yield was 
increased to 97 % at 45 °C.49 
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Scheme 9: Synthesis of (phenoxymethyl)ethylene carbonate by Aoyagi, Furusho, and Endo.49 
 
Continuation of the above work showed that when secondary alcohols were 
used as solvent instead of 1-methyl-2-pyrrolidone, phosphonium iodide 8c 
performed better than ammonium iodide 8b. The catalytic system was 
remarkably active even under ambient conditions (Scheme 10). The use of 2-
propanol and 1-methoxy-2-propanol as solvent produced optimal conversions to 
cyclic carbonate (97 % and 99 % yield of (phenoxymethyl)ethylene carbonate 
respectively, 1 atm CO2, 25 °C, 24 h, 5.0 mol % 8c w.r.t. epoxide, 0.2 mL 
solvent). In contrast, the yield of (phenoxymethyl)ethylene carbonate dropped 
drastically to 2 % when 1-methyl-2-pyrrolidone was used as solvent instead. 
Thus the authors postulated that the solvent activates the epoxide via hydrogen 
bonding. Meanwhile, the identity of the halide anion was demonstrated to be  
crucial to catalyst activity since it was responsible for both epoxide activation 
and leaving during the ring-closing step.50  
 
Scheme 10: Synthesis of (phenoxymethyl)ethylene carbonate by Aoyagi, Furusho, and Endo.50  
 
It is unclear if kinetic resolution is possible with metal-free catalysts since no 
mention is made of enantioselectivity. However, the lack of chirality in 
ammonium and phosphonium salts studied to date forbids the formation of a 
diastereomeric catalyst-substrate transition state and therefore discrimination 
between enantiomers would be impossible.  
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1.5.5. Summary of literature precedent 
Table 1 provides a summary of selected literature prior to the start of this 
project. We postulate that the ability of cobalt(salen) complexes to carry out a 
kinetic resolution may be caused by two fundamental differences - thus leading 
to our two hypotheses as given on page 3. Following synthesis and 
characterisation of the proposed metal(salen) complexes shown on page 7, we 
will make use of kinetic analyses and X-ray structure analysis to test the two 
hypotheses. Greater understanding of the subject will facilitate later enhanced 
catalyst design.  
Table 1: Synthesis of cyclic carbonates from epoxides and CO2 using aluminium, cobalt, 
chromium, zinc, and alternative metal-free catalysts. 
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1 5a (2.5) TBAB (2.5) 1.0 25 6.7 ca.10 (SC) -  6 
2 5b (2.5) TBAB (2.5) 1.0 25 6.7 ca. 50 (SC) -  6 
3 5c (2.5) - 1.0 25 6 97 (SC) -  43 
4 5d (NA) - 1.0 25 20 69 (SC) -  46 
5 5e (0.025) - 19.7 100 4 89 (PC) -  7 
6 6a (0.1) TBAC (0.2) 15.0 0 15 40 (PC) 70 8.99 2 
7 6a (0.1) TBAC (0.5) 1.0 -20 18 36 (PC) 65 6.69 3 
8 6b (0.05) PPN+DNP- (25.0) 8.2 -25 12 10 (PC) 97 75.58 4 
9 6c (0.1) BMIOH (0.01) 5.0 25 3 45 (PC) 83 21.79 51 
10 6d (1.0) - 10.0 25 14 65 (PC) 25 3.09 5 
11 7a (1.0)a DMAP (1.0) 3.5 75 1.5 100 (PC) -  8 
12 7b (0.075)a DMAP (0.075) 6.8 75 2 19 (PC) -  8 
13 7c (0.05) DMAP (0.1) 14.8 40 3 93 (PC) -  53 
17 7d (0.02) - 19.7 80 1 42 (PC) -  54 
18 8a (bulk) - 1.0 120 1 90 (PMEC) -  48 
19 8b (5.0) - 1.0 45 24 
84 (SC) 
97 (PMEC) -  49 
20 8c (5.0) - 1.0 25 24 97 (PMEC) -  50 
a0.5mL of CH2Cl2 added to solubilise catalyst. 
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2. Results and Discussion 
2.1. Hypothesis 1: The rate is second-order w.r.t. enantioselective 
metal(salen) catalysts only 
Jacobsen observed a second-order rate dependence with the studied 
cobalt(salen) catalysts (as well as good fit to assumed first-order dependence 
on substrate) from which it was deduced that the transition state involved two 
catalyst molecules.1,9 Given the similarities between the hydrolytic kinetic 
process and the ring-opening of epoxides to form cyclic carbonates, we 
hypothesised that cobalt(salen) catalysts exhibit stereoselectivity due to a 
similar stepped bimetallic transition structure, which would present as a second-
order rate dependence on catalyst. Meanwhile, we would expect first-order rate 
dependence on non-enantioselective catalysts. This hypothesis is dependent 
on the assumption that the rate-determining step is the ring-opening of the 
epoxide using carbon dioxide as the ring-opening agent. 
2.1.1. Enantioselectivity of aluminium(salen) catalysts 
Our initial plan was to study both propylene oxide and styrene oxide as 
substrates in accordance with much of the available literature. However, 
propylene oxide (b.p. 34 °C) was quickly lost during sampling. On the other 
hand, while styrene oxide performed well as substrate in previous studies by 
the group in Newcastle University, the reactivity was inexplicably much 
decreased in our facilities in York (Table 2, Entry 1 and 2). 1H NMR analysis 
showed that our substrate had not decomposed, and distillation of styrene oxide 
in order to remove any impurities did not improve conversions. The reaction 
was then repeated with both freshly purchased substrate (Table 2, Entry 3 and 
4), and a second batch of catalyst 5b (Table 2, Entry 5 and 6) with no success. 
Photolysis of styrene carbonate back to the epoxide at 254 nm, previously 
reported by White and Ma, was dismissed when the exclusion of light did not 
increase conversions (Table 2, Entry 7).57  
Since we could not explain the loss of activity for styrene oxide as substrate, we 
proceeded to screen different substrates (Table 2). As the reaction was 
performed neat, in each case the epoxide acts not only as substrate but also as 
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solvent, at least when epoxide is present in excess in the initial stages. For 
convenience, we desired to obtain 50 % conversion to cyclic carbonate in 3 h, 
which would enable us to monitor the reaction to completion over the course of 
a day. The substrate phenyl glycidyl ether (Table 2, Entry 18) was eventually 
identified as being suitable for further kinetic runs. 
 
Figure 4: General scheme for the conversion of epoxides to cyclic carbonates. 
 
Table 2: Synthesis of cyclic carbonates catalysed by 5b (2.5 mol % w.r.t. substrate) and 
tetrabutylammonium bromide (2.5 mol % w.r.t. substrate) at 25 °C and 1 atm CO2. 
Entry R 
Conversion to cyclic carbonate (%)a 
3 h 24 h 
1 Ph 23b 72c 
2 Ph 17d 70d 
3 Ph 21e - 
4 Ph 21f - 
5 p-ClC6H5 27 68 
6 p-BrC6H5 28 70 
7 CH2CH3 100 - 
8 CH2Cl 61 93 
9 CH2OH 39 85 
10 CH2OPh 51 75 
11 C4H9 78 100 
12 C8H17 14 80 
13 C10H23 9 100 
aConversions to cyclic carbonate were obtained by 1H NMR. 
bThe yield previously reported in the group (1 atm CO2, 26 °C, 2.5 mol % Al(III) w.r.t. epoxide, 
2.5 mol % tetrabutylammonium bromide w.r.t. epoxide) was 62 %. 
cThe yield previously reported in the group (1 atm CO2, 26 °C, 2.5 mol % Al(III) w.r.t. epoxide, 
2.5 mol % tetrabutylammonium bromide w.r.t. epoxide) was 98 %. 
dNew substrate was purchased from Sigma Aldrich. 
eSecond batch of catalyst 5b. 
fReaction vessel was covered in foil to prevent photolysis. 
 
Enantioselectivity testing was carried out using the selected substrate to 
establish the ability of aluminium(salen) catalysts to carry out a kinetic 
resolution. Since cyclic carbonate formation is performed neat, the composition 
of the reaction mixture changes from being largely epoxide to being largely 
cyclic carbonate over the course of the reaction. This drastic change in 
composition may affect rate dependence on substrate.58 As such a krel value 
has been calculated for each sample taken.  
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We confirmed that aluminium(salen) complexes are unable to kinetically resolve 
styrene oxide, in agreement with previous research (Table 3, Entries 1 to 4).34,59 
To our surprise, however, our aluminium(salen) complexes (Figure 5) 
demonstrated enantioselectivity with phenyl glycidyl ether (Table 3, Entries 5 to 
12). Encouraged by this result, we tested N-(2,3-epoxypropyl)diphenylamine, 
which until then had been unexplored within the group. Despite a significant 
improvement in enantioselectivity with N-(2,3-epoxypropyl)diphenylamine 
(Table 3, Entries 13 to 20), further studies were performed with phenyl glycidyl 
ether due to its commercial availability at low cost.  
 
Figure 5: Structures of aluminium(salen) complexes 2a to 2c and 5b. 
 
We consistently found that all catalysts produced cyclic carbonate in favour of 
the second peak eluted by chiral HPLC (Table 3, enantiomeric ratios). In 
addition, catalyst 2a gave the highest conversions without sacrificing 
enantioselectivity (Table 3, Entries 6, 10, 14, and 18). Meanwhile, catalyst 2c 
had the lowest level of activity and extended running times were sometimes 
required in order to obtain significant conversion (Table 3, Entries 3, 7, 11, 15, 
and 19). In addition, lowered reaction temperatures decreased conversions but 
successfully improved enantioselectivity across both phenyl glycidyl ether and 
N-(2,3-epoxypropyl)diphenylamine and across all catalysts (Table 3, Entries 5 
to 20). This is expected of a typical kinetic resolution as lower temperatures 
decrease the energy available for activation of the disfavoured enantiomer to a 
greater extent compared to the favoured enantiomer. 
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Table 3: Activity and enantioselectivity of aluminium(salen) catalysts, 2a, 2b, 2c and 5b, (2.5 mol %) 
and tetrabutylammonium bromide (2.5 mol %) under solvent-free conditions. 
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1 2a Pha 3 25 21.4 NAe 47: 53 5 1.13 
2 2b Ph 3 25 28.0 NAe 50: 50 0 1.01 
3 2c Ph 3 25 6.6 NAe 47: 53 6 1.14 
4 5b Ph 3 25 21.0 NAe 48: 52 4 1.08 
5 2a CH2OPhb 1 25 34.8 7.0 42: 58 17 1.52 
6 2b CH2OPh 1 25 40.7 NAf 39: 61 22 1.82 
7 2c CH2OPh 1 25 3.7 NAf 32: 68 37 2.18 
8 5b CH2OPh 1 25 33.5 NAf 40: 60 20 1.66 
9 2a CH2OPh 24 0 17.2 10.2 25: 75 49 3.26 
10 2b CH2OPh 24 0 35.5 NAf 23: 77 53 4.32 
11 2c CH2OPh 72 0 8.2 NAf 21: 78 56 3.77 
12 5b CH2OPh 42 0 25.1 NAf 25:75 51 3.63 
13 2a CH2NPh2b 4 25 35.5 NAe 16: 84 69 7.73 
14 2b CH2NPh2 4 25 55.8 NAe 23: 77 53 6.43 
15 2c CH2NPh2 18 25 19.0 NAe 21: 79 58 4.32 
16 5b CH2NPh2 4 25 58.6 NAe 27: 73 47 5.27 
17 2a CH2NPh2 24 0 11.2 NAe 8: 92 85 13.70 
18 2b CH2NPh2 24 0 14.8 NAe 7: 93 86 15.38 
19 2c CH2NPh2 64 0 13.9 NAe 10: 90 80 10.70 
20 5b CH2NPh2 24 0 2.9 NAe 8: 92 84 11.63 
aConversions to cyclic carbonate were obtained by 1H NMR. 
bConversions to cyclic carbonate were obtained by HPLC. 
ce.r. values were obtained by chiral HPLC and correspond to area under first peak: area under 
second peak. dkrel is calculated as 
ln[1−𝑐(1+𝑒𝑒)]
ln[1−𝑐(1−𝑒𝑒)]
. eThe epoxide could not be resolved on our 
existing HPLC columns. fThe substrate was not detected due to decomposition in the time taken 
for HPLC analysis.  
 
The inability of our aluminium(salen) complexes to kinetically resolve styrene 
oxide may be attributed to the proximity of the phenyl functional group. Although 
the prevailing theory is that terminal epoxides undergo attack at the unhindered 
end (Figure 6, route A),59 this may not hold true for styrene oxide. Nucleophilic 
attack at the CH site, which is more electrophilic, may be favoured over attack 
at the CH2 site (Figure 6, route B), thus producing a conjugated intermediate. 
Since the intermediate formed from phenyl glycidyl ether lacks the stabilising 
effect of such conjugation, we might expect differences in mechanism between 
the two substrates. Since earlier research indicates a first-order dependence on 
styrene oxide, which was not kinetically resolved, we decided to determine if a 
second-order rate-dependence on phenyl glycidyl ether would be observed.  
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Figure 6: Two possible routes for nucleophilic attack on styrene oxide. 
 
It is also plausible that catalyst-substrate interaction may be influenced by steric 
effects. In phenyl glycidyl ether, the bulky phenyl group projects further out than 
in styrene oxide. In N-(2,3-epoxypropyl)diphenylamine, the presence of two 
phenyl groups would further increase steric hindrance during epoxide activation. 
Alternatively, the presence of a heteroatom may be sufficient to induce a kinetic 
resolution.  
We then carried out an experiment investigating the variation of ee against 
conversion using the conditions used for Table 3, Entry 16, for which the 
catalyst (5b) was determined to have a krel of 5.27. The calculations for the 
theoretical curve are based on the assumption that the system exhibits a first-
order rate dependence on substrate. Although the determination of krel from 
known conversions and ee values is elementary, calculations to obtain 
conversion or ee values from a known krel value are by no means as simple and 
require the help of an online graphing calculator (Figure 7, in green). Our data 
obtained from experiments done in duplicate (Figure 7, in blue and red) fits well 
to the calculated data. We therefore report the first instance of catalyst 5b 
successfully demonstrating the ability to carry out a classical kinetic resolution. 
 
Figure 7: Observed ee of 4-(N,N-diphenylaminomethyl)-1,3-dioxolan-2-one against conversion for 
two separate runs (blue and red). Both reactions were carried out using catalyst 5b (krel 5.27, 2.5 
mol %) and tetrabutylammonium bromide (2.5 mol %) under solvent-free conditions. The reactions 
were carried out at 25 °C and 1 atm CO2 and monitored over 8 h by HPLC.  The theoretical ee 
against conversion for a catalyst with krel 5.27 is shown in green and is obtained by plotting 𝟓. 𝟐𝟕 =
𝐥𝐧(𝟏−𝒄(𝟏+𝒆𝒆))
𝐥𝐧(𝟏−𝒄(𝟏−𝒆𝒆))
 on the Desmos Graphing Calculator.60 
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2.1.2. Order of reaction w.r.t. aluminium(salen) catalysts 
In kinetic analyses, we began with the rate equation (Eqn. 1) given as follows, 
where the orders of reaction a, b, c, and d are unknown. This assumes that 
there is no back reaction which is consistent with experimental findings and the 
highly negative heat of reaction.6,61  
𝑟𝑎𝑡𝑒 =  𝑘[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]𝑎[𝐶𝑂2]
𝑏[𝑐𝑎𝑡𝑎𝑙𝑦𝑠𝑡]𝑐[𝐵𝑢4𝑁𝐵𝑟]
𝑑  − Eqn. 1   
Since CO2 is present in large excess, the concentration of CO2 remains 
unchanged over the course of a reaction. Catalyst and Bu4NBr concentrations 
also remain constant throughout the run. We thus have a simplified rate 
equation that is applicable for each catalyst screened. 
𝑟𝑎𝑡𝑒 =  𝑘𝑜𝑏𝑠[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]
𝑎, 𝑤ℎ𝑒𝑟𝑒 𝑘𝑜𝑏𝑠  =  𝑘[𝐶𝑂2]
𝑏[𝑐𝑎𝑡𝑎𝑙𝑦𝑠𝑡]𝑐[𝐵𝑢4𝑁𝐵𝑟]
𝑑    
The application of logarithms to both sides gives Eqn. 2 below. 
ln 𝑘𝑜𝑏𝑠   =  ln 𝑘  +  𝑏 ln[𝐶𝑂2]  +  𝑐 ln[𝑐𝑎𝑡𝑎𝑙𝑦𝑠𝑡]  +  𝑑 ln[𝐵𝑢4𝑁𝐵𝑟]  − Eqn. 2 
By keeping [Bu4NBr] constant and under the assumption that carbon dioxide 
diffuses into the bulk solution at a much faster rate than the rate of cyclic 
carbonate formation, Eqn. 2 simplifies to Eqn. 3, where the unknown constant c 
is the order of reaction w.r.t. catalyst.  
𝐥𝐧 𝒌𝒐𝒃𝒔   = 𝒄 𝐥𝐧[𝒄𝒂𝒕𝒂𝒍𝒚𝒔𝒕] + 𝒌
′,
𝑤ℎ𝑒𝑟𝑒 𝑘′ =  ln 𝑘 +  𝑏 ln[𝐶𝑂2]  +  𝑑 ln[𝐵𝑢4𝑁𝐵𝑟]  − Eqn. 3 
 
A plot of ln kobs, which is experimentally derived, against ln[catalyst], gives the 
constant c (order of reaction w.r.t. catalyst) as the gradient of the resultant line. 
As kinetic analyses using catalyst 5b, and styrene oxide as substrate have 
already been performed,34,59 we decided to carry out our kinetic analysis with 
catalyst 5b, and with phenyl glycidyl ether as substrate. 
Unlike our substrate screening where the bulk of the reaction mixture changes 
drastically from epoxide to cyclic carbonate, in performing kinetic runs a solvent 
is necessary. Solvents were chosen according to literature precedent showing 
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that solvents containing carbonyl functional groups were better able to solubilise 
CO2.62 Preliminary screening for the conversion of phenyl glycidyl ether to cyclic 
carbonate in ethyl acetate (0.5 mL) showed significant solvent loss via 
evaporation. As such, ethylene carbonate (b.p. 248 °C)10 (Figure 8, blue) and 
propylene carbonate (b.p. 242-243 °C)10 (Figure 8, red) were tested as solvent. 
As ethylene carbonate is a solid, the corresponding reaction was carried out at 
45 °C. Since both reactions failed to reach completion in a suitable timescale, 
we then tested the use of propylene carbonate at 45 °C as well (Figure 8, 
green), which was found agreeable as approximately three half-lives could be 
observed over 8.5 h. These reactions were performed in open 28 mL 
borosilicate glass vials in a water bath. 
 
Figure 8: Addition of carbon dioxide to phenyl glycidyl ether catalysed by complex 5b (2.5 mol %) 
6and tetrabutylammonium bromide (2.5 mol %) in solvent. The reaction was monitored by 1H NMR. 
 
In order to determine kobs, we needed to first determine the order of reaction 
w.r.t. epoxide. From Figure 8 it is evident that order of reaction w.r.t. epoxide 
(the constant a) is not zero since a linear fit is not observed. Assuming a first-
order rate dependence on epoxide, the differential rate law (Eqn. 4) follows: 
𝑟𝑎𝑡𝑒 =  𝑘𝑜𝑏𝑠[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]
1  = −
𝑑[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]
𝑑𝑡
 
Hence,
𝑑[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]
[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]
=  −𝑘𝑜𝑏𝑠𝑑𝑡 −  Eqn. 4 
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Integration on both sides gives:  
∫
1
[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]
𝑑[𝑒𝑝𝑜𝑥𝑖𝑑𝑒] =  − ∫ 𝑘𝑜𝑏𝑠𝑑𝑡 
 ln[𝑒𝑝𝑜𝑥𝑖𝑑𝑒] = −𝑘𝑜𝑏𝑠𝑡 + 𝐶 
At t = 0, ln[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]0 = 𝐶. 
Hence, ln 𝑒𝑝𝑜𝑥𝑖𝑑𝑒 = ln[𝑒𝑝𝑜𝑥𝑖𝑑𝑒]0 − 𝑘𝑜𝑏𝑠𝑡 
The plot of ln[epoxide], which was experimentally derived, against time, closely 
approximated first-order rate dependence on substrate as indicated by the R2 
value of 0.9929 (Figure 9). In contrast, the R2 values for the zero- and second-
order rate dependence on epoxide indicated considerably poorer fit. Further 
information about duplicate runs may be found in Appendix A. 
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 Figure 9: Plot of ln[epoxide] against time for the addition of carbon dioxide to phenyl glycidyl ether 
(1.66 mmol) catalysed by complex 5b (2.5 mol %) and tetrabutylammonium bromide (2.5 mol %) in 
propylene carbonate as solvent (0.5 mL). The reaction was carried out at 45 °C and 1 atm CO2 and 
monitored over 5 h by HPLC.  
 
As previous research within the group showed a first-order rate dependence on 
catalyst 5b using styrene oxide as substrate and propylene carbonate (5 equiv. 
v/v) as solvent,59 our preference would have been to use parallel conditions in 
the conversion of phenyl glycidyl ether. Unfortunately, although our initial 
screening in propylene carbonate produced strong evidence for the first-order 
rate dependence on substrate (Figure 9), reproducibility was problematic. Runs 
performed under the same conditions (1.66 mmol of phenyl glycidyl ether, 2.5 
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mol % catalyst 5b, 2.5 mol % tetrabutylammonium bromide in 0.5 mL propylene 
carbonate at 45 °C and 1 atm CO2) gave a range of kobs values ranging from 
0.3742 to 0.2173 mol dm-3 h-1 (Figure 10). 
 
 
  
[5b]/mol dm-3 kobs/mol dm-3 h-1 
0.02875 0.2940 
0.05761 0.3742 
0.05761 0.2173 
0.05761 0.2977 
0.08648 0.1847 
0.1152 0.3539 
0.1152 0.2290 
  
Figure 10: Double logarithmic plot to determine order of reaction w.r.t. catalyst 5b. (2.5 mol % 
tetrabutylammonium bromide, 1 atm CO2, 25 °C, 2 vol. equivalents of propylene carbonate as 
solvent). As the reaction mixture was not homogeneous, the data was not reproducible. 
 
The lack of reproducibility was attributed to the incomplete dissolution of 
catalyst 5b even at elevated temperatures (45 °C, 25 mg of catalyst in 1.0 mL of 
propylene carbonate). Addition of more solvent only served to slow reaction 
rates. Replacement of propylene carbonate with conventional solvents with 
good solvating power such as dichloromethane and ethyl acetate were also 
found to be unsuitable due to volatility issues. The use of condensation 
apparatus in a conventional setup with round-bottomed flasks was also 
ineffective due to a number of reasons. In comparison to the volume of solvent 
itself (2 mL), the volume of the entire setup was still too large to eliminate 
significant solvent loss over the course of the reaction. Furthermore, the use of 
low volumes in round-bottomed flasks made sampling very difficult.  
We therefore resorted to using stoppered 28 mL borosilicate glass vials as 
reaction vessels, and selected p-cymene (b.p. 176 °C)63 as solvent although the 
temperature had to be increased to 75 °C in order to perform kinetics in 8 
hours. Despite the high b.p. of the solvent and the use of septa to prevent 
solvent loss, a steady decrease in solvent levels over 8 h was still observed. As 
such, only initial rates were used in further kinetic analysis. 
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The final conditions were 1 atm CO2, 75 °C, 20 vol. equivalents of p-cymene as 
solvent and 2.5 mol % of tetrabutylammonium bromide. By varying catalyst 
loading (2.5 mol %, 3.0 mol %, 4.0 mol % and 5.0 mol % of 5b w.r.t substrate) a 
straight line with gradient 1.0628 was obtained. Since we had observed 
enantioselectivity with phenyl glycidyl ether (albeit under solvent-free 
conditions), we had expected a bimetallic transition state similar to Jacobsen’s 
computation model, which would present as second-order rate dependence on 
catalyst. Instead, the gradient indicates first-order rate dependence on catalyst 
5b. This was in agreement with the rate against [5b] plot which approximated a 
straight line passing through the origin (Figure 11). 
 
Figure 11: (left) Double logarithmic plot to determine order of reaction w.r.t catalyst 5b. (right) 
Linear plot to demonstrate first-order rate dependence on catalyst 5b. (2.5 mol % tetrabutyl-
ammonium bromide, 1 atm CO2, 75 °C, 20 vol. equivalents of p-cymene as solvent). Error bars are 
within a 95 % confidence interval. Each point shown is the mean of experiments done in duplicate. 
 
Assuming that the addition of a solvent does not change the rate-determining 
step or the rate dependence on catalyst, the first-order rate dependence on 5b 
indicated that the HKR process was not an accurate model for the synthesis of 
cyclic carbonate from epoxides and CO2. Furthermore, while the aluminium-
(salen) catalysts demonstrated enantioselectivity only with selected substrates, 
the cobalt(salen) complexes were enantioselective for all epoxides tested 
(Section 2.1.3). Evidently, our aluminium(salen) catalysts are dissimilar to 
Jacobsen’s cobalt(salen) complexes. 
y = 1.0628x + 2.6701
R² = 0.9885
-3.00
-2.50
-2.00
-1.50
-1.00
-0.50
0.00
-4.80 -4.60 -4.40 -4.20 -4.00 -3.80
ln
[k
o
b
s]
ln[5b]
y = 11.467x - 0.0055
R² = 0.9923
0.00
0.05
0.10
0.15
0.20
0.25
0.000 0.005 0.010 0.015 0.020
k o
b
s
(m
o
l d
m
-3
h
-1
)
[5b] (mol dm-3)
 30 
2.1.3 Enantioselectivity of cobalt(salen) catalysts 
Literature precedent has shown that cobalt(salen) catalysts are enantioselective 
for propylene oxide.2-5,51 Our priority was therefore to establish 
enantioselectivity for phenyl glycidyl ether, which has a much bulkier functional 
group, using cobalt(salen) catalysts 3a to 3d (Figure 12). Figure 4 (General 
scheme for the conversion of epoxides to cyclic carbonates.) has been 
reproduced for easy reference. Although tetrabutylammonium bromide is active 
for the formation of cyclic carbonate, only racemic product was produced. No 
cyclic carbonate was observed in the absence of tetrabutylammonium bromide. 
Unlike the aluminium(salen) catalysts,  the cobalt(salen) catalysts did not 
produce a marked improvement in krel in changing the substrate from styrene 
oxide to phenyl glycidyl ether (Table 4, Entries 1 to 16). The increase in krel 
when the substrate was changed to N-(2,3-epoxypropyl)diphenylamine (Table 
4, Entries 17 to 24) was also much smaller than that observed using our 
aluminium(salen) complexes. The cobalt(salen) system consistently produced 
cyclic carbonate in favour of the second isomer of 4-(N,N-diphenylamino-
methyl)-1,3-dioxolan-2-one by chiral HPLC (Table 4, Entries 17 to 24), but the 
trend was less clear for styrene carbonate and (phenoxymethyl)ethylene 
carbonate. 
Conversions were on the whole rather comparable across both classes of 
catalysts. Meanwhile, lowering the temperature to 0 °C decreased conversions, 
but did not significantly improve krel values. It appears that the cobalt(salen) 
complexes are indeed dissimilar to the aluminium(salen) complexes in that the 
aluminium(salen) complexes were more dependent on both substrate and 
temperature. However, given literature precedent it is unexpected that our 
cobalt(salen) complexes were considerably less enantioselective than the 
aluminium counterparts in the conversion of phenyl glycidyl ether and N-(2,3-
epoxypropyl)diphenylamine. 
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Figure 12: Structures of cobalt(salen) complexes 3a to 3d. 
 
 
Figure 4: General scheme for the conversion of epoxides to cyclic carbonates. 
 
Table 4: Activity and enantioselectivity of cobalt(salen) catalysts 3a to 3d (2.5 mol %) and 
tetrabutylammonium bromide (2.5 mol %) under solvent-free conditions. 
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1 3a Pha 6 25 66.8 45: 55 10 1.43 
2 3b Ph 6 25 69.3 56: 44 11 1.53 
3 3c Ph 6 25 24.0 48: 52 4 1.10 
4 3d Ph 6 25 68.0 53: 47 7 1.28 
5 3a Ph 24 0 59.0 48: 52 4 1.13 
6 3b Ph 24 0 46.3 52: 48 4 1.13 
7 3c Ph 24 0 31.0 53: 47 6 1.16 
8 3d Ph 24 0 47.1 53: 47 6 1.19 
9 3a CH2OPhb 3 25 22.7 51: 49 1 1.03 
10 3b CH2OPh 3 25 72.8 53: 47 7 1.32 
11 3c CH2OPh 3 25 29.9 57: 43 14 1.41 
12 3d CH2OPh 3 25 72.4 55: 45 11 1.56 
13 3a CH2OPh 24 0 20.7 52: 48 4 1.09 
14 3b CH2OPh 24 0 17.3 48: 52 3 1.08 
15 3c CH2OPh 24 0 55.1 56: 44 11 1.42 
16 3d CH2OPh 24 0 56.1 53: 47 7 1.23 
17 3a CH2NPh2b 6 25 36.1 41: 59 18 1.59 
18 3b CH2NPh2 6 25 49.5 43: 57 15 1.52 
19 3c CH2NPh2 6 25 29.8 41: 59 18 1.54 
20 3d CH2NPh2 6 25 44.1 36: 64 27 2.13 
21 3a CH2NPh2 24 0 8.3 32: 68 36 2.20 
22 3b CH2NPh2 24 0 21.0 33: 67 35 2.26 
23 3c CH2NPh2 64 0 16.5 39: 61 21 1.61 
24 3d CH2NPh2 24 0 34.2 41: 59 19 1.60 
aConversions to cyclic carbonate were obtained by 1H NMR. 
bConversions to cyclic carbonate were obtained by HPLC. 
ce.r. values were obtained by chiral HPLC and correspond to area under first peak: area under 
second peak. 
dkrel is calculated as 
ln[1−𝑐(1+𝑒𝑒)]
ln[1−𝑐(1−𝑒𝑒)]
.  
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2.1.3. Order of reaction w.r.t. cobalt(salen) catalysts 
The rate equation for the conversion of epoxides to cyclic carbonates in the 
presence of cobalt(salen) catalysts may be given as  
𝐥𝐧 𝒌𝒐𝒃𝒔   = 𝒄 𝐥𝐧[𝒄𝒂𝒕𝒂𝒍𝒚𝒔𝒕] + 𝒌
′, 𝑤ℎ𝑒𝑟𝑒 𝑘′ =  ln 𝑘 +  𝑏 ln[𝐶𝑂2]  +  𝑑 ln[𝐵𝑢4𝑁𝐵𝑟] 
As shown in Section 2.1.2, a plot of ln kobs, which is experimentally derived, 
against ln[catalyst], gives the constant c (i.e. order of reaction w.r.t. catalyst) as 
the gradient. We attempted to preserve reaction conditions used in Section 
2.1.2, Figure 11 (1 atm CO2, 75 °C, and 20 vol. equivalents of p-cymene as 
solvent). However, catalyst 3c failed to fully dissolve under the same conditions. 
Additionally, the epoxide was prone to ring-opening with water as shown in 
Figure 13.  
 
Figure 13: Possible mechanism for the ring-opening of phenyl glycidyl ether in the presence of a 
small amount of water. Product and possible isomers have been isolated and identified by ESI-MS, 
1H NMR, and 13C NMR.  
 
As such alternative conditions of 1 atm CO2, 25 °C, and 20 vol. equivalents of 
ethyl acetate as solvent had to be selected. Care was taken to exclude moisture 
from the experimental setup. A plot of ln[epoxide] against time showed good 
approximation to first-order rate dependence on substrate (Figure 14). We thus 
used first-order rate constants to determine order of reaction with respect to 
catalyst. 
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  Figure 14: Plot of ln[epoxide] against time for the addition of carbon dioxide to phenyl glycidyl 
ether (0.83 mmol) catalysed by complex 3c (2.5 mol %) and tetrabutylammonium bromide (10.0 mol 
%) in ethyl acetate as solvent (2.2 mL). The reaction was carried out at 25 °C and 1 atm CO2 and 
monitored over 4 h by HPLC. A duplicate run gave a gradient of 1.4216 with an R2 value of 0.9978, 
proving good reproducibility between runs. 
 
However, when the co-catalyst was present in less than equimolar amounts 
w.r.t. 3c, e.g. 3.75 mol % 3c and 2.5 mol % co-catalyst, no conversion was 
observed. Therefore, in order to facilitate variation in catalyst loading, the 
amount of co-catalyst had to be increased to 10.0 mol %. We then performed 
kinetic analyses for 1.0 mol %, 2.5 mol % and 5.0 mol % 3c w.r.t substrate to 
obtain the plot shown in Figure 15, which gave reproducible results, but not a 
straight line.  
 
  
  
[3c]/mol dm-3 kobs/mol dm-3 h-1 
0.003593 1.416 
0.003593 1.385 
0.008983 0.7487 
0.008983 0.8017 
0.01796 0.7564 
0.01796 0.7824 
  
Figure 15: Double logarithmic plot to determine order of reaction w.r.t. catalyst 3c. (10.0 mol % 
tetrabutylammonium bromide, 1 atm CO2, 25 °C, 20 vol. equivalents of ethyl acetate as solvent). 
Error bars are within a 95 % confidence interval. Each point shown is the mean of experiments 
done in duplicate. 
 
As such we investigated the possible anion exchange of catalyst 3c with 
tetrabutylammonium bromide to form potentially active species 3d, which might 
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explain the inactivity of the catalyst system when the co-catalyst was the limiting 
reagent. Unfortunately, catalyst 3d was inactive when used in the absence of 
co-catalyst. Nonetheless, we carried out further investigation with catalyst 3d to 
eliminate the possibility of the OTs- anion being active for cyclic carbonate 
formation.  
Reactions with catalyst 3d exhibited the same approximation to first-order rate 
dependence on epoxide (Figure 16). We carried out the same kinetic analyses 
for 1.0 mol %, 2.5 mol % and 5.0 mol % 3d w.r.t substrate as we did with 
catalyst 3c (Figure 17). However, despite the good reproducibility of the points 
as demonstrated in Figure 17, a good linear fit was still not established. 
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  Figure 16: Plot of ln[epoxide] against time for the addition of carbon dioxide to phenyl glycidyl 
ether (0.83 mmol) catalysed by complex 3d (2.5 mol %) and tetrabutylammonium bromide (10.0 mol 
%) in ethyl acetate as solvent (2.2 mL). The reaction was carried out at 25 °C and 1 atm CO2 and 
monitored over 4.5 h by HPLC. A duplicate run gave a gradient of 0.8909 with an R2 value of 0.9836, 
proving good reproducibility between runs. 
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[3d]/mol dm-3 kobs/mol dm-3 h-1 
0.003593 0.27838 
0.003593 0.24613 
0.008983 0.89089 
0.008983 0.81599 
0.01796 0.79917 
0.01796 0.91502 
  
  
Figure 17: Double logarithmic plot to determine order of reaction w.r.t. catalyst 3d. (10.0 mol % 
tetrabutylammonium bromide, 1 atm CO2, 25 °C, 20 vol. equivalents of ethyl acetate as solvent). 
Error bars are within a 95 % confidence interval. Each point shown is the mean of experiments 
done in duplicate. 
 
Our next step was to treat the [3d + tetrabutylammonium bromide] system as 
one such that ln 𝑘𝑜𝑏𝑠   = 𝑐′ ln[3𝑑 + 𝑇𝐵𝐴𝐵] + 𝑘′′, where the unknown constant c’ 
now refers to the combined order of reaction for both components of the 
catalyst system. By subtracting the order of reaction w.r.t. tetrabutylammonium 
bromide only (to be found separately) from c’, the order of reaction w.r.t. 
catalyst 3d only can be obtained. 
Catalyst 3d loading was fixed at 2.5 mol % for the following kinetic runs at 2.5, 
5.0, 10.0, and 15.0 mol % of tetrabutylammonium bromide. Excellent fit was 
observed for both the double logarithmic plot and the linear plot, indicating a 
first-order rate dependence on tetrabutylammonium bromide (Figure 18). 
  
Figure 18: (left) Double logarithmic plot to determine order of reaction w.r.t tetrabutylammonium 
bromide. (right) Linear plot to demonstrate first-order rate dependence on tetrabutylammonium 
bromide. (1 atm CO2, 25 °C, 20 vol. equivalents of ethyl acetate as solvent). Error bars are within a 
95 % confidence interval. Each point shown is the mean of experiments done in duplicate. 
 
Since the optimum rate was observed at 2.5 mol % of 3d and 15.0 mol % of 
tetrabutylammonium bromide, this ratio was preserved when varying both 3d 
and tetrabutylammonium bromide. Kinetics were then run using a 1:6 ratio of 3d 
to co-catalyst (2.5 mol %, 3.3 mol %, and 5.0 mol % of 3d). Once again, an 
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excellent fit was observed for both the double logarithmic plot and the linear 
plot, indicating that the combined order of reaction closely approximates 1 
(Figure 19). 
 
Figure 19: (left) Double logarithmic plot to determine order of reaction w.r.t [3d + 
tetrabutylammonium bromide]. (right) Linear plot to demonstrate first-order rate dependence on 
the combined catalyst system. (1 atm CO2, 25 °C, 20 vol. equivalents of ethyl acetate as solvent). 
Error bars are within a 95 % confidence interval. Each point shown is the mean of experiments 
done in duplicate. 
 
Since both the combined order and the order of reaction w.r.t. 
tetrabutylammonium bromide is 1, the order of reaction w.r.t. 3d alone would 
appear to be 0. However, we note that a 1:6 ratio of 3d to tetrabutylammonium 
bromide may have saturated the system with co-catalyst, producing pseudo 
first-order kinetics.  
To determine if this was the case, a fourth set of kinetics were performed. A 
constant 30.0 mol % of tetrabutylammonium bromide was used while varying 
catalyst 3d (2.0 mol %, 3.0 mol %, 4.0 mol %, and 5.0 mol %). As 
tetrabutylammonium bromide is known to be active for the non-enantioselective 
ring-opening of epoxides,48 a control was first performed, giving 6.0 % of 
(phenoxymethyl)ethylene carbonate after 24 h (30.0 mol % tetrabutylammonum 
bromide, 20 vol. equivalents of EtOAc, 25 °C, 1 atm anhydrous CO2). This level 
of activity was deemed negligible.  
Kinetic analysis afforded good linear approximation showing that the order of 
reaction w.r.t. catalyst 3d is 1 (Figure 20), and that pseudo first-order kinetics 
had indeed been observed at 1:6 ratio of 3d to co-catalyst. Therefore although 
cobalt(salen) catalysts are enantioselective for phenyl glycidyl ether, we were 
unable to demonstrate a second-order rate dependence on catalyst. 
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Figure 20: (left) Double logarithmic plot to determine order of reaction w.r.t catalyst 3d. (right) 
Linear plot to demonstrate first-order rate dependence on catalyst 3d. (1 atm CO2, 25 °C, 20 vol. 
equivalents of ethyl acetate as solvent). Error bars are within a 95 % confidence interval. Each 
point shown is the mean of experiments done in duplicate. 
 
2.1.4. Nature of the active cobalt(salen) catalyst 
From kinetic experiments it is apparent that the cobalt(salen) system required 
tetrabutylammonium bromide (at least 1 equivalent) in the conversion of 
terminal epoxides to cyclic carbonates. However, the active catalyst is not 
formed from a simple anion displacement as evidenced by the inactivity of 
catalyst 3d in the absence of tetrabutylammonium bromide. Kinetic analysis has 
also shown that the order of reaction w.r.t. tetrabutylammonium bromide is 1 
(Figure 18, page 35). 
Darensbourg and Moncada have unequivocally proven by X-ray crystallography 
that chromium(salen)Cl forms six-coordinate complexes in the presence of two 
equivalents of anions such as CN-, N3-, and NCO-.64 By extending this 
reasoning to our cobalt(salen) system, tetrabutylammonium bromide could act 
as an anion source to form a theoretical six-coordinate cobalt(salen)Br2- 
complex (Scheme 11). This would explain the need for excess 
tetrabutylammonium bromide in our cobalt(salen)/co-catalyst system. 
  
Scheme 11: Formation of postulated Co(III)salenBr2- active catalyst in the presence of excess 
bromide anions. 
 
As suspected, the 1H NMR spectrum of cobalt(salen)bromide catalyst 3d with 
excess tetrabutylammonium bromide exhibits a shift in the aryl region. In the 
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presence of 15 equivalents of tetrabutylammonium bromide, the singlet at 8.35 
ppm shifts to 8.20 ppm while the doublets at 7.35 ppm and 7.02 ppm shift to 
7.20 ppm and 6.88 ppm respectively. The changes in the cyclohexyl region, if 
any, are swamped by the signals from tetrabutylammonium bromide (Figure 21, 
top).  
 
Figure 21: 1H NMR spectrum of catalyst 3d in the presence of 15 equivalents of 
tetrabutylammonium bromide in CDCl3 (top, blue), and 1H NMR spectrum of catalyst 3d alone in 
CDCl3 (bottom, red). 
 
However, there were no differences in the 13C NMR spectra. Furthermore, 
electrospray ionisation mass spectrometry did not produce the desired peak, 
which we predicted to be a [3d+Br]- ion at 761.1733. The observed species 
were instead a major peak at m/z 402.1180 and a minor peak corresponding to 
[3d]-.  
The UV spectrum of catalyst 3d in a large excess of tetrabutylammonium 
bromide also failed to show either a shift in wavelength, or the presence of a 
new peak. The resultant spectrum (Figure 22, red) appears to be the sum 
spectrum of catalyst 3d (Figure 22, green) and tetrabutylammonium bromide 
(Figure 22, blue). 
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Figure 22: UV spectra of catalyst 3d in acetonitrile (green), tetrabutylammonium bromide in 
acetonitrile (blue), and catalyst 3d in the presence of 100 equiv. of tetrabutylammonium bromide in 
acetonitrile (red). 
 
Although 1H NMR analysis appears to indicate formation of a new complex in 
situ, the shifts in signals may also be attributed to the addition of 
tetrabutylammonium bromide, which would alter solvent polarity. We also 
attempted crystal growth of 3d in the presence of tetrabutylammonium bromide. 
The resultant crystal structure was shown to contain 3d alone. In the absence 
of further evidence we were unable to ascertain the formation of Co(III)salenBr2- 
by adding tetrabutylammonium bromide to 3d.  
At the beginning of the project we had a pre-conceived belief that cobalt(salen) 
catalysts were unique in producing enantio-enriched cyclic carbonates from 
epoxides and carbon dioxide. However, our work on aluminium(salen) (Section 
2.1.1) and chromium(salen) complexes (Section 0) proves otherwise. We 
therefore opted out of further investigating the properties of the active 
cobalt(salen) catalysts.  
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2.1.5. Enantioselectivity of chromium(salen) catalysts 
Since chiral chromium(salen) catalysts have demonstrated enantioselectivity for 
the ring-opening of epoxides, they therefore have the potential to produce 
enantio-enriched cyclic carbonates. Indeed, we observed enantioselectivity in 
the production of cyclic carbonates from racemic epoxides using our 
chromium(salen) catalysts with a range of co-catalysts (Figure 23, Table 5). 
With the exception of Entry 32, the catalysts favoured production of the second 
enantiomer of cyclic carbonate by chiral HPLC. 
 
Figure 23: Structures of chromium(salen) catalysts 4a to 4c. 
 
Due to the presence of side products when phenyl glycidyl ether was used as 
substrate, our standard quantification method based on HPLC response factors 
was rendered inaccurate. The presence of paramagnetic chromium(III) also 
complicated 1H NMR analysis due to peak broadening. As most of the peak 
area may be assigned to either substrate or product, which have similar 
response factors (923109 and 901514 respectively), area % by HPLC was 
considered sufficient for quantitative analysis. 
Controls performed in the absence of co-catalysts showed conversions that 
were too low to be viable (Table 5, Entries 1, 18, and 23). In addition, much like 
the aluminium(salen) catalysts, catalyst 4a was less enantioselective for styrene 
oxide even at doubled catalyst loading (Table 5, Entry 15) but more 
enantioselective for N-(2,3-epoxypropyl)diphenylamine (Table 5, Entry 16). 
Furthermore, the enantioselectivity of the chromium(salen) catalysts surpassed 
that of the cobalt(salen) catalysts.  
Co-catalyst testing with 4a and 4c showed that amongst the tetrabutyl-
ammonium halide catalysts, the bromide salt consistently produced the highest 
% ee values (Table 5, Entries 2 to 9 and 25 to 31). Using phenyl glycidyl ether 
as substrate, we then tested a range of alternative co-catalysts, (Table 5, 
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Entries 10 to 13, 17, and 18). Since the highest krel value of 3.10 was observed 
using bis(triphenylphosphine)iminium chloride (Table 5, Entry 13), further 
optimisation was performed with that co-catalyst. Doubling the catalyst loading 
successfully produced an increase of ee values to 43 % (Table 5, Entry 14).  
Table 5 Activity and enantioselectivity of chromium(salen) catalysts 4a to 4c (2.5 mol %) and 
various co-catalysts using phenyl glycidyl ether as substrate under solvent-free conditions at 25 
°C. 
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1 4a - 24 6.1 34: 66 31 1.94 
2 4a NBu4F 6 Not detected NA NA - 
3 4a NBu4F 24 63.4 43: 57 13 1.57 
4 4a NBu4Cl 6 4.6 36: 65 29 1.84 
5 4a NBu4Cl 24 89.2 44: 56 12 2.92 
6 4a NBu4Br 6 61.8 49: 51 2 1.07 
7 4a NBu4Br 24 86.5 48: 52 4 1.30 
8 4a NBu4I 6 43.4 49: 52 3 1.08 
9 4a NBu4I 24 88.6 47: 53 5 1.45 
10 4a 4-dimethylaminopyridine 6 9.8 40: 60 21 1.57 
11 4a 4-dimethylaminopyridine 24 61.5 39: 62 23 2.20 
12 4a PPN+Cl-ε 6 16.5 37: 63 27 1.83 
13 4a PPN+Cl- 24 84.3 42: 58 16 3.10 
14 4aβ PPN+Cl- 3 16.8 29: 71 43 2.72 
15 4aβ, γ PPN+Cl- 4 13.0 47: 54 7 1.16 
16 4aδ PPN+Cl- 3 20.9 14: 86 72 7.32 
17 4a Guanidinium chloride 6 8.3 33: 67 33 2.04 
18 4a Guanidinium chloride 24 17.4 45: 55 11 1.28 
19 4b - 24 6.5 44: 56 12 1.28 
20 4b NBu4Br 6 77.7 49: 51 1 1.05 
21 4b NBu4Br 24 91.2 46: 54 8 2.29 
22 4b 4-dimethylaminopyridine 6 2.7 39: 61 21 1.54 
23 4b 4-dimethylaminopyridine 24 52.2 46: 55 9 1.31 
24 4c - 24 5.2 40: 60 21 1.55 
25 4c NBu4F 6 11.0 38: 63 25 1.72 
26 4c NBu4F 24 18.2 38: 62 24 1.72 
27 4c NBu4Cl 6 17.0 41: 59 18 1.49 
28 4c NBu4Cl 24 31.5 40: 60 21 1.68 
30 4c NBu4Br 24 23.0 37: 63 25 1.86 
31 4c NBu4I 24 7.9 42: 58 15 1.38 
32 4c 4-dimethylaminopyridine 24 6.1 53: 47 6 1.12 
33 4c PPN+Cl- 6 11.0 40: 60 20 1.54 
34 4c PPN+Cl- 24 21.5 37: 63 24 1.74 
αkrel is calculated as 
ln[1−𝑐(1+𝑒𝑒)]
ln[1−𝑐(1−𝑒𝑒)]
. βReaction was carried out using 5.0 mol % of 4a and 5.0 mol % 
of co-catalyst. γStyrene oxide as substrate, conversion obtained by 1H NMR. δN-(2,3-
Epoxypropyl)diphenylamine as substrate, conversion obtained by HPLC. εPPN+: 
Bis(triphenylphosphine)iminium. 
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Section 2.1.3 (page 32) disproves the hypothesis that the reaction is second-
order w.r.t. cobalt(salen) catalysts. Consequently, we worked on improving krel 
values by varying ligand design (Figure 24, Table 6) instead of performing 
kinetic analyses on our chromium(salen) complexes. Indeed, our krel values 
were only modest at best. In comparison, Jacobsen and co-workers reported 
krel values ranging from 49 to 500 for the hydrolytic kinetic resolution of 
epoxides.1  
Chromium(salen) complexes 4d to 4j (Figure 24) were selected with our optimal 
results in mind (Table 5, Entries 13 and 14), i.e. the chromium(salen)chloride in 
combination with bis(triphenylphosphine)iminium salts. Insolubility issues with 
the bis(triphenylphosphine)iminium co-catalysts were rectified by a pre-
treatment step reported by Darensbourg and Moncada. This step involved 
dissolving both the chromium(salen) complex and the PPN+X- salts in 
dichloromethane, or any suitable solvent, followed by solvent removal in vacuo 
and finally substrate introduction.64  
Pretreatment was ineffective as it produced an increase in activity but a 
corresponding decrease in krel (Table 6, Entries 7 to 12, and 15 to 16), as did 
the use of PPN+Br- (Table 6, Entries 13 and 14) instead of PPN+Cl- (Table 6, 
Entries 7 and 8). The presence of t-Bu groups enhanced solubility and 
increased conversions, but likewise did little to increase enantioselectivity 
(Table 6, Entries 3 to 8, 17 and 18). The presence of electron-donating groups 
were likewise largely detrimental to enantioselectivity (Table 6, Entries 19 to 
22). The presence of electron-withdrawing Br substituents slightly increased krel 
values, but conversions were decreased (Table 6, Entries 23 to 26). In 
summary, the variation of R groups on the phenyl rings did not significantly 
change the enantioselectivity of the reaction.  
We then investigated the effect of the diimine backbone on enantioselectivity. 
Since the enantioselectivity of the reaction is dependent on the “step” of the 
ligand, we reasoned that the presence of bulky phenyl groups on the backbone 
might improve enantioselectivity. As the optimum ee values were observed 
when R2 = H and R3 = t-Bu (Table 6, Entries 7 and 8), we selected 3-tert-butyl-
2-hydroxybenzaldehyde, and (R,R)-1,2-diphenyl-1,2-ethanediamine as the 
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desired synthons. However, the increased cost of the ligand was not justified as 
the complex was barely enantioselective (Table 6, Entries 27 and 28).  
 
Figure 24: Variants of Cr(III)(salen) complexes 4a to 4k. 
 
Table 6: Activity and enantioselectivity of chromium(salen) chloride catalysts 4a to 4k (2.5 mol % 
loading, 1: 1 Cr to PPN+X- salts) using phenyl glycidyl ether as substrate. 
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1 - PPN+Cl- No 25 24 12.6 2.0 - 
2 - PPN+Br- No 25 24 17.9 0.2 - 
3 4a PPN+Cl- No 25 6 16.5 27 1.83 
4 4a PPN+Cl- No 25 24 84.3 16 3.10 
5 4d PPN+Cl- No 25 6 19.7 31 2.04 
6 4d PPN+Cl- No 25 24 36.1 22 1.76 
7 4e PPN+Cl- No 25 6 28.0 36 2.43 
8 4e PPN+Cl- No 25 24 51.0 15 1.55 
9 4e PPN+Cl- Yes 25 6 57.4 9 1.31 
10 4e PPN+Cl- Yes 25 24 61.3 8 1.29 
11 4e PPN+Cl- No 0 72 1.3 44 2.60 
12 4e PPN+Cl- Yes 0 72 4.1 32 1.97 
13 4e PPN+Br- No 25 6 49.3 4 1.13 
14 4e PPN+Br-  No 25 24 69.0 4 1.17 
15 4e PPN+Br- No 0 72 11.9 29 1.90 
16 4e PPN+Br- Yes 0 72 21.0 25 1.79 
17 4f PPN+Cl- No 25 6 26.2 26 1.86 
18 4f PPN+Cl- No 25 24 54.2 20 1.85 
19 4g PPN+Cl- No 25 6 23.3 28 1.93 
20 4g PPN+Cl- No 25 24 54.1 18 1.73 
21 4h PPN+Cl- No 25 6 52.3 14 1.52 
22 4h PPN+Cl- No 25 24 65.2 9 1.38 
23 4i PPN+Cl- No 25 6 16.8 28 1.88 
24 4i PPN+Cl- No 25 24 41.8 24 1.91 
25 4j PPN+Cl- No 25 6 17.3 32 2.08 
26 4j PPN+Cl- No 25 24 36.7 19 1.63 
27 4k PPN+Cl- No 25 6 20.3 30 1.98 
28 4k PPN+Cl- No 25 24 43.3 15 1.50 
29 4k TBAB No 25 6 74.4 0 1.02 
30 4k TBAB No 25 24 89.7 4 1.35 
  
 44 
2.2. Hypothesis 2: Cobalt(salen) catalysts exhibit the most stepped 
conformation 
If the ring-opening of epoxides is truly similar to Jacobsen’s hydrolytic kinetic 
resolution, the cobalt(salen) complexes would exhibit a more stepped 
conformation than similar metal(salen) complexes which exhibit lesser 
stereoselectivity. To verify this hypothesis we examined crystal structures of 
aluminium, cobalt, and chromium complexes obtained from the Cambridge 
Structural Database. Attempts at crystal growth were also successful in yielding 
a crystal structure (Table 7, Entry 8). Details of the crystal structure, including 
acquisition data, may be found in Appendix B. 
We first limited the search to complexes containing the (R,R)-N,N′-bis(3,5-di-
tert-butylsalicylidene)-1,2-cyclohexanediamine ligand. The step was then 
approximated by measuring the angle between two planes. The first plane was 
drawn using the four donor atoms of the ligand (Figure 25, red plane) and the 
second plane was extended from the aryl rings (Figure 25, green plane). 
However, the angles proved to be different for each aryl ring even within the 
same molecule (Figure 26, blue and green planes). The differences between 
the two tilts for each molecule ranged from 0.18 ° to a significant 10.89 ° (CSD 
reference – ZUQCIX)65 even in a single crystal structure containing two 
complexes which may have been caused by crystal-packing forces. 
 
Figure 25: Approximation of step in ((R,R)-(-)-N,N'-bis(3,5-Di-t-butylsalicylidene)-1,2-
cyclohexanediamino)-cobalt(II) chloroform solvate, CSD reference – ZUQCIX.65 Hydrogen atoms, 
solvent molecules, and the second complex molecule have been omitted for clarity. The red plane 
is extended from the four donor atoms surrounding the cobalt centre. The green plane is extended 
from the aryl ring on the left. 
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Figure 26: Planes extended from the aryl rings in ((R,R)-(-)-N,N'-bis(3,5-Di-t-butylsalicylidene)-1,2-
cyclohexanediamino)-cobalt(II) chloroform solvate, CSD reference – ZUQCIX.65 Hydrogen atoms, 
solvent molecules, and the second complex molecule have been omitted for clarity. The green 
plane is extended from the aryl ring on the left. The blue plane is extended from the aryl ring on the 
right, and is clearly not parallel to the green plane. 
 
Since each crystal exhibits signs of distortion from crystal packing, the scope of 
comparison was extended to include the range of steps for each aryl ring. Even 
then, the available data was fairly restricted. Consequently, complexes with 
differing R groups on the 5 and 5’ positions (Figure 27) were included with the 
view that the diamine backbone dictates the step of the complex and that the 
distance at the 5 and 5’ positions from the metal centre would minimise effects 
on the step. 
While this assumption holds true for the 4-coordinate cobalt(salen) complexes 
which are expected to remain relatively planar (Table 7, Entries 3 to 5), there is 
a significant increase in step when the R-group is changed from MeO to a bulky 
t-Bu in the 6-coordinate cobalt(salen) complexes (Table 7, Entries 9 and 10). It 
appears that the combined bulk of both the axial ligands and the t-Bu functional 
groups may be sufficient to induce distortion. 
Although the smallest angle measured for the 4-coordinate cobalt(salen) 
complexes was considerably less than that of the 5-coordinate cobalt(salen) 
complexes, there was little change in the maximum angle measured. (Table 7, 
Entries 3 to 8). However, the 6-coordinate cobalt(salen) complexes showed 
drastically different angles dependent on the identity of the axial ligands (Table 
7, Entries 10 and 11). The same may be said for the 6-coordinate 
chromium(salen) complexes (Table 7, Entries 12 and 13). 
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Figure 27: General structure of crystal structures examined in Table 7. 
 
Table 7: Range of angles obtained for various metal(salen) complexes containing a 1,2-
cyclohexanediamine backbone. The angles are approximated using the two corresponding planes 
in Figure 25 for each crystal structure. 
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1 Al t-bu 5 (S)-chloropropanol 2.3466 14.2566 
2 Al t-bu 5 Bis(trimethylsilyl)amide 22.4267 31.5667 
3 Co H 4 - 2.4247 18.0447 
4 Co MeO 4 - 2.3268 19.4868 
5 Co t-bu 4 - 4.2965 15.1865 
6 Co t-bu 5 1,3-butadien-2-yl 2.8169 17.1969 
7 Co t-bu 5 Cl- 8.9170 18.8970 
8 Co t-bu 5 Br- 8.27 17.41 
9 Co MeO 6 1-methyl-1H-imidazole,  
1-methyl-1H-imidazole 
1.0168 7.4268 
10 Co t-bu 6 1-methyl-1H-imidazole,  
1-methyl-1H-imidazole 
7.2971 9.7471 
11 Co t-bu 6 (2R,3S)-2-Phenyl-3-methylaziridine-N, 
(2R,3S)-2-Phenyl-3-methylaziridine-N 
18.7972 28.6672 
12 Cr t-bu 6 N3-, THF 4.1373 10.2373 
13 Cr t-bu 6 Cl-, Cl- 6.1074 15.5674 
 
Our hypothesis was that cobalt(salen) complexes exhibit the largest step, thus 
resulting in high enantioselectivity for a broad range of substrates. However, 
given the unpredictability of angles observed in the cobalt(salen) complexes 
and the fact that the largest tilt was observed in an aluminium(salen) complex 
(Table 7, Entry 1), we were unable to unequivocably prove our hypothesis. 
Extensive distortion from crystal packing forces may have rendered the data 
irrelevant. Alternative justifications include the failure of the premise that 
cobalt(salen) complexes are unique in producing enantio-enriched product for 
which our work on aluminium(salen) complexes (Section 2.1.1) and 
chromium(salen) complexes (Section 2.1.5) provides corroborating evidence
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3. Conclusion  
The two hypotheses put forward were based on the assumption that only 
cobalt(salen) catalysts are able to kinetically resolve cyclic carbonates. Our 
work on enantioselective aluminium(salen) and chromium(salen) complexes 
has shown that this assumption is false. Furthermore, first-order rate 
dependence on catalyst was observed for catalysts affording enantioselectivity, 
in contrast with our expectations of a second-order rate dependence. 
Examination of the crystal structures of similar metal(salen) catalysts showed 
little correlation between the “step” of the catalyst and the extent of 
enantioselectivity. Therefore we were unable to prove either hypothesis.  
Furthermore, unlike the HKR process where enantioselectivity is largely 
substrate-independent, we have evidence that enantioselective cyclic carbonate 
formation from epoxides is reliant on the substrate across all tested catalysts. 
While we were limited by the inability of our current equipment to analyse other 
substrates, it is clear that the HKR process is an unlikely model for the 
synthesis of cyclic carbonates from epoxides and CO2.  
Without doubt, the most intriguing results were the unexpected 
enantioselectivities of aluminium(salen) and chromium(salen) complexes, 
where none had been expected. The enantioselectivity of the reaction may be 
improved by substrate choice, and by lowering the temperature, but not by pre-
treatment with compatible solvents or by varying ligand design for the 
chromium(salen) catalysts. Both aluminium(salen) and chromium(salen) 
complexes exhibited stronger substrate-dependence than the cobalt(salen) 
catalysts. In the cases where enantioselectivity was observed, the krel values 
obtained using aluminium(salen) and chromium(salen) catalysts surpassed that 
obtained using the cobalt(salen) catalysts.  
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4. Future Work 
The range of epoxides for which aluminium(salen) and chromium(salen) 
complexes are enantioselective needs to be fully established. Investigations 
using a series of epoxides containing alkyl chains of differing lengths such as 
butylene oxide, hexylene oxide, and decylene oxide, should reveal if the 
enantioselectivity is dependent on steric factors alone. Substrate screening 
using substituted styrene oxide such as p-chlorostyrene oxide and p-
bromostyrene oxide would likewise reveal any influence arising from inductive 
effects. 
It would be enlightening to examine how functional groups on the salen ligand 
of our aluminium(salen) complexes would affect enantioselectivity, particularly 
as the aluminium(salen) complexes afforded the highest krel values observed 
thus far. In hindsight, greater effort needed to be expended in increasing krel 
values for aluminium(salen) complexes as opposed to the chromium(salen) 
complexes, particularly as chromium is a relatively scarce resource75 and 
aluminium is the most abundant metal in the Earth’s crust.76  
In order to increase the green credentials of aluminium(salen) complexes, 
alternative sources of aluminium should be explored. From an industrial 
viewpoint, there is a need to investigate opportunities for catalyst recycling and 
immobilisation onto heterogeneous supports. Furthermore, development of a 
single-component aluminium(salen) catalyst would be desirable. However, 
these investigations should be carried out only after ascertaining that kinetic 
resolution using aluminium(salen) catalysts is viable i.e. krel values approaching 
50. 
Since we were unable to vastly improve ee and krel values by varying ligand 
design, better enantioselectivity may be observed with other metal centres such 
as iron, a cheap and readily abundant material.76  
Finally, due to the short duration of this project we found it unnecessary to 
continue performing kinetics on the chromium(salen) complexes. Nonetheless a 
kinetic study carried out using chromium(salen) complexes would be useful in 
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elucidating if the ring-opening step is homologous to the corresponding step in 
the HKR process.  
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5. Preparation of catalysts, co-catalysts, and reagents 
General experimental procedures. Reactions were carried out in oven-dried 
round bottomed flasks, unless otherwise noted. Commercially available 
reagents were purchased from Aldrich, Fluka, Acros, and Alfa Aesar. 
Commercial-grade solvents were used as received unless otherwise noted. 
Instrumentation. 1H and 13C NMR spectra were recorded on a Jeol ECX400 or 
Jeol ECS400 spectrometer at 400 MHz and 101 MHz respectively unless 
otherwise noted. All spectra were recorded at room temperature unless 
otherwise stated in a suitable solvent that is reported in parentheses.  Chemical 
shifts for protons are reported in parts per million and are referenced to residual 
protons in the NMR solvent (CHCl3: δ = 7.26). Chemical shifts for carbon are 
reported in parts per million and are referenced to the carbon resonances of the 
solvent (CDCl3: δ = 77.16). Data are represented as follows: chemical shift, 
multiplicity, integration. Abbreviations for NMR spectral multiplicities are as 
follows: br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet.  
Infrared (IR) spectra were obtained on a Bruker Vertex 700 spectrometer using 
a range between 600 cm-1 and 4000 cm-1 using attenuated total reflectance. 
Data are represented as follows: frequency of absorption (cm-1), intensity of 
absorption (s = strong, m = medium, w = weak, br = broad). UV-vis spectra 
were obtained on a JASCO V-550 spectrophotometer. Optical rotations were 
measured using a 2 mL cell with a 100 mm path length on a JASCO DIP-370 
digital polarimeter at the sodium D-line in a suitable solvent that is reported in 
parentheses (concentration given in g/100 mL). Melting points were measured 
on a Stuart SMP3 melting point machine. 
High resolution mass spectra were recorded on a Bruker microTOF operating in 
positive electrospray ionisation mode unless stated otherwise. Low resolution 
mass spectra were recorded on a Waters Micromass GCT Premier orthogonal 
time-of-flight instrument using liquid injection field desorption/ionization.  
X-ray analysis was carried out using a Oxford Diffraction SuperNova equipped 
with a 4-circle goniometer, microfocus Mo X-ray source and CCD detector. The 
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crystal was kept at 110.00(14) K during data collection. Details of the crystal 
structures obtained are given in Appendix B.  
Crystallographic Data. The crystal structures of metal(salen) complexes were 
downloaded from the Cambridge Structural Database77 if they were already 
available. Mercury78 was used to analyse the crystallographic information. 
5.1. Preparation of aldehydes 
3,5-Di-tert-butyl-2-hydroxybenzaldehyde: 
Synthesis was carried out according to a reported literature 
procedure.79 Et3N (2.64 mL, 19.38 mmol) was added dropwise 
to a suspension of 2,4-di-tert-butylphenol (2.00 g, 9.69 mmol), 
MgCl2 (1.84 g, 19.38 mmol), and paraformaldehyde (0.64 g, 
21.33 mmol) in THF (50 mL). The mixture was refluxed at 70 °C for 20 h to give 
a yellow suspension. The reaction was quenched with water (60 mL) and 
extracted with CH2Cl2 (2 x 100 mL). The combined organic extracts were 
washed with brine (2 x 100 mL), dried (MgSO4) and the solvent removed in 
vacuo. The yellow residue was purified by flash chromatography using 
petroleum ether/CHCl3 (7:1) as eluent to give a pale yellow solid, Rf (petroleum 
ether/CHCl3 7:1) 0.24. Yield: 1.43 g, 27 %. M.P: 58.5 -59.7 °C (lit. 59 - 61 °C).80 
1H NMR (400 MHz, CDCl3) δ: 11.64 (s, 1H), 9.87 (s, 1H), 7.59 (d, J = 2.5 Hz, 
1H), 7.35 (d, J = 2.5 Hz, 1H), 1.43 (s, 9H), 1.33 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ: 197.7, 159.4, 141.9, 137.9, 132.2, 128.1, 120.3, 35.3, 34.5, 31.6, 
29.6. FT-IR (ATR): υ [cm-1] = 2959 (s), 2872 (m), 2361 (w), 1648 (s), 1614 (m), 
1441 (s), 1363 (m), 1271 (m), 1171 (s), 1027 (m), 896 (m), 770 (m), 715 (s). 
HRMS (EI): Calculated for [C15H22O2] ([M]+): 234.1620; Found: 234.1619. 
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5-Tert-butyl-2-hydroxybenzaldehyde: 
Synthesis was carried out following the procedure for 3,5-di-tert-
butyl-2-hydroxybenzaldehyde, refluxing overnight. Et3N (12.99 mL, 
93.19 mmol) was added dropwise to a suspension of 4-tert-
butylphenol (7.00 g, 46.59 mmol), MgCl2 (8.87 g, 93.19 mmol), and 
paraformaldehyde (3.07 g, 102.5 mmol) in THF (200mL). The mixture was 
refluxed at 70 °C overnight to give a yellow suspension. The reaction was 
quenched with water (150 mL) and extracted with CH2Cl2 (2 x 100 mL). The 
combined organic extracts were washed with brine (2 x 100 mL), dried (MgSO4) 
and the solvent removed in vacuo. A brown oil was obtained, which was purified 
by flash chromatography using petroleum ether/EtOAc (5:1) as eluent to yield a 
yellow oil, Rf (petroleum ether/EtOAc 5:1) 0.44. Yield:  4.49 g, 54 %. 1H NMR 
(400 MHz, CDCl3) δ: 10.87 (s, 1H), 9.89 (s, 1H), 7.59 (dd, J = 8.8 Hz, 2.5 Hz, 
1H), 7.52 (d, J = 2.5 Hz, 1H), 6.94 (d, J = 8.8 Hz, 1H), 1.33 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ: 196.9, 159.6, 142.8, 134.8, 129.9, 120.1, 117.3, 34.2, 
31.3. FT-IR (ATR): υ [cm-1] = 2962 (m), 1652 (s), 1484 (s), 1264 (s), 1229 (s), 
924 (m), 833 (s), 600 (s). HRMS (ESI): Calculated for [C12H18NaO3] 
([M+Na+MeOH]+): 233.1154; Found: 233.1141. 
3-Tert-butyl-2-hydroxybenzaldehyde: 
Synthesis was carried out following the procedure for 3,5-di-tert-
butyl-2-hydroxybenzaldehyde. Et3N (7.26 mL, 52.07 mmol) was 
added dropwise to a suspension of 3-tert-butylphenol (4.0 mL, 
26.04 mmol), MgCl2 (4.96 g, 52.07 mmol), and paraformaldehyde (1.72 g, 57.29 
mmol) in THF (100mL). The pink mixture was refluxed at 70 °C overnight to 
give a brown suspension. The reaction was quenched with water (50 mL) and 
extracted with CH2Cl2 (3 x 100 mL). The combined organic extracts were 
washed with brine (3 x 80 mL), dried (MgSO4) and the solvent removed in 
vacuo. A dark green oil was obtained on standing, which was purified by flash 
chromatography using petroleum ether/EtOAc (25:1) as eluent to yield an 
orange oil, Rf (petroleum ether/EtOAc 25:1) 0.26. Yield: 2.70 g, 58 %. 1H NMR 
(400 MHz, CDCl3) δ: 11.77 (s, 1H), 9.87 (s, 1H), 7.52 (dd, J = 7.5 Hz, 1.7 Hz, 
1H), 7.38 (dd, J = 7.5 Hz, 1.7 Hz, 1H), 1.41 (s, 9H). 13C NMR (101 MHz, CDCl3) 
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δ: 197.2, 161.2, 138.3, 134.1, 132.0, 120.7, 34.9, 29.2. FT-IR (ATR): υ [cm-1] = 
2959 (m), 1650 (s), 1431 (s), 1311 (s), 1196 (s), 750 (s). HRMS (EI): Calculated 
for [C11H14O2] ([M]+): 178.0994; Found: 178.0992. 
 
3-Tert-butyl-5-bromo-2-hydroxybenzaldehyde: 
Synthesis was carried out according to a literature procedure.81 
A round-bottomed flask was charged with 3-tert-butyl-2-
hydroxybenzaldehyde (0.29 g, 1.65 mmol) in 15 mL of glacial 
acetic acid. A solution of bromine (0.09 mL, 1.70 mmol) in 30 mL 
of glacial acetic acid was then added dropwise. The resulting brown solution 
was stirred at r.t. for 18 h. The solution was diluted to 100 mL with CH2Cl2 and 
washed with water (100 mL), Na2S2O5 (100 mL), NaHCO3 (100 mL), and brine 
(100 mL). After drying over MgSO4, the solvent was removed in vacuo to yield a 
yellow solid which was used without further purification. Yield: 0.36 g, 86 %.1H 
NMR (400 MHz, CDCl3) δ: 11.73 (s, 1H), 9.81 (s, 1H), 7.58 (d, J = 2.3 Hz, 1H), 
7.52 (d, J = 2.3 Hz, 1H), 1.40 (s, 9H). 13C NMR (101 MHz, CDCl3) δ: 196.1, 
160.3, 141.2, 137.1, 133.7, 121.7, 111.2. FT-IR (ATR): υ [cm-1] = 3088 (w), 
2957 (m), 1657 (s), 1427 (s), 1302 (s), 1271 (s), 1165 (s), 867 (s), 700 (s). 
HRMS (EI): Calculated for [C11H1379BrO2] ([M]+): 256.0099; Found: 256.011.  
5.2. Preparation of salen ligands 
 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine: 
Synthesis was carried out according to a literature 
procedure.82 3,5-Di-tert-butyl-2-hydroxybenzaldehyde 
(18.59 g, 79.3 mmol) was added to a round-bottomed 
flask and dissolved in EtOH (200 mL) to give a pale 
yellow solution. A solution of K2CO3 (12.06 g, 87.3 mmol) 
and (R,R)-1,2-diaminocyclohexane tartrate (9.77 g, 39.7 
mmol) in EtOH/water (1:1, 200 mL) was added to the 3,5-
di-tert-butyl-2-hydroxybenzaldehyde solution, giving a 
bright yellow suspension. The mixture was refluxed for 18 h, quenched with 
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water (150 mL), and extracted with CH2Cl2 (2 x 200 mL). The organic extracts 
were washed with brine (200 mL), and dried (MgSO4). Solvent was removed in 
vacuo to yield a yellow solid, which was purified by washing with ethanol. Yield: 
14.5 g, 69 %. M.P: 206.0 – 206.5 °C (lit. 201 - 204 °C).82 1H NMR (400 MHz, 
CDCl3) δ: 13.72 (s, 2H), 8.30 (s, 2H), 7.30 (d, J = 2.5 Hz, 2H), 6.98 (d, J = 2.5 
Hz, 2H), 3.33 – 3.30 (m, 2H), 1.96 – 1.72 (m, 2H), 1.41 (s, 18H), 1.23 (s, 18H). 
13C NMR (101 MHz, CDCl3) δ: 165.93, 158.1, 140.0, 136.4, 126.8, 126.8, 117.9, 
72.5, 35.0, 34.1, 33.4, 31.5, 29.5, 24.5. FT-IR (ATR): υ [cm-1] 2951 (s), 2907 
(m), 2865 (m), 2361 (w), 2324 (w), 1630 (s), 1391 (m), 828 (m), 772 (m), 644 
(m). HRMS (ESI): Calculated for [C36H55N2O2] ([M+H]+): 547.4258; Found: 
547.4262. [α]D -288 (c = 0.9, CH2Cl2) (lit. -315).82 
(R,R)-N,N′-Bis(salicylidene)-1,2-cyclohexanediamine: 
Synthesis was carried out according to a literature procedure.83 
K2CO3 (0.69 g, 5.0 mmol) and (R,R)-1,2-diaminocyclohexane 
tartrate (1.17 g, 4.76 mmol) were added to a two-necked round-
bottomed flask. Water (10 mL) was added to the mixture, which 
was heated at 60 °C until complete dissolution. EtOH (30 mL) 
was added and the mixture heated to reflux. Salicyaldehyde 
was dissolved in EtOH (30 mL) and added dropwise to give a bright yellow 
solution. The solution was refluxed for 1 h. The solvent was reduced to half the 
volume in vacuo, and extracted with CH2Cl2 (50 mL). The organic phase was 
washed with water (50 mL) and dried (MgSO4). The solvent was removed in 
vacuo to yield a yellow glass which crystallised on standing. The solid was used 
without further purification. Yield: 1.34 g, 88 %. 1H NMR (400 MHz, CDCl3) δ: 
13.31 (s, 2H), 8.26 (s, 2H), 7.22 (m, 2H), 7.13 (dd, J = 7.3, 1.4 Hz, 2H), 6.86 (d, 
J = 7.4 Hz, 2H), 6.80 – 6.75 (m, 2H), 3.38 – 3.26 (m, 2H), 1.99 – 1.82 (m, 4H), 
1.82 – 1.65 (m, 2H), 1.52 – 1.40 (m, 2H). 13C NMR (101 MHz, CDCl3) δ: 164.77, 
161.0, 132.2, 131.6, 118.7, 118.6, 116.8, 33.2, 24.3. FT-IR (ATR): υ [cm-1] 2931 
(m), 2858 (m), 1626 (s), 1496 (m), 1276 (s), 1150 (m), 847 (m), 751 (s).HRMS 
(ESI): Calculated for [C20H23N2O2] ([M+H]+): 323.1754; Found: 323.1761. 
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(R,R)-N,N′-Bis(3-tert-butylsalicylidene)-1,2-cyclohexanediamine: 
Synthesis was carried out according to a literature 
procedure.84 K2CO3 (0.40 g, 2.86 mmol) was added to a 
solution of (R,R)-1,2-diaminocyclohexane tartrate (0.35 g, 
1.43 mmol) in EtOH (100 mL) and water (5 mL). The 
mixture was heated at 60 °C for 10 minutes. 3-Tert-butyl-
2-hydroxybenzaldehyde was dissolved in EtOH (30 mL) 
and added dropwise. The yellow solution was then refluxed for 1 h. After 
cooling to r.t., the solvent was removed in vacuo. The resulting residue was 
taken up in CH2Cl2 (80 mL) and washed with brine (80 mL), water (80 mL) and 
dried (Na2SO4). Solvent was removed in vacuo to yield a yellow solid which was 
used without further purification. Yield: 0.57 g, 91 %. 1H NMR (400 MHz, CDCl3) 
δ: 8.29 (s, 2H), 7.24 (dd, J = 7.9, 1.5 Hz, 2H), 7.0 (dd, J = 7.6, 1.6 Hz, 2H), 6.70 
(t, J = 8.0 Hz, 2H), 3.40 – 3.26 (m, 2H), 2.0 – 1.93 (m, 2H), 1.93 – 1.83 (m, 2H), 
1.79 – 1.67 (m, 2H), 1.53 – 1.45 (m, 2H), 1.41 (s, 18H). 13C NMR (101 MHz, 
CDCl3) δ: 165.6, 160.4, 137.1, 129.8, 129.3, 118.6, 117.8, 72.4, 34.8, 33.2, 
31.0, 29.4, 24.4. FT-IR (ATR): υ [cm-1] 2937 (m), 2861 (m), 1627 (s), 1484 (s), 
1265 (m), 1145 (m), 1084 (m), 851 (m), 749 (s). HRMS (ESI): Calculated for 
[C28H39N2O2] ([M+H]+): 435.3006; Found: 435.3009. 
(R,R)-N,N′-Bis(5-tert-butylsalicylidene)-1,2-cyclohexanediamine:  
Synthesis was carried out according to a literature 
procedure.85 K2CO3 (0.28 g, 2.04 mmol) was added to a 
solution of (R,R)-1,2-diaminocyclohexane tartrate (0.25 g, 1.02 
mmol) in EtOH (20 mL) and water (10 mL). The mixture was 
heated to reflux for 10 minutes. 5-Tert-butyl-2-
hydroxybenzaldehyde was dissolved in EtOH (40 mL) and 
added dropwise. The yellow solution was then refluxed for 2 h. 
After cooling to r.t., the solvent was removed in vacuo. The 
resulting residue was taken up in CH2Cl2 (50 mL) and washed with water (2 x 
25 mL), brine (20 mL) and dried (Na2SO4). Solvent was removed in vacuo to 
yield a yellow solid which was used without further purification. Yield: 0.35 g, 
79 %. 1H NMR (400 MHz, CDCl3) δ: 13.10 (br, 2H), 8.25 (s, 2H), 7.27 (dd, J = 
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8.5, 2.8 Hz, 2H), 7.0 (d, J = 2.8 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 3.36 – 3.25 
(m, 2H), 2.0 – 1.82 (m, 4H), 1.80 – 1.65 (m, 2H), 1.53 – 1.38 (m, 2H). 13C NMR 
(101 MHz, CDCl3) δ: 165.11, 158.7, 141.3, 129.5, 128.0, 118.0, 116.3, 72.9, 
33.9, 33.3, 31.5, 24.3. FT-IR (ATR): υ [cm-1] 2956 (m), 2865 (m), 1633 (s), 1493 
(s), 1268 (s), 1045 (w), 825 (s). HRMS (ESI): Calculated for [C28H39N2O2] 
([M+H]+): 435.3006; Found: 435.3016. 
(R,R)-N,N′-Bis(5-methoxysalicylidene)-1,2-cyclohexanediamine:  
Synthesis was carried out following the procedure for (R,R)-
N,N′-bis(5-tert-butylsalicylidene)-1,2-cyclohexanediamine. 
K2CO3 (0.45 g, 3.29 mmol) was added to a solution of (R,R)-
1,2-diaminocyclohexane tartrate (0.40 g, 1.64 mmol) in EtOH 
(25 mL) and water (10 mL). The mixture was heated to reflux 
for 10 minutes. 5-Methoxy-2-hydroxybenzaldehyde was 
dissolved in EtOH (25 mL) and added dropwise. The yellow 
solution was then refluxed for 2 h. After cooling to r.t., the 
solvent was removed in vacuo to half the original volume. The resulting solution 
was diluted to 100 mL with water and extracted with CH2Cl2 (2 x50 mL). The 
organic phase was washed with brine (50 mL) and dried (Na2SO4). Solvent was 
removed in vacuo to yield a brown sticky solid which crystallised on standing. 
The crude product was purified by washing with hexane. Yield: 0.32 g, 51 %. 1H 
NMR (400 MHz, CDCl3) δ: 12.80 (br, 2H), 8.19 (s, 2H), 6.85 - 6.82 (m, 4H), 6.65 
(dd, J = 2.4, 0.9 Hz, 2H), 3.70 (s, 6H), 3.55 – 3.23 (m, 2H), 2.00 – 1.83 (m, 4H), 
1.81 – 1.56 (m, 2H), 1.54 – 1.41 (m, 2H). 13C NMR (101 MHz, CDCl3) δ: 164.5, 
155.1, 152.0, 119.5, 118.3, 117.5, 114.9, 72.8, 55.9, 33.1, 24.2. FT-IR (ATR): υ 
[cm-1] 2942 (m), 1954 (m), 1631 (s), 1590 (s), 1491 (s), 1268 (s), 1095 (m), 
1035 (s), 809 (s). HRMS (ESI): Calculated for [C22H27N2O4] ([M+H]+): 383.1965; 
Found: 383.1974. 
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(R,R)-N,N′-Bis(3-tert-butyl-5-methoxysalicylidene)-1,2-cyclohexanediamine:  
Synthesis was carried out according to a literature 
procedure.84 K2CO3 (0.43 g, 3.12 mmol) was added to a 
solution of (R,R)-1,2-diaminocyclohexane tartrate (0.38 g, 
1.56 mmol) in water (15 mL). The mixture was heated to 
reflux for 10 minutes. 3-Tert-butyl-5-methoxy-2-
hydroxybenzaldehyde was dissolved in EtOH (75 mL) and 
added dropwise. The yellow solution was then refluxed for 
1 h. After cooling to r.t., the solvent was removed in 
vacuo. The residue was taken up in CH2Cl2 (80 mL) and washed with water (50 
mL) and brine (50 mL). The organic phase was dried (Na2SO4). Solvent was 
removed in vacuo to yield a yellow solid which was used without further 
purification. Yield: 0.67 g, 86 %. 1H NMR (400 MHz, CDCl3) δ: 8.23 (s, 2H), 6.89 
(d, J = 3.2 Hz, 2H), 6.47 (d J = 3.3 Hz, 2H), 3.68 (s, 6H), 3.36 – 3.26 (m, 2H), 
2.00 – 1.90 (m, 2H), 1.93 – 1.83 (m, 2H), 1.82 – 1.67 (m, 2H), 1.52 – 1.42 (m, 
2H), 1.39 (s, 18H). 13C NMR (101 MHz, CDCl3) δ: 165.5, 154.9, 151.2, 138.7, 
118.3, 117.9, 111.4, 72.5, 55.8, 35.0, 33.2, 29.3, 24.4. FT-IR (ATR): υ [cm-1] 
2936 (m), 2861 (m), 1632 (s), 1597 (s), 1429 (s), 1330 (s), 1097 (s), 782 
(s).HRMS (ESI): Calculated for [C30H43N2O4] ([M+H]+): 495.3217; Found: 
495.3234. 
(R,R)-N,N′-Bis(5-bromosalicylidene)-1,2-cyclohexanediamine:  
Synthesis was carried out following the procedure for (R,R)-
N,N′-Bis(5-tert-butylsalicylidene)-1,2-cyclohexanediamine. 
K2CO3 (0.21 g, 1.50 mmol) was added to a solution of (R,R)-
1,2-diaminocyclohexane tartrate (0.18 g, 0.75 mmol) in EtOH 
(20 mL) and water (2 mL). The mixture was heated to reflux for 
10 minutes. 5-Bromo-2-hydroxybenzaldehyde (0.3 g, 1.5 mmol) 
was dissolved in EtOH (50 mL) and added dropwise. The 
yellow solution was then refluxed for 2 h. After cooling to r.t., 
the solution was diluted to 50 mL with CH2Cl2 and washed with water (50 mL). 
The organic phase was washed with brine (3 x 50 mL) and dried (MgSO4). 
Solvent was removed in vacuo to yield an orange solid which was used without 
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further purification. Yield: 0.33 g, 91 %. 1H NMR (400 MHz, CDCl3) δ: 13.23 (br, 
2H), 8.16 (s, 2H), 7.31 (d, J = 8.3 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 7.24 (d, J = 
2.3 Hz, 2H), 6.78 (d, J = 8.9 Hz, 2H), 3.27 – 3.25 (m, 2H), 1.98 – 1.80 (m, 4H), 
1.79 – 1.61 (m, 2H), 1.50 – 1.40 (m, 2H). 13C NMR (101 MHz, CDCl3) δ: 163.6, 
160.1, 135.0, 133.6, 120.0, 119.0, 72.8, 33.0, 24.1. FT-IR (ATR): υ [cm-1] 2919 
(m), 2854 (m), 1631 (m), 1474 (s), 1280 (s), 1184 (s), 827 (s). HRMS (ESI): 
Calculated for [C20H2179Br2N2O2] ([M+H]+): 478.9964; Found: 478.9978 
(R,R)-N,N′-Bis(3-tert-butyl-5-bromosalicylidene)-1,2-cyclohexanediamine:  
Synthesis was carried out following the procedure for 
(R,R)-N,N′-Bis(5-tert-butylsalicylidene)-1,2-
cyclohexanediamine. K2CO3 (0.11 g, 0.78 mmol) was 
added to a solution of (R,R)-1,2-diaminocyclohexane 
tartrate (0.10 g, 0.39 mmol) in EtOH (5 mL) and water (1 
mL). The mixture was heated to reflux for 10 minutes. 3-
Tert-butyl-5-bromo-2-hydroxybenzaldehyde (0.20 g, 0.78 
mmol) was dissolved in ethanol (20 mL) and added 
dropwise. The yellow solution was then refluxed for 1.5 h. After cooling to r.t., 
the solution was diluted to 50 mL with CH2Cl2 and washed with water (3 x50 
mL). The organic phase was washed with brine (50 mL) and dried (MgSO4). 
Solvent was removed in vacuo to yield a yellow solid which was used without 
further purification. Yield: 0.20 g, 88 %. 1H NMR (400 MHz, CDCl3) δ: 8.17 (s, 
2H), 7.32 – 7.30 (m, 2H), 7.08 (d, J = 2.5 Hz, 2H), 3.37 – 3.20 (m, 2H), 2.04 – 
1.94 (m, 2H), 1.93 – 1.83 (m, 2H), 1.82 – 1.75 (m, 2H), 1.53 – 1.42 (m, 2H). 13C 
NMR (101 MHz, CDCl3) δ: 164.5, 159.4, 139.9, 132.4, 131.6, 119.8, 109.8, 
72.4, 35.1, 32.9, 29.2, 24.3. FT-IR (ATR): υ [cm-1] 2936 (m), 2861 (m), 1629 (s), 
1428 (s), 1302 (s), 1201 (s), 867 (s), 705 (s). HRMS (ESI): Calculated for 
[C28H3779Br2N2O2] ([M+H]+): 591.1216; Found: 591.1202. 
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(R,R)-N,N′-Bis(3-tert-butylsalicylidene)-1,2-diphenyl-1,2-ethanediamine:  
Synthesis was carried out following a literature 
procedure.86 (1R, 2R)-(+)-1,2-Diphenyl-1,2-ethanediamine 
(0.12 g, 0.56 mmol) was dissolved in EtOH (15 mL) and 
added to a solution of 3-tert-butyl-2-hydroxybenzaldehyde 
(0.20 g, 1.12 mmol) in EtOH (5 mL). The solution 
immediately turned yellow. The mixture was heated to 
reflux for 18 h. After cooling to r.t., the solvent was removed in vacuo to yield a 
yellow solid which was used without further purification. Yield: 0.29 g, 99 %. 1H 
NMR (400 MHz, CDCl3) δ: 8.35 (s, 2H), 7.28 – 7.13 (m, 12H), 7.00 (d, J = 7.0 
Hz, 1.8 Hz, 2H), 6.70 (t, J = 7.7 Hz, 2H), 4.71 (s, 1H), 1.41 (s, 18H). 13C NMR 
(101 MHz, CDCl3) δ: 166.9, 160.3, 139.6, 137.2, 129.7, 128.4, 128.1, 127.6, 
118.6, 117.9, 80.2, 34.9, 29.4. FT-IR (ATR): υ [cm-1] 2958 (m), 1625 (s), 1494 
(s), 1266 (m), 1203 (m), 751 (s), 700 (s). HRMS (ESI): Calculated for 
[C36H41N2O2] ([M+H]+): 533.3163; Found: 533.3159. 
5.3. Preparation of aluminium(salen) complexes 
Riccardo’s catalyst (5b): 
Synthesis was carried out according 
to a literature procedure.87 
Shredded aluminium foil (0.85 g, 
31.64 mmol) was added to 
EtOH/MePh (400 mL, 3:1 ratio). A 
crystal of I2 was added and the 
mixture was refluxed for 1.5 h, 
during which the aluminium was 
seen to disintegrate into a grey precipitate. A solution of (R,R)-N,N′-bis(3,5-di-
tert-butylsalicylidene)-1,2-cyclohexanediamine (8.65 g, 15.82 mmol) in MePh 
was added and the resulting mixture was refluxed for 20 h. After cooling to r.t., 
the suspension was filtered through celite and the solvent removed in vacuo. 
The residue was taken up in CH2Cl2 (200 mL), washed with water (3 x 200 mL) 
and brine (200 mL), and dried (Na2SO4). Solvent was removed in vacuo to yield 
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a grey-yellow solid which was washed with hexanes to afford a light yellow 
precipitate. Yield: 3.64 g, 40 %. 1H NMR (400 MHz, CDCl3) δ: 8.09 (s, 4H), 7.46 
(s, 4H), 7.03 (s, 4H),  2.88-3.54 (m, 4H), 1.66-2.44 (m, 16H), 1.42 (s, 36H), 1.30 
(s, 36H) FT-IR (ATR): υ [cm-1] = 2951 (s), 2866 (m), 1625 (s), 1354 (m), 1175 
(m), 1026 (m), 865 (m), 753 (m). HRMS (ESI): Calculated for [C72H105AlN4O5] 
([M+H]+): 1159.7719; Found: 1159.7710. 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminoaluminium(III) chloride (2a): 
Synthesis was carried out according to a reported 
literature procedure.59 Diethylaluminium chloride solution 
(0.9 M in MePh, 4.10 mL, 3.69 mmol) was added 
dropwise via syringe to a solution of (R,R)-N,N′-bis(3,5-di-
tert-butylsalicylidene)-1,2-cyclohexanediamine (2.00 g, 
3.66 mmol) in dry MePh. The resulting solution was stirred 
under nitrogen for 24 h. Solvent was removed in vacuo to 
yield a yellow solid which was used without further 
purification. Yield: 2.20 g, 99 %. 1H NMR (400 MHz, CDCl3) δ: 8.37 (s, 2H), 8.18 
(s, 2H), 7.54 (s, 2H), 3.17-3.92 (m, 2H), 2.08-2.58 (m, 8H), 1.54 (s, 18H), 1.30 
(18H).  FT-IR (ATR): υ [cm-1] = 2952 (m), 2867 (w), 1615 (s), 1542 (m), 1315 
(m), 1178 (m), 865 (m). HRMS (ESI): Calculated for [C37H56AlN2O3] ([M-
Cl+MeOH]+): 603.4106; Found: 603.4117. [α]D -580 (c = 0.1, CHCl3) (lit. -503)59 
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(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminoaluminium(III) acetate (2b):  
Synthesis was carried out according to a modified 
literature procedure.88 Silver(I) acetate (0.35 g, 2.12 
mmol) was added to a solution of (R,R)-N,N′-bis(3,5-di-
tert-butylsalicylidene)-1,2-cyclohexanediamino-
aluminium(III) chloride (1.28 g, 2.12 mmol) in methyl tert-
butyl ether (25 mL). The resultant solution was stirred at 
r.t. overnight in darkness and filtered over celite. The 
celite was flushed with methyl tert-butyl ether (15 mL) and 
the solvent was removed in vacuo to yield a yellow solid. The solid was used 
without further purification. Yield: 0.97 g, 72 %. 1H NMR (400 MHz, CDCl3) δ: 
8.37 (s, 1H), 8.18 (s, 1H), 7.52 (br, 2H), 7.11 (m, 1H), 7.03 (m, 1H), 4.00 (br, 
1H), 3.11 (m, 1H), 2.57 (s, 2H), 2.42 (s, 2H), 2.06 (s, 4H), 1.76 (m, 3H), 1.50 (s, 
18H), 1.31 (s, 9H), 1.29 (s, 9H). 13C NMR (101 MHz, CDCl3) δ: 165.9, 158.1, 
140.8, 139.9, 136.4, 126.8, 126.1, 117.9, 72.5, 35.6, 35.0, 34.1, 33.4, 31.5, 
29.7, 29.5, 24.5. FT-IR (ATR): υ [cm-1] = 2952 (m), 2867 (w), 2164 (w), 1625 
(s), 1464 (s), 1441 (s), 1359 (s), 1174 (s), 1051 (m), 846 (s), 787 (s), 731 (s). 
HRMS (ESI): Calculated for [C37H56AlN2O3] ([M-OAc+MeOH]+): 603.4106; 
Found: 603.4107. LRMS (LIFDI): Calculated for [C38H58AlN2O4] ([M]+): 
630.3977. Found: 630.40. 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminoaluminium(III) tosylate (2c): 
Synthesis was carried out according to a literature 
procedure.3 To a solution of silver(I) tosylate (0.63 
g, 2.27 mmol) in MeCN (50 mL) was added a 
solution of (R,R)-N,N′-bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediamino-
aluminium(III) chloride (1.30 g, 2.14 mmol) in 
MeCN (3 mL) under nitrogen. The mixture was 
stirred at r.t for 16 h in darkness. The resultant 
suspension was filtered over celite and the absorbent flushed with MeCN (15 
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mL). The solvent was removed in vacuo to yield a yellow solid. The solid was 
used without further purification. Yield: 1.34 g, 84 %. 1H NMR (400 MHz, CDCl3) 
δ: 8.30 (s, 2H), 7.52 (d, J= 2.5 Hz, 2H), 7.31 (d, J = 7.3 Hz, 2H), 7.09 (d, J = 2.5 
Hz, 2H), 6.85 (d, J = 2.5 Hz, 2H), 2.55 (m, 2H), 2.24 (s, 3H), 2.10 (m, 2H), 1.75 
(m, 2H), 1.60 – 1.45 (m, 4H), 1.39 (s, 18H), 1.33 (s, 18H). FT-IR (ATR): υ [cm-1] 
= 2954 (m), 2869 (w), 2362 (w), 1625 (s), 1545 (m), 1238 (m), 1176 (s), 1037 
(m), 847 (s), 819 (m), 682 (m). HRMS (ESI): Calculated for [C37H56AlN2O3] ([M-
OTs+MeOH]+): 603.4106; Found: 603.4117. LRMS (LIFDI): Calculated for 
[C43H59AlN2O5S] ([M]+): 742.3960. Found: 742.40. 
5.4. Preparation of cobalt(salen) complexes 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) : 
Synthesis was carried out according to a literature 
procedure.89 To a solution of (R,R)-N,N′-bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediamine (2.00 g, 3.65 
mmol) in CH2Cl2 (15 mL) was added a solution of 
cobalt(II) acetate tetrahydrate (1.09 g, 4.39 mmol) in 
MeOH (10 mL) under nitrogen. The mixture was stirred at 
r.t. for 5 minutes, then cooled to 0 °C and stirred for 
another 15 minutes. A red precipitate was formed which 
was washed with ice-cold MeOH (10 mL). Yield: 1.83 g, 83 %. M.P: > 298 °C 
(decomposition) (lit. >300 °C).90 FT-IR (ATR): υ [cm-1] = 2951 (s), 2867 (m), 
1594 (s), 1526 (s), 1320 (s), 1253 (s), 1175 (s), 1049 (w), 786 (s). HRMS (ESI): 
Calculated for [C36H52CoN2O2] ([M]+): 603.3361. Found: 603.3338. [α]D -742 (c 
= 0.0038, CHCl3) (lit. -1145)69 
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(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(III) 
chloride (3a): 
Synthesis was carried out according to a literature 
procedure.91 (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-
1,2-cyclohexanediaminocobalt(III) tosylate (1.13 g, 1.46 
mmol) was dissolved in CH2Cl2 (40 mL) and washed with 
brine (3 x 40 mL). The organic phase was dried over 
Na2SO4. Solvent was removed in vacuo to yield a dark 
green powder. Yield: 0.76 g, 81 %. 1H NMR (400 MHz, 
DMSO-d6) δ: 7.81 (s, 2H), 7.51 (m, 2H), 7.47 (m, 2H), 
3.58 - 3.68 (m, 2H), 3.04 - 3.15 (m, 2H), 1.99 - 2.11 (m, 2H), 1.89 - 1.99 (m, 
2H), 1.78 (s, 18H), 1.56 - 1.67 (m, 2H), 1.34 (s, 18H). FT-IR (ATR): υ [cm-1] = 
2954 (m), 2866 (m), 1981 (w), 1607 (m), 1525 (m), 1360 (m), 1254 (s), 1174 
(m), 1092 (m), 1011 (s), 803 (s). LRMS (LIFDI): Calculated for 
[C36H5235ClCoN2O2] ([M]+): 638.3049. Found: 638.31. [α]D -526 (c = 0.0038, 
CHCl3) 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(III) 
acetate (3b): 
Synthesis was carried out according to a literature 
procedure.91 To a solution of (R,R)-N,N′-bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediamine (1.69 g, 3.10 
mmol) in CH2Cl2 (10 mL) was added a solution of 
cobalt(II) acetate tetrahydrate (0.93 g, 3.72 mmol) in 
MeOH (10 mL). The mixture was stirred at r.t. under air for 
1 h. Solvent was removed in vacuo to yield a brown solid. 
The solid was redissolved in MeOH (10 mL) and 
precipitated by slow addition of water (10 mL). The precipitate was filtered, 
rinsed with water (3 x 10 mL), and dried in vacuo to yield a brown powder. 
Yield: 1.30 g, 63 %. 1H NMR (400 MHz, CD2Cl2) δ: 7.47 (br, s, 1H), 7.30 (br, s, 
1H), 7.25 (br, s, 1H), 7.20 (br, s, 1H), 7.17 (br, s, 1H), 6.70 (s, 1H), 4.4-4.6 (m, 
2H), 3.2-3.4 (m, 2H), 2.7-2.8 (m, 2H), 1.9-2.0 (m, 2H), 1.8-1.9 (m, 2H), 1.67 (s, 
3H), 1.49 (s, 9H), 1.36 (s, 9H), 1.31 (s, 9H), 1.22 (s, 9H);  M.P: > 180 °C 
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(decomposition). FT-IR (ATR): υ [cm-1] 3355 (br), 2950 (s), 2906 (m), 2866 (m), 
2361 (w), 2163 (w), 2050 (w), 1980 (w), 1635 (s), 1528 (s), 1459 (s), 1436 (s), 
1255 (s), 1169 (s), 1026 (m), 834 (m), 783 (m). HRMS (ESI): Calculated for 
[C36H52CoN2O2]: 603.3355; Found: 603.3338. [α]D +502 ° (c = 0.0038, CHCl3) 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(III) 
tosylate (3c): 
Synthesis was carried out according to a 
literature procedure.3 (R,R)-N,N′-bis(3,5-di-tert-
butylsalicylidene)- 1,2-cyclohexanediamino-
cobalt(II) (1.83 g, 3.03 mmol) was dissolved in 
CH2Cl2 (25 mL). p-toluene sulfonic acid (0.61 g, 
3.22 mmol) was added. The resultant mixture 
was stirred open to the atmosphere for 2 h at r.t. 
A colour change from orange to dark green was 
observed. Solvent was removed in vacuo to yield a dark green powder. The 
solid was used without further purification. Yield: 2.34 g, 99 %. 1H NMR (400 
MHz, DMSO-d6) δ: 7.86 (s, 2H), 7.51 (m, 2H), 7.49 (m, 2H), 7.48 (m, 2H), 7.14 - 
7.16 (m, 2H), 3.60 - 3.69 (m, 2H), 3.09 - 3.12 (m, 2H), 2.32 (s, 3H), 2.00 - 2.10 
(m, 2H), 1.90 - 2.00 (m, 2H), 1.78 (s, 18H), 1.62 - 1.66 (m, 2H), 1.34 (s, 18H). 
13C NMR (101 MHz, DMSO-d6) δ:165.6, 163.1, 146.8, 142.8, 138.5, 136.9, 
130.3, 129.8, 129.0, 126.5, 119.6, 70.2, 36.8, 34.5, 32.5, 31.4, 30.5, 25.3, 21.8. 
HRMS (ESI): Calculated for [C36H52CoN2O2] ([M-OTs]+): 603.3355; Found: 
603.3352. [α]D -665 (c = 0.0038, CHCl3) 
  
 65 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(III) 
bromide (3d): 
Synthesis was carried out according to a literature 
procedure.92 (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-
1,2-cyclohexanediaminocobalt(III) tosylate (1.83 g, 2.36 
mmol) was dissolved in CH2Cl2 (80 mL) and washed with 
sat’d NaBr(aq) (3 x 50 mL). The organic phase was dried 
over Na2SO4. Solvent was removed in vacuo to yield a 
dark green powder. Yield: 1.38 g, 85 %. 1H NMR (400 
MHz, CDCl3) δ: 8.32 (s, 2H), 7.31 (d, J = 2.4 Hz, 2H), 7.00 
(d, J = 2.4 Hz, 2H), 3.30 - 3.40 (m, 2H), 1.82 - 2.01 (m, 4H), 1.67 - 1.82 (m, 2H), 
1.44 -1.56 (m, 2H), 1.42 (s, 18H), 1.25 (s, 18H). 13C NMR (101 MHz, CDCl3) δ: 
165.9, 158.1, 140.0, 136.6, 126.8, 126.2, 117.9, 72.6, 35.1, 34.1, 33.4, 31.6, 
29.6, 24.5. FT-IR (ATR): υ [cm-1] = 2953 (s), 2862 (m), 1627 (s), 1440 (s), 1391 
(m), 1361 (s), 1273 (s), 1252 (s), 1203 (m), 1174 (s), 1097 (w), 877 (m), 830 
(m), 772 (m), 733 (m), 713 (m). LRMS (LIFDI): Calculated for 
[C36H5279BrCoN2O2] ([M]+): 682.2544. Found: 682.25. [α]D -287 (c = 0.0132, 
CH2Cl2) 
  
 66 
5.5. Preparation of chromium(salen) complexes 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) chloride (4a): 
Synthesis was carried out according to a literature 
procedure.55 (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-
1,2-cyclohexanediamine (2.00 g, 3.66 mmol) was 
dissolved in dry, degassed THF. Chromium(II) chloride 
(0.49 g, 4.02 mmol) was suspended in dry, degassed 
THF and then added to the (R,R)-N,N′-bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediamine solution. The 
yellow solution rapidly turned brown. The solution was 
stirred under N2 for 4 h, and under air for 18 h. The solution was diluted with 
methyl tert-butyl ether (50 mL) and washed with saturated NH4Cl (aq) (3 x 100 
mL) and brine (3 x 100 mL). The organic phase was dried (Na2SO4) and solvent 
removed in vacuo to yield a red-brown solid. The solid was used without further 
purification. Yield: 2.24 g, 97 %. M.P: > 222 °C (decomposition) (lit. >375-
398 °C).55 FT-IR (ATR): υ [cm-1] 2951 (s), 2867 (m), 1619 (s), 1435 (m), 1361 
(m), 1030 (s), 967 (m), 814 (m). HRMS (ESI): Calculated for [C36H52CrN2O2] 
([M-Cl]+): 596.3434; Found: 596.3450. [α]D -259 (c = 0.087, CHCl3) 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) acetate (4b): 
Synthesis was carried out according to a literature 
procedure.93 Silver(I) acetate (0.33 g, 1.99 mmol) was 
added to a solution of (R,R)-N,N′-bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediaminochromium(III) 
chloride (1.26 g, 1.99 mmol) in methyl tert-butyl ether (20 
mL). The resultant solution was stirred at r.t. overnight in 
darkness and filtered over celite. The celite was flushed 
with methyl tert-butyl ether (10 mL) and the solvent was 
removed in vacuo to yield a red-brown solid. The solid was used without further 
purification. Yield: 1.09 g, 84 %. M.P: > 148 °C (decomposition). FT-IR (ATR): υ 
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[cm-1] 2951 (s), 2907 (m), 2866 (m), 2363 (w), 1727 (w), 1622 (s), 1530 (s), 
1435 (s), 1360 (s), 1255 (s), 1200 (s), 1167 (s), 1032 (m), 1026 (m), 836 (m). 
HRMS (ESI): Calculated for [C36H52CrN2O2] ([M-OAc]+): 596.3429; Found: 
546.3431. LRMS (LIFDI): Calculated for [C38H55CrN2O4] ([M]+): 655.3657. 
Found: 655.39. [α]D +281 ° (c = 0.07, CHCl3) 
(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) tosylate (4c): 
Synthesis was carried out according to a literature 
procedure.3 Silver(I) p-toluenesulfonate (0.57 g, 
2.03 mmol) was dissolved in dry, degassed MeCN 
(3 mL) under nitrogen. To this solution was added 
a solution of (R,R)-N,N′-bis(3,5-di-tert-butyl-
salicylidene)-1,2-cyclohexanediaminochromium(III) 
chloride (1.20 g, 1.90 mmol) in dry, degassed 
MeCN (20 mL). The resultant solution was stirred 
at r.t. overnight in darkness and filtered over celite. The celite was flushed with 
MeCN (15 mL) and the solvent was removed in vacuo to yield a red brown 
solid. The solid was used without further purification. Yield: 1.42 g, 98 %. M.P: > 
178 °C (decomposition). FT-IR (ATR): υ [cm-1] 2952 (s), 2867 (m), 2324 (w), 
2164 (w), 1981 (w), 1727 (w), 1620 (s), 1435 (s), 1235 (m), 1166 (s), 1032 (m), 
1012 (m), 837 (m), 681 (m). LRMS (LIFDI): Calculated for [C43H59CrN2O5S] 
([M]+): 767.3550. Found: 767.36. [α]D +71 (c = 0.0626, CHCl3) 
(R,R)-N,N′-Bis(salicylidene)-1,2-cyclohexanediaminochromium(III) chloride (4d): 
Synthesis was carried out following the procedure for (R,R)-
N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino-
chromium(III) chloride (4a). (R,R)-N,N′-bis(salicylidene)-1,2-
cyclohexanediamine (0.44 g, 1.37 mmol) was dissolved in dry, 
degassed THF. Chromium(II) chloride (0.18 g, 1.50 mmol) was 
suspended in dry, degassed THF and then added to the (R,R)-
N,N′-bis(salicylidene)-1,2-cyclohexanediamine solution. The yellow solution 
rapidly turned brown. The solution was stirred under N2 for 4 h, and under air 
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for 18 h. The solution was diluted with methyl tert-butyl ether (50 mL) and 
washed with saturated NH4Cl (aq) (3 x 100 mL) and brine (3 x 100 mL). The 
organic phase was dried (Na2SO4) and solvent removed in vacuo to yield a 
yellow-brown solid. The solid was used without further purification. Yield: 0.33 
g, 59 %. M.P: > 290 °C. FT-IR (ATR): υ [cm-1] 2937 (w), 1632 (s), 1621 (s), 
1469 (s), 1315 (s), 1194 (m), 1024 (m), 906 (s), 749 (s). HRMS (ESI): 
Calculated for [C20H20CrN2O2] ([M-Cl]+): 372.0924; Found: 372.0924. LRMS 
(LIFDI): Calculated for [C20H2035ClCrN2O2] ([M]+): 407.06; Found: 407.08. [α]D -
543 (c = 0.025, THF) 
(R,R)-N,N′-Bis(3-tert-butyl-salicylidene-1,2-cyclohexanediaminochromium(III) 
chloride (4e): 
Synthesis was carried out following the procedure for 
(R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) chloride (4a). (R,R)-
N,N′-bis(3-tert-butyl-salicylidene)-1,2-cyclohexanediamine 
(0.56 g, 1.29 mmol) was dissolved in dry, degassed THF 
(15 mL). Chromium(II) chloride (0.17 g, 1.42 mmol) was 
suspended in dry, degassed THF (15 mL) and then added to the (R,R)-N,N′-
bis(3-tert-butyl-salicylidene)-1,2-cyclohexanediamine solution. The yellow 
solution rapidly turned brown. The solution was stirred under N2 for 4 h, and 
under air for 18 h. The solution was diluted with methyl tert-butyl ether (15 mL) 
and washed with saturated NH4Cl (aq) (3 x 20 mL) and brine (3 x 20 mL). The 
organic phase was dried (Na2SO4) and solvent removed in vacuo to yield a red-
brown solid. The solid was used without further purification. Yield: 0.63 g, 94 %. 
M.P: > 290 °C. FT-IR (ATR): υ [cm-1] 2941 (m), 2858 (w), 1619 (s), 1532 (s), 
1543 (s), 1421 (s), 1316 (m), 1190 (m), 1024 (m), 870 (s), 749 (s). HRMS (ESI): 
Calculated for [C28H36CrN2O2] ([M-Cl]+): 484.2176; Found: 484.2190. LRMS 
(LIFDI): Calculated for [C28H3635ClCrN2O2] ([M]+): 519.19; Found: 519.20. [α]D -
1285 (c = 0.040, THF) 
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(R,R)-N,N′-Bis(5-tert-butyl-salicylidene-1,2-cyclohexanediaminochromium(III) 
chloride (4f): 
Synthesis was carried out following the procedure for (R,R)-
N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino-
chromium(III) chloride (4a). (R,R)-N,N′-bis(5-tert-butyl-
salicylidene)-1,2-cyclohexanediamine (0.56 g, 1.29 mmol) was 
dissolved in dry, degassed THF (25 mL). Chromium(II) 
chloride (0.17 g, 1.42 mmol) was suspended in dry, degassed 
THF (15 mL) and then added to the (R,R)-N,N′-bis(5-tert-butyl-
salicylidene)-1,2-cyclohexanediamine solution. The yellow solution rapidly 
turned brown. The solution was stirred under N2 for 4 h, and under air for 18 h. 
The solution was diluted with methyl tert-butyl ether (20 mL) and washed with 
saturated NH4Cl (aq) (3 x 40 mL) and brine (3 x 40 mL). The organic phase was 
dried (Na2SO4) and solvent removed in vacuo to yield a brown solid. The solid 
was used without further purification. Yield: 0.29 g, 79 %. M.P: > 270 °C 
(decomposition). FT-IR (ATR): υ [cm-1] 2963 (m), 2858 (w), 1621 (s), 1258 (s), 
1177 (s), 1062 (m), 1033 (m), 831 (s). HRMS (ESI): Calculated for 
[C28H36CrN2O2] ([M-Cl]+): 484.2176; Found: 484.2162. LRMS (LIFDI): 
Calculated for [C28H3635ClCrN2O2] ([M]+): 519.19; Found: 519.20. [α]D + 425 (c = 
0.034, THF) 
(R,R)-N,N′-Bis(5-methoxy-salicylidene-1,2-cyclohexanediaminochromium(III) 
chloride (4g): 
Synthesis was carried out following the procedure for (R,R)-
N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino-
chromium(III) chloride (4a). (R,R)-N,N′-bis(5-methoxy-
salicylidene)-1,2-cyclohexanediamine (0.25 g, 0.65 mmol) was 
dissolved in dry, degassed THF (5 mL). Chromium(II) chloride 
(88 mg, 0.72 mmol) was suspended in dry, degassed THF (15 
mL) and then added to the (R,R)-N,N′-bis(5-methoxy-
salicylidene)-1,2-cyclohexanediamine solution. The yellow 
solution rapidly turned brown. The solution was stirred under N2 for 4 h, and 
under air for 18 h. The solution was diluted with methyl tert-butyl ether (20 mL) 
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and washed with saturated NH4Cl (aq) (3 x 50 mL) and brine (3 x 50 mL). The 
organic phase was dried (Na2SO4) and solvent removed in vacuo to yield a 
brown solid. The solid was used without further purification. Yield: 0.24 g, 78 %. 
M.P: > 290 °C. FT-IR (ATR): υ [cm-1] 2933 (m), 1630 (m), 1543 (m), 1475 (s), 
1158 (s), 1030 (s), 817 (s), 783 (m). LRMS (LIFDI): Calculated for 
[C22H2435ClCrN2O4] ([M]+): 467.08; Found: 467.08. [α]D -266 (c = 0.048, THF) 
(R,R)-N,N′-Bis(3-tert-butyl-5-methoxy-salicylidene-1,2-
cyclohexanediaminochromium(III) chloride (4h): 
 
Synthesis was carried out following the procedure for 
(R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) chloride (4a). (R,R)-
N,N′-bis(5-methoxy-3-tert-butyl-salicylidene)-1,2-
cyclohexanediamine (0.67 g, 1.35 mmol) was dissolved in 
dry, degassed THF (15 mL). Chromium(II) chloride (0.18 
g, 1.49 mmol) was suspended in dry, degassed THF (15 
mL) and then added to the (R,R)-N,N′-bis(3-tert-butyl-5-
methoxy-salicylidene)-1,2-cyclohexanediamine solution. The yellow solution 
rapidly turned brown. The solution was stirred under N2 for 4 h, and under air 
for 18 h. The solution was diluted with methyl tert-butyl ether (15 mL) and 
washed with saturated NH4Cl (aq) (3 x 20 mL) and brine (3 x 20 mL). The 
organic phase was dried (Na2SO4) and solvent removed in vacuo to yield a 
brown solid. The solid was used without further purification. Yield: 0.48 g, 61 %. 
M.P: > 230 °C. FT-IR (ATR): υ [cm-1] 2939 (m), 1864 (w), 1622 (s), 1543 (m), 
1416 (s), 1315 (s), 1209 (s), 1064 (s), 823 (s), 800 (s). HRMS (ESI): Calculated 
for [C30H40CrN2O4] ([M-Cl]+): 544.2388; Found: 544.2381. LRMS (LIFDI): 
Calculated for [C30H4035ClCrN2O4] ([M]+): 579.21; Found: 579.21. [α]D -948 (c = 
0.056, THF) 
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(R,R)-N,N′-Bis(5-bromo-salicylidene-1,2-cyclohexanediaminochromium(III) 
chloride (4i): 
Synthesis was carried out following the procedure for (R,R)-
N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino-
chromium(III) chloride (4a). A dry round-bottomed flask was 
charged with (R,R)-N,N′-bis(5-bromo-salicylidene)-1,2-
cyclohexanediamine (0.20 g, 0.42 mmol) and chromium(II) 
chloride (56 mg, 0.45 mmol). Dry, degassed THF (10 mL) was 
syringed in to form a brown solution. The solution was stirred 
under N2 for 4 h, and under air for 18 h. The resulting yellow-
brown precipitate was filtered off and used without further purification. Yield: 
0.12 g, 49 %. M.P: > 290 °C. FT-IR (ATR): υ [cm-1] 2933 (m), 2867 (w), 1622 
(m), 1460 (m), 1176 (s), 812 (s), 652 (s). LRMS (LIFDI): Calculated for 
[C20H1879Br81BrCrN2O2] ([M-Cl]+): 529.91; Found: 529.93. [α]D -121 (c = 0.025, 
EtOH) 
(R,R)-N,N′-Bis(5-bromo-3-tert-butyl-salicylidene-1,2-
cyclohexanediaminochromium(III) chloride (4j): 
Synthesis was carried out following the procedure for 
(R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) chloride (4a). A dry 
round-bottomed flask was charged with (R,R)-N,N′-bis(3-
tert-butyl-5-bromo-salicylidene)-1,2-cyclohexanediamine 
(0.15 g, 0.25 mmol) and chromium(II) chloride (34 mg, 
0.28 mmol). Dry, degassed THF (10 mL) was syringed in 
to form a brown solution. The solution was stirred under 
N2 for 4 h, and under air for 18 h. The solution was washed with saturated 
NH4Cl (aq) (10 mL), dried (Na2SO4) and solvent removed in vacuo to yield a 
brown solid. The solid was used without further purification. Yield: 0.17 g, 99 %. 
M.P: > 290 °C. FT-IR (ATR): υ [cm-1] 2943 (m), 2864 (w), 1620 (s), 1428 (m), 
1316 (s), 1165 (s), 734 (s). LRMS (LIFDI): Calculated for 
[C28H3479Br81Br35ClCrN2O2] ([M]+): 677.01; Found: 677.02. [α]D -429 (c = 0.047, 
EtOH) 
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(R,R)-N,N′-Bis(3-tert-butyl-salicylidene-1,2-diphenyl-1,2-
ethanediaminochromium(III) chloride (4k): 
 
Synthesis was carried out following the procedure for 
(R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminochromium(III) chloride (4a). A dry 
round-bottomed flask was charged with (R,R)-N,N′-bis(3-
tert-butyl-salicylidene-1,2-diphenyl-1,2-ethanediamine 
(0.23 g, 0.47 mmol) and chromium(II) chloride (63 mg, 
0.51 mmol). Dry, degassed THF (15 mL) was syringed in to form a brown 
solution. The solution was stirred under N2 for 3 h, and under air for 18 h. The 
solution was washed with saturated NH4Cl (aq) (10 mL), dried (Na2SO4) and 
solvent removed in vacuo to yield a brown solid. The solid was used without 
further purification. Yield: 0.28 g, 97 %. M.P: > 290 °C. FT-IR (ATR): υ [cm-1] 
2955 (m), 1655 (s), 1595 (s), 1544(s), 1421 (s), 1322 (s), 815 (s), 717 (s). 
HRMS (ESI): Calculated for [C36H38CrN2O2] ([M-Cl]+): 582.2333; Found: 
582.2324. LRMS (LIFDI): Calculated for [C36H3835ClCrN2O2] ([M]+): 617.20; 
Found: 617.22. [α]D -360 (c = 0.041, EtOH) 
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5.6. Preparation of N-(2,3-Epoxypropyl)diphenylamine 
Synthesis was carried out according to a modified literature 
procedure.94 A suspension of K2CO3 (5.18 g, 37.5 mmol) and 
diphenylamine (4.23 g, 25.0 mmol) in epichlorohydrin (20.2 mL, 250 mmol) was 
stirred for 20 minutes at r.t. Powdered KOH (35.05 g, 625 mmol) was added 
slowly. The suspension was stirred at r.t. for 3 days. Reaction progress was 
monitored by TLC using petroleum ether/chloroform (1:1). The mixture was 
quenched with water (250 mL), and extracted with Et2O (250 mL). The solvent 
was removed in vacuo. The crude product was purified by distillation under 
vacuum (160 °C) to yield a pale yellow oil, Rf (petroleum ether/chloroform 1:1) 
0.20. Yield: 4.96 g, 78 %. 1H NMR (400 MHz, CDCl3) δ: 7.33 – 7.20 (m, 5H), 
7.08 – 6.91 (m, 5H), 3.91 (dq, J = 15.5, 3.8 Hz, 2H), 3.26 – 3.19 (m, 1H), 2.78 
(t, J = 4.3 Hz, 1H), 2.56 (dd, J = 5.2 Hz, 5.1 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ: 148.0, 129.5, 121.8, 121.1, 53.9,m 50.5, 46.1. FT-IR (ATR): υ [cm-1] = 
1591 (s), 1494 (s), 1364 (m), 1254 (m), 1230 (m), 749 (s), 695 (m). HRMS 
(ESI): Calculated for [C15H16NO] ([M+H]+): 226.1226; Found: 226.1223. 
 
  
 74 
5.7. General procedure for the conversion of epoxides to cyclic carbonates  
Setup. Kinetic experiments were performed anhydrously in oven-dried 25 mL 
Schlenk vessels.  The Schlenk vessels were charged with 12 mm stirrer bars, 
then evacuated and refilled with CO2 before charging with catalyst and co-
catalyst. 99.9 % purity liquid CO2 was obtained from BOC Industrial Gases UK 
and used without purification. The vessels were evacuated and refilled thrice. 
Solvent was added and the setup was allowed to equilibrate thermally in a 
water bath for at least 15 minutes, after which epoxide was added via syringe. 
Stirring was carried out at 500 rpm. Samples were removed at regular intervals 
and passed through a silica plug using ispropanol as the eluent prior to chiral 
HPLC analysis to determine the enantiomeric excess of the cyclic carbonate.  
If anhydrous conditions were not necessary the kinetic experiments were 
carried out in glass mixing vessels charged with 12 mm stirrer bars. These 
vessels were 28 mL, O.D. 28 mm borosilicate vials. The reagents were added 
in the following order: catalyst, co-catalyst, then solvent. The resultant mixture 
was allowed to equilibrate thermally in a water bath for at least 15 minutes, after 
which epoxide (1.66 mmol) was added. The glass vessel was sealed with a 
rubber septum. Carbon dioxide was obtained by evaporation of Cardice pellets 
without drying of the resulting gas. The rubber septum was pierced with a 
balloon containing the carbon dioxide, and with a separate vent needle to 
facilitate flushing. The vent needle was removed after 15 seconds. Stirring was 
carried out at 500 rpm. Samples were removed at regular intervals and passed 
through a silica plug using ispropanol as the eluent prior to chiral HPLC analysis 
to determine the enantiomeric excess of the cyclic carbonate. 
Materials. Commercially available substrates and co-catalysts were purchased 
from Aldrich, Fluka, Acros, and Alfa Aesar. They were used as received with the 
following exceptions: Tetrabutylammonium chloride, which was dried in vacuo 
prior to use to remove water. 
Instrumentation. The conversion of epoxides to carbonates was obtained by 
1H NMR (400 MHz, CDCl3), with the exception of (phenoxymethyl)ethylene 
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carbonate and 4-(N,N-diphenylaminomethyl)-1,3-dioxolan-2-one which were 
determined by HPLC on an Agilent 1220. 
5.7.1. Preparation of propylene carbonate 
Propylene oxide was removed in vacuo. Propylene carbonate was 
isolated as a colourless oil by flash chromatography using hexane/ 
EtOAc (4:1) as eluent. Rf (hexane/EtOAc 4:1) 0.15. 1H NMR (400 
MHz, CDCl3) δ: 4.82 (m, 1H), 4.52 (t, J = 8.4 Hz, 1H), 3.99 (dd, J = 8.4, 7.3, 
1H), 1.45 (d, J = 6.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ: 155.11, 73.65, 
70.66, 19.24. 
(R)-propylene carbonate: [α]D +2.435 ° (neat) (lit. +2 °)95 
5.7.2. Preparation of butylene carbonate 
 
Butylene carbonate was isolated as a colourless oil by flash 
chromatography using hexane/EtOAc (3:1) as eluent. Rf 
(hexane/EtOAc 3:1) 0.24. 1H NMR (400 MHz, CDCl3) δ: 4.69 (m, 
1H), 4.55 (t, J = 8.8 Hz, 1H), 4.11 (dd, J = 8.4, 7.4 Hz, 1H), 1.91 - 1.67 (m, 2H), 
1.10 - 0.90 (m, 3H). 13C NMR (101 MHz, CDCl3) δ: 155.2, 69.1, 63.9, 27.0, 
14.4, 8.6. 
5.7.3. Preparation of hexylene carbonate 
Hexylene carbonate was isolated as a colourless oil by flash 
chromatography using hexane/EtOAc (3:1) as eluent. Rf 
(hexane/EtOAc 3:1) 0.24. 1H NMR (400 MHz, CDCl3) δ: 4.69 (m, 
1H), 4.51 (t, J = 7.9 Hz, 1H), 4.04 (dd, J = 8.4, 7.2 Hz, 1H), 2.0 - 1.6 
(m, 2H), 1.6 - 1.2 (m, 4H), 1.00 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ: 155.2, 69.4, 33.5, 26.4, 22.2, 13.8. 
5.7.4. Preparation of styrene carbonate 
Styrene carbonate was isolated as a colourless solid by flash 
chromatography using hexane/EtOAc (4:1) as eluent. Rf 
(hexane/EtOAc 4:1) 0.21. 1H NMR (400 MHz, CDCl3) δ: 7.48 - 7.20 
(m, 5H), 5.66 (t, J = 7.8 Hz, 1H), 4.78 (t, J = 8.6 Hz, 1H), 4.33 (dd, J = 9.0, 8.0 
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Hz, 1H). 13C NMR (101 MHz, CDCl3) δ: 154.9, 135.8, 129.8, 129.3, 125.9, 78.1, 
71.2, 31.0. 
The % ee of styrene carbonate was obtained by chiral HPLC on an Agilent 
1220. The following HPLC column was used: Chiralcel OD (25 cm by 4.6 mm), 
using hexane/isopropanol (80:20 %v/v) as eluent and a flow rate of 1.00 
mL/min. tR[SC] = 16.1 min, 18.2 min. Detection wavelength: 216 nm. % ee values 
were accurate for a racemic sample with concentration greater than 300 ppm. 
 
Figure 28: HPLC trace of a racemic sample of styrene carbonate. 
 
 
Figure 29: HPLC trace of a sample of styrene carbonate with 5 % ee in favour of the second peak. 
5.7.5. Preparation of (phenoxymethyl)ethylene carbonate 
(Phenoxymethyl)ethylene carbonate was isolated as a colourless 
solid by flash chromatography using petroleum ether/EtOAc (3:2) 
as eluent. Rf (petroleum ether/EtOAc 3:2) 0.38. 1H NMR (400 
MHz, CDCl3) δ: 7.35 - 7.25 (m, 2H), 6.89 (d, J = 7.6 Hz, 2H), 6.70 (t, J = 7.6 Hz, 
1H), 5.00 – 5.05 (m, 1H),  4.65 - 4.50 (m, 2H), 4.25 – 4.20 (dd, J = 10.4, 4.5 Hz, 
1H), 4.20 - 4.10 (dd, J = 10.4, 3.5 Hz, 1H) 13C NMR (101 MHz, CDCl3) δ: 157.8, 
154.7, 129.8, 122.1, 114.7, 74.2, 66.9, 66.3.  
The conversion of phenyl glycidyl ether to (phenoxymethyl)ethylene carbonate 
was monitored by HPLC on an Agilent 1220. The following HPLC column was 
used: Chiralcel IA (25 cm by 4.6 mm), using hexane/isopropanol (85:15 %v/v) 
as eluent and a flow rate of 1.000 mL/min. tR[substrate] = 4.87 min, Rf = 923109, 
tR[carbonate] = 11.90 min, Rf = 901514. Detection wavelength: 216 nm. 
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Figure 30: HPLC trace of a sample containing phenyl glycidyl ether and (phenoxymethyl)ethylene 
carbonate. 
The % ee of phenyl glycidyl ether was obtained by chiral HPLC on an Agilent 
1220. The following HPLC column was used: Chiralcel IA (25 cm by 4.6 mm), 
using hexane/isopropanol (99.5:0.5 %v/v) as eluent and a flow rate of 0.60 
mL/min. tR[PGE] = 50.5 min, 56.3 min. Detection wavelength: 216 nm.  
 
Figure 31: HPLC trace of a sample of racemic phenyl glycidyl ether. 
 
 
Figure 32: HPLC trace of a sample of phenyl glycidyl ether with 7 % ee in favour of the second 
peak. 
 
The % ee of (phenoxymethyl)ethylene carbonate was obtained by chiral HPLC 
on an Agilent 1220. The following HPLC column was used: Chiralcel OD (25 cm 
by 4.6 mm), using hexane/isopropanol (80:20 %v/v) as eluent and a flow rate of 
1.00 mL/min. tR[PMEC] = 30.0 min, 41.0 min. Detection wavelength: 216 nm. % ee 
values were accurate for a racemic sample with concentration greater than 600 
ppm. 
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Figure 33: HPLC trace of a sample of racemic (phenoxymethyl)ethylene carbonate. 
 
 
Figure 34: HPLC trace of a sample of (phenoxymethyl)ethylene carbonate with 31 % ee in favour of 
the second peak. 
5.7.6. Preparation of 4-(N,N-diphenylaminomethyl)-1,3-dioxolan-2-one 
4-(N,N-Diphenylaminomethyl)-1,3-dioxolan-2-one was isolated 
as a colourless solid by flash chromatography using petroleum 
ether/EtOAc (2:1) as eluent. Rf (petroleum ether/EtOAc 2:1) 0.21. 
1H NMR (400 MHz, CDCl3) δ: 7.34 - 7.25 (m, 5H), 7.00 – 6.93 
(m, 5H), 5.00 – 4.90  (m, 1H), 4.45 (t, J = 8.1 Hz, 1H),  4.22 – 4.00 (m, 2H), 4.00 
– 3.95 (m, 1H). 13C NMR (101 MHz, CDCl3) δ: 154.3, 147.4, 129.8, 122.8, 
121.3, 74.5, 67.7, 54.5.  
The conversion of N-(2,3-epoxypropyl)diphenylamine to 4-(N,N-
diphenylaminomethyl)-1,3-dioxolan-2-one was monitored by HPLC on an 
Agilent 1220. The following HPLC column was used: Chiralcel IA (25 cm by 4.6 
mm), using hexane/isopropanol (88:12%v/v) as eluent and a flow rate of 1.000 
mL/min. tR[substrate] = 5.7 min, 6.9 min, Rf = 1325462, tR[carbonate] = 18.5 min, 21.3 
min, Rf = 1086901. Detection wavelength: 286 nm. 
 
Figure 35: HPLC trace of a sample containing N-(2,3-epoxypropyl)diphenylamine and 4-(N,N-
diphenylaminomethyl)-1,3-dioxolan-2-one. 
 
 79 
The % ee of 4-(N,N-diphenylaminomethyl)-1,3-dioxolan-2-one was obtained by 
chiral HPLC on an Agilent 1220. The following HPLC column was used: 
Chiralcel IA (25 cm by 4.6 mm), using hexane/EtOAc (88:12 %v/v) as eluent 
and a flow rate of 1.00 mL/min. tR[DPAC] = 18.5 min, 21.3 min. Detection 
wavelength: 286 nm.  
 
Figure 36: HPLC trace of a sample of racemic 4-(N,N-diphenylaminomethyl)-1,3-dioxolan-2-one. 
 
 
Figure 37: HPLC trace of a sample of 4-(N,N-diphenylaminomethyl)-1,3-dioxolan-2-one with 85 % ee 
in favour of the second peak. 
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6. Appendix A 
The following pages show the parameters for each experiment, as well as the 
corresponding graph for determining the order of reaction w.r.t. catalyst. Each 
kinetic run is done in duplicate. First-order rate dependence on catalyst is 
demonstrated by plotting the natural logarithm of epoxide concentration against 
time. The small but observable changes in gradient over the duration of the 
experiment may be explained by gradual solvent loss.  
6.1. Order with respect to aluminium(salen) complex 5b 
      
  
Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 2.5 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.8972 
 1 0.9901 
 2 0.9640 
 
   kobs: 0.0951 h-1 
      
 
      
  
Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 2.5 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9747 
 1 0.9458 
 2 0.8682 
 
   kobs: 0.0912 h-1 
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Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 3.0 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9931 
 1 0.9902 
 2 0.8769 
 
   kobs: 0.1134 h-1 
      
 
      
 
Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 3.0 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9809 
 1 0.9991 
 2 0.9888 
 
   kobs: 0.1312 h-1 
      
 
      
 
Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 4.0 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9946 
 1 0.9700 
 2 0.9108 
 
   kobs: 0.1565 h-1 
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Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 4.0 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9986 
 1 0.9889 
 2 0.8576 
 
   kobs: 0.1672 h-1 
      
 
      
 
Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 5.0 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9960 
 1 0.9815 
 2 0.9522 
 
   kobs: 0.2184 h-1 
      
 
      
 
Temperature: 75 oC 
Solvent: p-cymene 
 Solvent/substrate: 20 v/v 
5b: 5.0 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.9981 
 1 0.9710 
 2 0.8034 
 
   kobs: 0.1779 h-1 
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6.2. Order with respect to cobalt(salen) complex 3c 
      
  
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3c: 1.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8808 
 1 0.9836 
 2 0.6841 
 
   kobs: 0.7487 h-1 
      
 
      
  
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3c: 1.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8494 
 1 0.9907 
 2 0.7181 
 
   kobs: 0.8018 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3c: 2.5 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.7899 
 1 0.9978 
 2 0.7104 
 
   kobs: 1.3854 h-1 
      
 
y = -0.7487x - 0.8726
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Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3c: 2.5 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.7363 
 1 0.9978 
 2 0.6810 
 
   kobs: 1.4216 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3c: 5.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.7961 
 1 0.9981 
 2 0.8423 
 
   kobs: 0.7564 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3c: 5.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.7710 
 1 0.9966 
 2 0.8126 
 
   kobs: 0.7824 h-1 
      
 
  
y = -1.4216x - 0.9166
R² = 0.9978
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6.3. Order with respect to cobalt(salen) complex 3d in slight excess of 
TBAB 
      
  
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 1.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.9285 
 1 0.9987 
 2 0.9309 
 
   kobs: 0.2784 h-1 
      
 
      
  
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 1.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.9263 
 1 0.9982 
 2 0.9541 
 
   kobs: 0.2461 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8004 
 1 0.9924 
 2 0.3694 
 
   kobs: 0.8160 h-1 
      
y = -0.2784x - 1.0767
R² = 0.9987
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Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8624 
 1 0.9836 
 2 0.6730 
 
   kobs: 0.8909 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 5.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8337 
 1 0.9905 
 2 0.7412 
 
   kobs: 0.7992 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 5.0 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8069 
 1 0.9848 
 2 0.6248 
 
   kobs: 0.9150 h-1 
      
y = -0.8909x - 0.954
R² = 0.9836
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6.4. Order with respect to TBAB 
 
    
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.8928 
 1 0.9801 
 2 0.9923 
 
   kobs: 0.2226 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 2.5 mol % 
   Order R2 
 0 0.8560 
 1 0.9971 
 2 0.9658 
 
   kobs: 0.2272 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 5.0 mol % 
   Order R2 
 0 0.8642 
 1 0.9959 
 2 0.8491 
 
   kobs: 0.4042 h-1 
      
 
y = -0.2226x - 1.1507
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Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 5.0 mol % 
   Order R2 
 0 0.8607 
 1 0.9967 
 2 0.8537 
 
   kobs: 0.4299 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8624 
 1 0.9836 
 2 0.6730 
 
   kobs: 0.8909 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 10.0 mol % 
   Order R2 
 0 0.8004 
 1 0.9924 
 2 0.3694 
 
   kobs: 0.8160 h-1 
      
 
  
y = -0.4299x - 1.103
R² = 0.9967
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Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 15.0 mol % 
   Order R2 
 0 0.8604 
 1 0.9667 
 2 0.5713 
 
   kobs: 1.1096 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 15.0 mol % 
   Order R2 
 0 0.8350 
 1 0.9830 
 2 0.5434 
 
   kobs: 1.1970 h-1 
      
  
y = -1.1096x - 0.7516
R² = 0.9667
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6.5. Combined order with respect to cobalt(salen) complex 3d and TBAB 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 15.0 mol % 
   Order R2 
 0 0.8604 
 1 0.9667 
 2 0.5713 
 
   kobs: 1.1096 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 2.5 mol % 
TBAB: 15.0 mol % 
   Order R2 
 0 0.8350 
 1 0.9830 
 2 0.5434 
 
   kobs: 1.1970 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 3.3 mol % 
TBAB: 20.0 mol % 
   Order R2 
 0 0.1223 
 1 0.9743 
 2 0.6449 
 
   kobs: 1.7002 h-1 
      
 
y = -1.1096x - 0.7516
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Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 3.3 mol % 
TBAB: 20.0 mol % 
   Order R2 
 0 0.8841 
 1 0.9550 
 2 0.5176 
 
   kobs: 1.6863 h-1 
      
 
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 5.0 mol % 
TBAB: 30.0 mol % 
   Order R2 
 0 0.9161 
 1 0.9573 
 2 0.5801 
 
   kobs: 2.7252 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
3d: 5.0 mol % 
TBAB: 30.0 mol % 
   Order R2 
 0 0.9215 
 1 0.9549 
 2 0.5727 
 
   kobs: 2.4493 h-1 
      
 
y = -1.6863x - 0.5283
R² = 0.955
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6.6. Order with respect to cobalt(salen) complex 3d in large excess of 
TBAB 
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 2.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9337 
 1 0.9647 
 2 0.6314 
 
   kobs: 1.1542 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 2.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9342 
 1 0.9647 
 2 0.6191 
 
   kobs: 1.1459 h-1 
      
  
y = -1.1542x - 0.7016
R² = 0.9647
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Temperature: 25 oC 
   
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 3.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.8676 
 1 0.9755 
 2 0.7296 
 
   kobs: 1.5079 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 3.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9110 
 1 0.9530 
 2 0.6044 
 
   kobs: 1.6616 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 4.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9378 
 1 0.9566 
 2 0.6078 
 
   kobs: 2.0653 h-1 
      
y = -1.5079x - 0.9656
R² = 0.9755
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Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 4.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9026 
 1 0.9393 
 2 0.4948 
 
   kobs: 2.0479 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 5.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9161 
 1 0.9573 
 2 0.5801 
 
   kobs: 2.7252 h-1 
      
 
      
 
Temperature: 25 oC 
Solvent: EtOAc 
 Solvent/substrate: 20 v/v 
5b: 5.0 mol % 
TBAB: 30.0 mol % 
 
  
Order R2 
 0 0.9215 
 1 0.9549 
 2 0.5727 
 
   kobs: 2.4493 h-1 
      
 
 
y = -2.0479x - 0.7556
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7. Appendix B 
7.1. Acquisition of X-ray data  
Diffraction data were collected at 110 K on an Oxford Diffraction SuperNova 
diffractometer with Cu-K radiation ( = 1.54184 Å) using an EOS CCD camera. 
The crystal was cooled with an Oxford Instruments Cryojet. Diffractometer 
control, data collection, initial unit cell determination, frame integration and unit-
cell refinement was carried out with CrysAlisPro.a Face-indexed absorption 
corrections were applied using spherical harmonics, implemented in SCALE3 
ABSPACK scaling algorithm.b OLEX2c was used for overall structure solution, 
refinement and preparation of computer graphics and publication data.  Within 
OLEX2, the direct methods algorithm was used for structure solution using 
SHELXS.d Refinement by full-matrix least-squares used the SHELXL-97 
algorithm within OLEX2.e All non-hydrogen atoms were refined anisotropically. 
Hydrogen atoms were placed using a “riding model” and included in the 
refinement at calculated positions. One tertiary butyl group showed disorder 
and was modelled with the terminal carbons in two positions with refined 
occupancies of 0.622:0.378(18). Corresponding atoms of the major and minor 
component were restrained to have similar C-C distances and, due to proximity, 
were restrained to have the same ADP. Atoms C66, C67, C66A and C67A were 
also restrained to be approximately isotropic. 
                                            
a CrysAlisPro, Oxford Diffraction Ltd. Version 1.171.34.40 
b Empirical absorption correction using spherical harmonics, implemented in SCALE3 
ABSPACK scaling algorithm within CrysAlisPro software, Oxford Diffraction Ltd. Version 
1.171.34.40 
c “Olex2” crystallography software, J. Appl. Cryst. 2009, 42, 339–341. 
d "SHELXS-97" - program for structure solution. G. M. Sheldrick, University of Göttingen, 
Göttingen, Germany, 1997. 
e "SHELXL-97" - program for the Refinement of Crystal Structures. G. M. Sheldrick, University 
of Göttingen, Göttingen, Germany, 1997. 
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7.2. Crystal data and structure refinement for complex 3d.  
Empirical formula  C36H52BrCoN2O2  
Formula weight  683.63  
Temperature/K  110.00(14)  
Crystal system  triclinic  
Space group  P1  
a/Å  10.7950(2)  
b/Å  12.6416(4)  
c/Å  14.6957(4)  
α/°  65.979(3)  
β/°  89.9734(19)  
γ/°  71.994(2)  
Volume/Å3  1723.82(9)  
Z  2  
ρcalcg/cm3  1.317  
μ/mm-1  5.502  
F(000)  720.0  
Crystal size/mm3  0.2554 × 0.1625 × 0.0289  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  8.01 to 142.31  
Index ranges  -9 ≤ h ≤ 13, -14 ≤ k ≤ 15, -17 ≤ l ≤ 17  
Reflections collected  11806  
Independent reflections  7887 [Rint = 0.0272, Rsigma = 0.0400]  
Data/restraints/parameters  7887/57/794  
Goodness-of-fit on F2  1.025  
Final R indexes [I>=2σ (I)]  R1 = 0.0325, wR2 = 0.0810  
Final R indexes [all data]  R1 = 0.0373, wR2 = 0.0845  
Largest diff. peak/hole / e Å-3  0.48/-0.47  
Flack parameter -0.017(5) 
  
Structure solved by Natalie Pridmore 
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7.3. Fractional Atomic Coordinates (×104) and Equivalent Isotropic 
Displacement Parameters (Å2×103) for 3d.  
Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
 
Atom x y z U(eq) 
Br1 7619.5(6) 3800.4(5) 9785.1(4) 22.42(14) 
C1 4439(4) 6261(4) 7480(3) 12.8(8) 
C2 4273(5) 6004(5) 6584(4) 19.6(12) 
C3 4362(5) 7072(5) 5631(3) 19.5(10) 
C4 5644(5) 7331(5) 5706(4) 19.5(10) 
C5 5793(5) 7587(5) 6619(4) 17.5(12) 
C6 5734(4) 6509(4) 7556(3) 15.6(9) 
C7 3824(5) 4534(5) 8587(4) 13.5(10) 
C8 3732(5) 3587(5) 9508(4) 15.9(11) 
C9 3006(5) 2841(5) 9449(4) 16.2(11) 
C10 2866(5) 1908(5) 10302(4) 15.2(11) 
C11 3517(5) 1705(5) 11237(4) 17.1(11) 
C12 4226(5) 2389(5) 11348(4) 15.1(11) 
C13 4275(5) 3419(5) 10453(4) 14.1(11) 
C14 2137(5) 1053(5) 10282(4) 22.0(12) 
C15 3181(6) -216(5) 10505(6) 47.1(19) 
C16 1374(6) 1518(6) 9242(5) 28.0(13) 
C17 1167(8) 969(8) 11030(5) 54(2) 
C18 4956(5) 2078(5) 12372(4) 17.7(11) 
C19 4927(6) 848(5) 13192(5) 23.0(13) 
C20 4304(6) 3103(5) 12713(5) 23.2(12) 
C21 6406(6) 1940(6) 12298(5) 25.9(13) 
C22 6260(5) 7394(5) 8636(4) 15.6(11) 
C23 6404(5) 7505(5) 9550(4) 15.0(11) 
C24 6913(5) 8428(5) 9527(4) 17.3(12) 
C25 7050(5) 8633(5) 10358(4) 14.8(11) 
C26 6651(5) 7905(5) 11234(4) 15.7(11) 
C27 6125(5) 7001(5) 11319(4) 14.7(11) 
C28 6023(5) 6770(5) 10450(4) 15.4(11) 
C29 7539(5) 9677(5) 10315(4) 15.4(11) 
C30 8104(6) 9453(5) 11353(4) 35.5(14) 
C31 6366(6) 10883(5) 9887(5) 30.2(15) 
C32 8604(6) 9831(5) 9636(5) 28.0(14) 
C33 5752(5) 6219(5) 12311(4) 16.7(12) 
C34 6682(6) 4871(5) 12697(4) 20.5(12) 
C35 4310(6) 6294(6) 12168(5) 20.5(12) 
C36 5862(6) 6673(6) 13128(4) 22.4(13) 
Co1 5412.7(8) 5313.8(7) 9561.2(6) 12.90(18) 
N1 4466(4) 5284(4) 8485(3) 12.2(9) 
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N2 5835(4) 6581(4) 8532(3) 12.8(9) 
O1 4798(4) 4189(3) 10548(3) 15.8(8) 
O2 5546(4) 5911(3) 10494(3) 16.0(8) 
Br2 8323.1(5) 9044.7(5) 7051.2(4) 21.61(14) 
C37 10852(5) 5994(4) 9307(3) 16.2(9) 
C38 10196(6) 5344(5) 10185(4) 22.4(13) 
C39 10925(5) 5166(5) 11158(4) 25.8(11) 
C40 11032(5) 6349(5) 11119(3) 22.8(10) 
C41 11631(5) 7020(5) 10205(4) 16.4(11) 
C42 10860(5) 7194(4) 9256(3) 16.3(9) 
C43 9820(5) 5465(5) 8187(4) 16.6(12) 
C44 9507(5) 5427(5) 7252(4) 15.7(11) 
C45 8967(5) 4523(5) 7291(4) 14.5(11) 
C46 8814(5) 4306(5) 6471(4) 15.1(11) 
C47 9215(5) 5022(5) 5573(4) 15.7(11) 
C48 9729(5) 5937(5) 5479(4) 14.9(11) 
C49 9872(5) 6157(5) 6346(4) 16.0(11) 
C50 8331(6) 3274(5) 6513(5) 19.4(12) 
C51 7321(6) 3728(5) 5576(4) 32.7(14) 
C52 7661(6) 2818(6) 7442(5) 29.8(14) 
C53 9509(6) 2202(6) 6567(6) 38.0(17) 
C54 10095(6) 6718(5) 4470(4) 17.5(12) 
C55 9938(6) 6280(6) 3662(5) 23.1(13) 
C56 11541(6) 6644(6) 4589(5) 21.4(13) 
C57 9169(6) 8056(5) 4107(5) 23.6(13) 
C58 11974(5) 8533(5) 8158(4) 16.1(11) 
C59 12217(5) 9351(5) 7229(4) 14.9(11) 
C60 12951(5) 10096(5) 7250(5) 17.4(11) 
C61 13084(5) 10999(5) 6395(5) 19.1(12) 
C62 12430(5) 11193(5) 5482(5) 19.6(12) 
C63 11698(5) 10508(5) 5388(4) 16.0(11) 
C64 11658(5) 9496(5) 6290(4) 14.4(11) 
C65 13873(5) 11826(4) 6388(3) 29.6(15) 
C66 13019(10) 13191(6) 5886(9) 47(3) 
C66A 12818(13) 13014(11) 6302(15) 47(3) 
C67 14965(9) 11605(12) 5750(8) 43(3) 
C67A 14684(15) 12159(18) 5522(10) 43(3) 
C68 14517(10) 11534(11) 7432(6) 23(2) 
C68A 14790(14) 11260(17) 7387(8) 23(2) 
C69 10900(5) 10846(5) 4382(4) 18.2(12) 
C70 9446(5) 11019(6) 4508(5) 24.7(13) 
C71 11447(6) 9851(5) 4022(4) 21.0(12) 
C72 10933(6) 12070(6) 3550(5) 27.1(14) 
Co2 10570.2(8) 7578.9(8) 7237.0(6) 12.77(18) 
N3 10335(4) 6202(4) 8299(3) 16.9(10) 
N4 11272(4) 7833(4) 8272(3) 15.0(9) 
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O3 10378(4) 7008(4) 6294(3) 17.8(8) 
O4 11122(4) 8716(3) 6236(3) 15.1(8) 
  
7.4. Anisotropic Displacement Parameters (Å2×103) for 3d.  
The Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+2hka*b*U12+…]. 
 
Atom U11 U22 U33 U23 U13 U12 
Br1 17.7(3) 24.2(3) 21.4(3) -6.6(2) 6.7(2) -6.4(2) 
C1 9(2) 15(2) 16(2) -7.0(17) 4.0(16) -4.2(16) 
C2 17(3) 27(3) 19(3) -13(2) 4(2) -10(2) 
C3 15(2) 31(3) 12(2) -9(2) 2.0(17) -7(2) 
C4 17(2) 27(3) 16(2) -9(2) 5.3(19) -10(2) 
C5 15(3) 21(3) 20(3) -9(2) 8(2) -11(2) 
C6 12(2) 22(2) 18(2) -11.9(19) 5.9(18) -8.1(18) 
C7 13(2) 16(2) 14(2) -8.4(19) -3.2(18) -6.2(18) 
C8 12(2) 16(2) 23(3) -11(2) 5(2) -5(2) 
C9 14(2) 19(3) 16(3) -9(2) 1.0(19) -5(2) 
C10 8(2) 18(2) 22(3) -11(2) 0.9(19) -4.8(19) 
C11 16(3) 16(3) 18(3) -5(2) 7(2) -7(2) 
C12 14(2) 17(2) 15(3) -9(2) 0.4(19) -3(2) 
C13 12(2) 16(2) 17(3) -8(2) 9(2) -7(2) 
C14 17(3) 25(3) 28(3) -10(2) 1(2) -13(2) 
C15 37(4) 19(3) 74(5) -11(3) -23(3) -8(3) 
C16 28(3) 31(3) 27(3) -8(3) -3(2) -19(3) 
C17 57(5) 97(6) 32(4) -25(4) 16(3) -64(5) 
C18 14(3) 21(3) 18(3) -6(2) 3(2) -10(2) 
C19 27(3) 23(3) 17(3) -4(2) -3(2) -11(2) 
C20 26(3) 30(3) 19(3) -13(2) 8(2) -13(2) 
C21 20(3) 31(3) 23(3) -7(3) 1(2) -10(2) 
C22 11(2) 21(3) 16(3) -7(2) 4(2) -10(2) 
C23 18(3) 16(2) 14(3) -6(2) 3(2) -11(2) 
C24 18(3) 21(3) 14(3) -5(2) 4(2) -12(2) 
C25 13(2) 14(2) 18(3) -7(2) 0(2) -6(2) 
C26 14(2) 21(3) 14(3) -8(2) 0(2) -7(2) 
C27 12(2) 19(3) 17(3) -10(2) 4.3(19) -6(2) 
C28 14(3) 19(3) 17(3) -9(2) 7(2) -9(2) 
C29 17(3) 14(2) 21(3) -10(2) 6(2) -9(2) 
C30 52(4) 35(3) 28(3) -10(2) -1(3) -30(3) 
C31 18(3) 20(3) 55(4) -18(3) 5(3) -6(2) 
C32 29(3) 29(3) 44(4) -25(3) 18(3) -20(2) 
C33 20(3) 19(3) 13(3) -8(2) 5(2) -8(2) 
C34 24(3) 22(3) 14(3) -5(2) 2(2) -9(2) 
C35 20(3) 26(3) 17(3) -7(2) 7(2) -13(2) 
C36 26(3) 35(3) 14(3) -12(2) 8(2) -18(2) 
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Co1 15.0(4) 16.2(4) 11.7(4) -7.0(3) 4.0(3) -9.3(3) 
N1 10.1(19) 15.3(19) 11(2) -5.2(16) 2.5(15) -5.1(15) 
N2 15(2) 13.0(19) 12(2) -4.7(17) 3.0(16) -6.9(16) 
O1 17.1(18) 18.6(19) 18(2) -9.0(16) 4.0(15) -13.3(15) 
O2 24(2) 19.9(19) 12.3(19) -9.3(16) 4.9(15) -14.2(16) 
Br2 16.0(3) 25.9(3) 21.6(3) -7.6(2) 4.9(2) -8.8(2) 
C37 18(2) 22(2) 11(2) -10.2(18) 3.9(18) -6.9(19) 
C38 32(3) 21(3) 13(3) -6(2) 4(2) -11(3) 
C39 27(3) 30(3) 14(2) -6(2) 4(2) -6(2) 
C40 25(3) 34(3) 13(2) -11(2) 5.1(19) -11(2) 
C41 19(3) 26(3) 9(2) -11(2) 2(2) -10(2) 
C42 15(2) 25(2) 11(2) -9.1(18) 2.2(17) -7.7(19) 
C43 22(3) 13(2) 13(3) -4(2) 7(2) -7(2) 
C44 12(2) 19(3) 16(3) -8(2) 3(2) -4(2) 
C45 14(3) 13(2) 16(3) -7(2) 4(2) -3(2) 
C46 10(2) 16(2) 20(3) -8(2) 2(2) -6(2) 
C47 14(2) 18(2) 18(3) -11(2) 2(2) -4(2) 
C48 14(2) 18(3) 13(3) -7(2) 3.0(19) -6(2) 
C49 17(3) 18(3) 14(3) -7(2) 2(2) -7(2) 
C50 19(3) 19(3) 23(3) -9(2) -2(2) -10(2) 
C51 40(3) 39(3) 27(3) -9(2) -1(3) -30(3) 
C52 32(3) 28(3) 37(4) -14(3) 8(3) -20(2) 
C53 30(3) 32(3) 66(5) -33(3) 8(3) -12(3) 
C54 20(3) 27(3) 11(3) -8(2) 4(2) -15(2) 
C55 27(3) 31(3) 21(3) -15(2) 8(2) -16(2) 
C56 23(3) 26(3) 19(3) -10(2) 7(2) -13(2) 
C57 27(3) 23(3) 16(3) -3(2) -1(2) -10(2) 
C58 13(2) 21(3) 17(3) -13(2) 6.2(19) -4.1(19) 
C59 12(2) 17(2) 18(3) -10(2) 5(2) -5(2) 
C60 10(2) 23(3) 25(3) -17(2) 1(2) -6(2) 
C61 12(2) 22(3) 26(3) -10(2) 5(2) -9(2) 
C62 14(3) 21(3) 25(3) -8(2) 4(2) -9(2) 
C63 10(2) 16(2) 22(3) -7(2) 6(2) -5(2) 
C64 8(2) 20(3) 19(3) -12(2) 2(2) -5(2) 
C65 30(3) 29(3) 31(3) -8(3) -7(3) -19(3) 
C66 51(4) 19(3) 60(6) 1(4) -19(4) -22(3) 
C66A 51(4) 19(3) 60(6) 1(4) -19(4) -22(3) 
C67 44(4) 51(6) 38(5) -3(4) 7(3) -44(4) 
C67A 44(4) 51(6) 38(5) -3(4) 7(3) -44(4) 
C68 19(5) 13(6) 43(4) -18(3) 4(3) -6(4) 
C68A 19(5) 13(6) 43(4) -18(3) 4(3) -6(4) 
C69 18(3) 20(3) 16(3) -4(2) 1(2) -11(2) 
C70 15(3) 33(3) 25(3) -9(3) -2(2) -11(2) 
C71 28(3) 22(3) 16(3) -5(2) 4(2) -17(2) 
C72 26(3) 27(3) 26(3) -4(3) 0(2) -16(2) 
Co2 15.0(4) 16.4(4) 11.0(4) -7.2(3) 3.5(3) -8.8(3) 
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N3 21(2) 20(2) 12(2) -10.2(18) 2.0(17) -5.3(18) 
N4 15(2) 16(2) 13(2) -7.2(16) 1.8(16) -3.6(16) 
O3 26(2) 18.9(19) 16(2) -8.9(16) 8.5(16) -15.7(16) 
O4 18.7(19) 19.4(18) 12.2(19) -8.1(15) 5.2(15) -11.1(15) 
  
7.5. Bond Lengths for 3d. 
Atom Atom Length/Å   Atom Atom Length/Å 
Br1 Co1 2.4727(9)   C37 C42 1.491(6) 
C1 C2 1.503(7)   C37 N3 1.473(6) 
C1 C6 1.538(6)   C38 C39 1.533(8) 
C1 N1 1.483(6)   C39 C40 1.513(7) 
C2 C3 1.528(7)   C40 C41 1.533(7) 
C3 C4 1.531(6)   C41 C42 1.524(6) 
C4 C5 1.522(7)   C42 N4 1.487(6) 
C5 C6 1.511(7)   C43 C44 1.437(8) 
C6 N2 1.480(6)   C43 N3 1.284(7) 
C7 C8 1.424(8)   C44 C45 1.417(7) 
C7 N1 1.302(7)   C44 C49 1.416(8) 
C8 C9 1.426(7)   C45 C46 1.361(8) 
C8 C13 1.414(8)   C46 C47 1.420(8) 
C9 C10 1.377(8)   C46 C50 1.528(7) 
C10 C11 1.431(8)   C47 C48 1.389(7) 
C10 C14 1.529(7)   C48 C49 1.428(8) 
C11 C12 1.373(8)   C48 C54 1.542(7) 
C12 C13 1.441(7)   C49 O3 1.325(6) 
C12 C18 1.539(8)   C50 C51 1.544(8) 
C13 O1 1.318(6)   C50 C52 1.528(8) 
C14 C15 1.552(8)   C50 C53 1.519(8) 
C14 C16 1.526(8)   C54 C55 1.528(8) 
C14 C17 1.513(8)   C54 C56 1.540(7) 
C18 C19 1.541(8)   C54 C57 1.538(8) 
C18 C20 1.547(8)   C58 C59 1.422(8) 
C18 C21 1.530(7)   C58 N4 1.295(7) 
C22 C23 1.420(8)   C59 C60 1.415(7) 
C22 N2 1.307(7)   C59 C64 1.423(8) 
C23 C24 1.424(7)   C60 C61 1.355(8) 
C23 C28 1.420(7)   C61 C62 1.408(8) 
C24 C25 1.366(8)   C61 C65 1.537(8) 
C25 C26 1.404(7)   C62 C63 1.383(7) 
C25 C29 1.545(7)   C63 C64 1.431(8) 
C26 C27 1.388(7)   C63 C69 1.539(8) 
C27 C28 1.432(8)   C64 O4 1.316(7) 
C27 C33 1.529(7)   C65 C66 1.533(5) 
C28 O2 1.318(6)   C65 C66A 1.535(5) 
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C29 C30 1.522(8)   C65 C67 1.535(5) 
C29 C31 1.533(7)   C65 C67A 1.534(5) 
C29 C32 1.528(7)   C65 C68 1.534(5) 
C33 C34 1.545(7)   C65 C68A 1.534(5) 
C33 C35 1.540(7)   C69 C70 1.538(7) 
C33 C36 1.546(8)   C69 C71 1.515(8) 
Co1 N1 1.903(4)   C69 C72 1.544(8) 
Co1 N2 1.882(4)   Co2 N3 1.895(5) 
Co1 O1 1.862(4)   Co2 N4 1.882(5) 
Co1 O2 1.839(4)   Co2 O3 1.842(4) 
Br2 Co2 2.4903(9)   Co2 O4 1.842(4) 
C37 C38 1.529(7)         
  
7.6. Bond Angles for 3d. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C2 C1 C6 111.3(4)   C37 C38 C39 108.0(5) 
N1 C1 C2 117.1(4)   C40 C39 C38 113.0(4) 
N1 C1 C6 104.7(3)   C39 C40 C41 113.1(4) 
C1 C2 C3 109.5(4)   C42 C41 C40 108.6(4) 
C2 C3 C4 112.1(4)   C37 C42 C41 111.3(4) 
C5 C4 C3 110.7(4)   N4 C42 C37 106.6(4) 
C6 C5 C4 109.3(4)   N4 C42 C41 117.8(4) 
C5 C6 C1 111.2(4)   N3 C43 C44 126.1(5) 
N2 C6 C1 104.7(4)   C45 C44 C43 117.5(5) 
N2 C6 C5 118.1(4)   C49 C44 C43 121.4(5) 
N1 C7 C8 126.2(5)   C49 C44 C45 120.7(5) 
C7 C8 C9 117.2(5)   C46 C45 C44 121.4(5) 
C13 C8 C7 122.2(5)   C45 C46 C47 117.4(5) 
C13 C8 C9 120.5(5)   C45 C46 C50 122.4(5) 
C10 C9 C8 121.1(5)   C47 C46 C50 120.0(5) 
C9 C10 C11 116.6(5)   C48 C47 C46 124.1(5) 
C9 C10 C14 123.3(5)   C47 C48 C49 117.6(5) 
C11 C10 C14 119.9(5)   C47 C48 C54 121.6(5) 
C12 C11 C10 125.3(5)   C49 C48 C54 120.8(5) 
C11 C12 C13 117.0(5)   C44 C49 C48 118.8(5) 
C11 C12 C18 122.3(5)   O3 C49 C44 121.6(5) 
C13 C12 C18 120.7(5)   O3 C49 C48 119.6(5) 
C8 C13 C12 119.1(5)   C46 C50 C51 110.6(5) 
O1 C13 C8 122.3(5)   C46 C50 C52 111.5(5) 
O1 C13 C12 118.6(5)   C52 C50 C51 107.6(5) 
C10 C14 C15 107.8(4)   C53 C50 C46 108.6(5) 
C16 C14 C10 111.5(5)   C53 C50 C51 110.3(5) 
C16 C14 C15 106.8(5)   C53 C50 C52 108.2(5) 
C17 C14 C10 110.2(5)   C55 C54 C48 112.0(5) 
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C17 C14 C15 112.5(6)   C55 C54 C56 106.7(5) 
C17 C14 C16 108.0(5)   C55 C54 C57 108.5(5) 
C12 C18 C19 111.8(5)   C56 C54 C48 111.1(5) 
C12 C18 C20 109.7(5)   C57 C54 C48 108.0(5) 
C19 C18 C20 108.2(5)   C57 C54 C56 110.4(5) 
C21 C18 C12 110.3(5)   N4 C58 C59 126.4(5) 
C21 C18 C19 106.7(5)   C58 C59 C64 121.4(5) 
C21 C18 C20 110.0(5)   C60 C59 C58 118.4(5) 
N2 C22 C23 124.9(5)   C60 C59 C64 120.0(5) 
C22 C23 C24 117.0(5)   C61 C60 C59 121.5(5) 
C22 C23 C28 122.6(5)   C60 C61 C62 117.4(5) 
C28 C23 C24 120.3(5)   C60 C61 C65 123.0(5) 
C25 C24 C23 121.5(5)   C62 C61 C65 119.6(5) 
C24 C25 C26 117.0(5)   C63 C62 C61 125.1(5) 
C24 C25 C29 121.3(5)   C62 C63 C64 116.6(5) 
C26 C25 C29 121.6(5)   C62 C63 C69 122.3(5) 
C27 C26 C25 125.3(5)   C64 C63 C69 121.0(5) 
C26 C27 C28 117.1(5)   C59 C64 C63 118.9(5) 
C26 C27 C33 122.0(5)   O4 C64 C59 121.5(5) 
C28 C27 C33 120.7(5)   O4 C64 C63 119.7(5) 
C23 C28 C27 118.7(5)   C66 C65 C61 111.5(6) 
O2 C28 C23 121.7(5)   C66 C65 C67 108.4(3) 
O2 C28 C27 119.5(5)   C66 C65 C68 108.5(3) 
C30 C29 C25 112.0(5)   C66A C65 C61 104.0(8) 
C30 C29 C31 108.7(5)   C67 C65 C61 105.5(6) 
C30 C29 C32 107.6(5)   C67A C65 C61 116.4(9) 
C31 C29 C25 108.2(4)   C67A C65 C66A 108.4(3) 
C32 C29 C25 112.1(5)   C67A C65 C68A 108.5(3) 
C32 C29 C31 108.2(5)   C68 C65 C61 114.4(6) 
C27 C33 C34 109.2(4)   C68 C65 C67 108.4(3) 
C27 C33 C35 110.7(5)   C68A C65 C61 110.8(9) 
C27 C33 C36 112.0(5)   C68A C65 C66A 108.4(3) 
C34 C33 C36 108.6(5)   C63 C69 C72 111.9(5) 
C35 C33 C34 110.3(5)   C70 C69 C63 110.0(5) 
C35 C33 C36 106.1(5)   C70 C69 C72 106.7(5) 
N1 Co1 Br1 103.27(13)   C71 C69 C63 110.4(5) 
N2 Co1 Br1 92.16(13)   C71 C69 C70 109.8(5) 
N2 Co1 N1 84.45(19)   C71 C69 C72 107.8(5) 
O1 Co1 Br1 94.43(12)   N3 Co2 Br2 96.16(14) 
O1 Co1 N1 93.42(18)   N4 Co2 Br2 94.35(13) 
O1 Co1 N2 173.38(17)   N4 Co2 N3 84.9(2) 
O2 Co1 Br1 104.60(13)   O3 Co2 Br2 102.56(13) 
O2 Co1 N1 152.10(18)   O3 Co2 N3 92.63(19) 
O2 Co1 N2 93.18(19)   O3 Co2 N4 163.08(19) 
O2 Co1 O1 85.77(17)   O3 Co2 O4 85.37(17) 
C1 N1 Co1 114.2(3)   O4 Co2 Br2 94.81(12) 
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C7 N1 C1 120.6(4)   O4 Co2 N3 169.02(18) 
C7 N1 Co1 125.1(4)   O4 Co2 N4 93.84(18) 
C6 N2 Co1 111.7(3)   C37 N3 Co2 113.9(3) 
C22 N2 C6 121.7(4)   C43 N3 C37 120.8(5) 
C22 N2 Co1 126.5(4)   C43 N3 Co2 125.2(4) 
C13 O1 Co1 128.0(4)   C42 N4 Co2 112.2(3) 
C28 O2 Co1 130.0(3)   C58 N4 C42 122.3(5) 
C42 C37 C38 112.2(4)   C58 N4 Co2 125.4(4) 
N3 C37 C38 116.8(4)   C49 O3 Co2 129.7(4) 
N3 C37 C42 108.0(4)   C64 O4 Co2 129.4(4) 
  
7.7. Torsion Angles for 3d. 
A B C D Angle/˚   A B C D Angle/˚ 
Br1 Co1 N2 C6 79.9(3)   C38 C37 C42 C41 61.3(5) 
Br1 Co1 N2 C22 -95.5(4)   C38 C37 C42 N4 -169.1(4) 
Br1 Co1 O1 C13 -85.0(4)   C38 C37 N3 C43 -29.4(7) 
Br1 Co1 O2 C28 81.7(5)   C38 C37 N3 Co2 152.8(4) 
C1 C2 C3 C4 55.5(6)   C38 C39 C40 C41 -53.4(6) 
C1 C6 N2 C22 -139.9(5)   C39 C40 C41 C42 53.1(6) 
C1 C6 N2 Co1 44.4(4)   C40 C41 C42 C37 -56.7(5) 
C2 C1 C6 C5 58.5(5)   C40 C41 C42 N4 179.8(4) 
C2 C1 C6 N2 -172.9(4)   C41 C42 N4 C58 -20.0(7) 
C2 C1 N1 C7 -29.7(6)   C41 C42 N4 Co2 163.6(3) 
C2 C1 N1 Co1 153.7(3)   C42 C37 C38 C39 -57.3(6) 
C2 C3 C4 C5 -56.6(6)   C42 C37 N3 C43 -157.0(5) 
C3 C4 C5 C6 56.8(5)   C42 C37 N3 Co2 25.3(5) 
C4 C5 C6 C1 -57.8(5)   C43 C44 C45 C46 -170.7(5) 
C4 C5 C6 N2 -178.9(4)   C43 C44 C49 C48 170.0(5) 
C5 C6 N2 C22 -15.6(7)   C43 C44 C49 O3 -8.0(8) 
C5 C6 N2 Co1 168.8(3)   C44 C43 N3 C37 -167.6(5) 
C6 C1 C2 C3 -55.7(5)   C44 C43 N3 Co2 9.9(8) 
C6 C1 N1 C7 -153.6(4)   C44 C45 C46 C47 -0.1(8) 
C6 C1 N1 Co1 29.8(4)   C44 C45 C46 C50 175.3(5) 
C7 C8 C9 C10 -179.9(5)   C44 C49 O3 Co2 -7.2(8) 
C7 C8 C13 C12 -175.7(5)   C45 C44 C49 C48 -2.1(8) 
C7 C8 C13 O1 6.0(8)   C45 C44 C49 O3 180.0(5) 
C8 C7 N1 C1 -177.7(5)   C45 C46 C47 C48 -1.2(8) 
C8 C7 N1 Co1 -1.5(8)   C45 C46 C50 C51 137.4(6) 
C8 C9 C10 C11 -2.0(8)   C45 C46 C50 C52 17.7(7) 
C8 C9 C10 C14 -178.0(5)   C45 C46 C50 C53 -101.4(6) 
C8 C13 O1 Co1 -20.0(7)   C46 C47 C48 C49 0.7(8) 
C9 C8 C13 C12 7.5(7)   C46 C47 C48 C54 -177.5(5) 
C9 C8 C13 O1 -170.8(5)   C47 C46 C50 C51 -47.4(7) 
C9 C10 C11 C12 2.3(8)   C47 C46 C50 C52 -167.1(5) 
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C9 C10 C14 C15 105.8(6)   C47 C46 C50 C53 73.8(7) 
C9 C10 C14 C16 -11.1(7)   C47 C48 C49 C44 0.9(8) 
C9 C10 C14 C17 -131.0(6)   C47 C48 C49 O3 178.9(5) 
C10 C11 C12 C13 2.3(8)   C47 C48 C54 C55 -5.0(7) 
C10 C11 C12 C18 -177.0(5)   C47 C48 C54 C56 -124.3(6) 
C11 C10 C14 C15 -70.1(7)   C47 C48 C54 C57 114.5(6) 
C11 C10 C14 C16 173.0(5)   C48 C49 O3 Co2 174.9(4) 
C11 C10 C14 C17 53.0(7)   C49 C44 C45 C46 1.7(8) 
C11 C12 C13 C8 -7.1(7)   C49 C48 C54 C55 176.8(5) 
C11 C12 C13 O1 171.3(5)   C49 C48 C54 C56 57.5(7) 
C11 C12 C18 C19 7.0(7)   C49 C48 C54 C57 -63.7(7) 
C11 C12 C18 C20 -113.1(6)   C50 C46 C47 C48 -176.7(5) 
C11 C12 C18 C21 125.6(6)   C54 C48 C49 C44 179.2(5) 
C12 C13 O1 Co1 161.7(4)   C54 C48 C49 O3 -2.8(8) 
C13 C8 C9 C10 -2.9(8)   C58 C59 C60 C61 -171.9(5) 
C13 C12 C18 C19 -172.2(5)   C58 C59 C64 C63 166.8(5) 
C13 C12 C18 C20 67.7(6)   C58 C59 C64 O4 -13.9(8) 
C13 C12 C18 C21 -53.7(7)   C59 C58 N4 C42 -167.8(5) 
C14 C10 C11 C12 178.4(5)   C59 C58 N4 Co2 8.1(8) 
C18 C12 C13 C8 172.2(5)   C59 C60 C61 C62 1.9(8) 
C18 C12 C13 O1 -9.4(7)   C59 C60 C61 C65 180.0(5) 
C22 C23 C24 C25 177.9(5)   C59 C64 O4 Co2 17.0(7) 
C22 C23 C28 C27 -176.0(5)   C60 C59 C64 C63 -8.4(7) 
C22 C23 C28 O2 2.1(9)   C60 C59 C64 O4 170.9(5) 
C23 C22 N2 C6 -178.8(5)   C60 C61 C62 C63 -2.3(9) 
C23 C22 N2 Co1 -3.9(8)   C60 C61 C65 C66 -122.7(7) 
C23 C24 C25 C26 -0.9(8)   C60 C61 C65 C66A -99.3(9) 
C23 C24 C25 C29 -177.0(5)   C60 C61 C65 C67 119.9(7) 
C23 C28 O2 Co1 7.5(8)   C60 C61 C65 C67A 141.6(9) 
C24 C23 C28 C27 1.7(8)   C60 C61 C65 C68 0.9(8) 
C24 C23 C28 O2 179.8(5)   C60 C61 C65 C68A 17.0(9) 
C24 C25 C26 C27 -0.3(8)   C61 C62 C63 C64 -2.7(8) 
C24 C25 C29 C30 -158.4(5)   C61 C62 C63 C69 174.0(5) 
C24 C25 C29 C31 81.8(6)   C62 C61 C65 C66 55.4(7) 
C24 C25 C29 C32 -37.4(7)   C62 C61 C65 C66A 78.8(9) 
C25 C26 C27 C28 2.1(8)   C62 C61 C65 C67 -62.0(7) 
C25 C26 C27 C33 178.1(5)   C62 C61 C65 C67A -40.4(10) 
C26 C25 C29 C30 25.6(7)   C62 C61 C65 C68 178.9(6) 
C26 C25 C29 C31 -94.1(6)   C62 C61 C65 C68A -164.9(8) 
C26 C25 C29 C32 146.6(5)   C62 C63 C64 C59 7.8(7) 
C26 C27 C28 C23 -2.7(8)   C62 C63 C64 O4 -171.5(5) 
C26 C27 C28 O2 179.2(5)   C62 C63 C69 C70 -123.2(6) 
C26 C27 C33 C34 -112.9(6)   C62 C63 C69 C71 115.4(6) 
C26 C27 C33 C35 125.5(6)   C62 C63 C69 C72 -4.8(7) 
C26 C27 C33 C36 7.4(7)   C63 C64 O4 Co2 -163.7(4) 
C27 C28 O2 Co1 -174.5(4)   C64 C59 C60 C61 3.4(8) 
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C28 C23 C24 C25 0.1(8)   C64 C63 C69 C70 53.3(7) 
C28 C27 C33 C34 63.0(7)   C64 C63 C69 C71 -68.1(6) 
C28 C27 C33 C35 -58.6(7)   C64 C63 C69 C72 171.8(5) 
C28 C27 C33 C36 -176.7(5)   C65 C61 C62 C63 179.5(5) 
C29 C25 C26 C27 175.9(5)   C69 C63 C64 C59 -168.9(5) 
C33 C27 C28 C23 -178.8(5)   C69 C63 C64 O4 11.8(8) 
C33 C27 C28 O2 3.1(8)   N3 C37 C38 C39 177.2(4) 
N1 C1 C2 C3 -176.2(4)   N3 C37 C42 C41 -168.6(4) 
N1 C1 C6 C5 -174.0(4)   N3 C37 C42 N4 -38.9(5) 
N1 C1 C6 N2 -45.4(4)   N3 C43 C44 C45 178.6(5) 
N1 C7 C8 C9 -178.2(5)   N3 C43 C44 C49 6.3(9) 
N1 C7 C8 C13 4.9(9)   N3 Co2 N4 C42 -19.8(3) 
N1 Co1 N2 C6 -23.2(3)   N3 Co2 N4 C58 164.0(4) 
N1 Co1 N2 C22 161.4(5)   N3 Co2 O3 C49 17.1(5) 
N1 Co1 O1 C13 18.6(4)   N3 Co2 O4 C64 -90.6(11) 
N1 Co1 O2 C28 -95.5(6)   N4 C58 C59 C60 176.5(5) 
N2 C22 C23 C24 178.5(5)   N4 C58 C59 C64 1.3(8) 
N2 C22 C23 C28 -3.8(9)   N4 Co2 N3 C37 -3.5(3) 
N2 Co1 O2 C28 -11.3(5)   N4 Co2 N3 C43 178.9(5) 
O1 Co1 O2 C28 175.2(5)   N4 Co2 O3 C49 98.4(7) 
O2 Co1 N2 C6 -175.3(3)   N4 Co2 O4 C64 -7.4(4) 
O2 Co1 N2 C22 9.3(5)   O3 Co2 N3 C37 159.8(3) 
O2 Co1 O1 C13 170.6(4)   O3 Co2 N3 C43 -17.9(5) 
Br2 Co2 N3 C37 -97.3(3)   O3 Co2 N4 C42 -102.1(6) 
Br2 Co2 N3 C43 85.0(4)   O3 Co2 N4 C58 81.6(7) 
Br2 Co2 N4 C42 76.1(3)   O3 Co2 O4 C64 -170.5(4) 
Br2 Co2 N4 C58 -100.2(4)   O4 Co2 N3 C37 80.6(10) 
Br2 Co2 O3 C49 -79.8(5)   O4 Co2 N3 C43 -97.1(10) 
Br2 Co2 O4 C64 87.3(4)   O4 Co2 N4 C42 171.2(3) 
C37 C38 C39 C40 53.1(6)   O4 Co2 N4 C58 -5.1(4) 
C37 C42 N4 C58 -145.8(4)   O4 Co2 O3 C49 -173.7(5) 
C37 C42 N4 Co2 37.8(4)             
  
7.8. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement 
Parameters (Å2×103) for 3d. 
Atom x y z U(eq) 
H1 3713 7006 7389 15 
H2A 3425 5904 6528 24 
H2B 4954 5247 6667 24 
H3A 3621 7806 5513 23 
H3B 4307 6880 5060 23 
H4A 6385 6627 5760 23 
H4B 5644 8036 5100 23 
H5A 6627 7711 6675 21 
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H5B 5092 8329 6543 21 
H6 6455 5780 7608 19 
H7 3382 4624 8002 16 
H9 2622 2988 8823 19 
H11 3455 1057 11816 20 
H15A 3775 -116 10015 71 
H15B 2750 -763 10473 71 
H15C 3665 -555 11165 71 
H16A 743 2323 9059 42 
H16B 925 965 9255 42 
H16C 1975 1557 8757 42 
H17A 1637 580 11700 80 
H17B 659 492 10967 80 
H17C 590 1781 10897 80 
H19A 4035 917 13304 35 
H19B 5444 655 13806 35 
H19C 5284 207 12977 35 
H20A 4275 3884 12197 35 
H20B 4807 2942 13322 35 
H20C 3424 3121 12831 35 
H21A 6802 1307 12081 39 
H21B 6855 1723 12946 39 
H21C 6472 2705 11821 39 
H22 6483 7941 8069 19 
H24 7157 8902 8931 21 
H26 6746 8038 11803 19 
H30A 7417 9477 11767 53 
H30B 8467 10080 11288 53 
H30C 8782 8661 11657 53 
H31A 6041 11066 9213 45 
H31B 6643 11539 9880 45 
H31C 5681 10801 10300 45 
H32A 9374 9107 9921 42 
H32B 8823 10533 9581 42 
H32C 8284 9950 8980 42 
H34A 6673 4597 12178 31 
H34B 6389 4360 13277 31 
H34C 7560 4820 12877 31 
H35A 3742 7131 11950 31 
H35B 4099 5786 12795 31 
H35C 4190 6011 11670 31 
H36A 6755 6621 13261 34 
H36B 5607 6169 13734 34 
H36C 5293 7512 12895 34 
H37 11775 5464 9443 19 
H38A 10241 4552 10213 27 
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H38B 9277 5836 10097 27 
H39A 10467 4830 11715 31 
H39B 11803 4574 11287 31 
H40A 11570 6165 11728 27 
H40B 10161 6892 11100 27 
H41A 11586 7813 10171 20 
H41B 12548 6540 10264 20 
H42 9945 7681 9230 20 
H43 9631 4904 8764 20 
H45 8713 4069 7889 17 
H47 9129 4869 5013 19 
H51A 6590 4415 5544 49 
H51B 7013 3074 5622 49 
H51C 7730 3976 4981 49 
H52A 8287 2474 8038 45 
H52B 7332 2200 7429 45 
H52C 6944 3495 7442 45 
H53A 9876 2439 5950 57 
H53B 9233 1514 6666 57 
H53C 10161 1973 7119 57 
H55A 10489 5436 3889 35 
H55B 10190 6778 3052 35 
H55C 9035 6351 3540 35 
H56A 11673 6952 5066 32 
H56B 11746 7130 3950 32 
H56C 12106 5803 4823 32 
H57A 8272 8086 4052 35 
H57B 9348 8552 3460 35 
H57C 9311 8367 4580 35 
H58 12356 8497 8742 19 
H60 13351 9964 7866 21 
H62 12495 11831 4898 24 
H66A 13525 13680 5926 70 
H66B 12266 13325 6226 70 
H66C 12732 13423 5193 70 
H66D 13230 13595 6281 70 
H66E 12355 12832 6873 70 
H66F 12209 13358 5696 70 
H67A 14578 11781 5094 64 
H67B 15533 10761 6071 64 
H67C 15467 12133 5687 64 
H67D 14105 12621 4893 64 
H67E 15290 11419 5525 64 
H67F 15164 12646 5607 64 
H68A 15049 10680 7758 34 
H68B 13845 11709 7829 34 
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H68C 15059 12031 7361 34 
H68D 15414 10483 7477 34 
H68E 14279 11139 7932 34 
H68F 15249 11804 7375 34 
H70A 9376 10261 4995 37 
H70B 8951 11250 3874 37 
H70C 9103 11652 4734 37 
H71A 12355 9747 3945 32 
H71B 10955 10085 3386 32 
H71C 11379 9091 4506 32 
H72A 10621 12711 3772 41 
H72B 10379 12277 2950 41 
H72C 11819 11983 3413 41 
  
7.9. Atomic Occupancy for 3d. 
Atom Occupancy   Atom Occupancy   Atom Occupancy 
C66 0.622(18)   H66A 0.622(18)   H66B 0.622(18) 
H66C 0.622(18)   C66A 0.378(18)   H66D 0.378(18) 
H66E 0.378(18)   H66F 0.378(18)   C67 0.622(18) 
H67A 0.622(18)   H67B 0.622(18)   H67C 0.622(18) 
C67A 0.378(18)   H67D 0.378(18)   H67E 0.378(18) 
H67F 0.378(18)   C68 0.622(18)   H68A 0.622(18) 
H68B 0.622(18)   H68C 0.622(18)   C68A 0.378(18) 
H68D 0.378(18)   H68E 0.378(18)   H68F 0.378(18) 
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Abbreviations 
HKR hydrolytic kinetic resolution 
scCO2 supercritical CO2 
w.r.t. With respect to 
TBAB tetrabutylammonium bromide 
TBAC tetrabutylammonium chloride 
TBAI tetrabutylammonium iodide 
DNP 2,4-dinitrophenoxide 
PPN+ bis(triphenylphosphine)iminium 
BMIOH 1-butyl-3-methylimidazolium hydroxide  
DMAP (4-dimethylamino)pyridine 
NMP N-methyl-2-pyrrolidone 
PO propylene oxide 
PC propylene carbonate 
SO styrene oxide 
SC styrene carbonate 
PGE phenyl glycidyl ether 
PMEC (phenoxymethyl)ethylene carbonate 
e.r. enantiomeric ratio 
ee enantiomeric excess 
g gram 
M molar 
mL millilitres 
mmol millimoles 
IR infrared 
MP melting point 
NMR nuclear magnetic resonance 
ppm parts per million 
Hz Hertz 
s (1H nuclear magnetic resonance) singlet 
d (1H nuclear magnetic resonance) doublet 
t (1H nuclear magnetic resonance) triplets 
m (1H nuclear magnetic resonance) multiplet 
br broad 
s (infrared spectra) strong 
m (infrared spectra) medium 
w (infrared spectra) weak 
MS mass spectrometry 
ESI electrospray ionisation 
GC gas chromatography 
HPLC high-performance liquid chromatography 
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